
<html lang="en"     class="pb-page"  data-request-id="698d0257-02b0-41e1-b30a-38b514e361bb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-1;website:website:acspubs;article:article:10.1021/jm201407j;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo" /></meta><meta name="dc.Creator" content="Zhong-Yue  Sun" /></meta><meta name="dc.Creator" content="Theodros  Asberom" /></meta><meta name="dc.Creator" content="Thomas  Bara" /></meta><meta name="dc.Creator" content="Chad  Bennett" /></meta><meta name="dc.Creator" content="Duane  Burnett" /></meta><meta name="dc.Creator" content="Inhou  Chu" /></meta><meta name="dc.Creator" content="John  Clader" /></meta><meta name="dc.Creator" content="Mary  Cohen-Williams" /></meta><meta name="dc.Creator" content="David  Cole" /></meta><meta name="dc.Creator" content="Michael  Czarniecki" /></meta><meta name="dc.Creator" content="James  Durkin" /></meta><meta name="dc.Creator" content="Gioconda  Gallo" /></meta><meta name="dc.Creator" content="William  Greenlee" /></meta><meta name="dc.Creator" content="Hubert  Josien" /></meta><meta name="dc.Creator" content="Xianhai  Huang" /></meta><meta name="dc.Creator" content="Lynn  Hyde" /></meta><meta name="dc.Creator" content="Nicholas  Jones" /></meta><meta name="dc.Creator" content="Irina  Kazakevich" /></meta><meta name="dc.Creator" content="Hongmei  Li" /></meta><meta name="dc.Creator" content="Xiaoxiang  Liu" /></meta><meta name="dc.Creator" content="Julie  Lee" /></meta><meta name="dc.Creator" content="Malcolm  MacCoss" /></meta><meta name="dc.Creator" content="Mihir B.  Mandal" /></meta><meta name="dc.Creator" content="Troy  McCracken" /></meta><meta name="dc.Creator" content="Amin  Nomeir" /></meta><meta name="dc.Creator" content="Robert  Mazzola" /></meta><meta name="dc.Creator" content="Anandan  Palani" /></meta><meta name="dc.Creator" content="Eric M.  Parker" /></meta><meta name="dc.Creator" content="Dmitri A.  Pissarnitski" /></meta><meta name="dc.Creator" content="Jun  Qin" /></meta><meta name="dc.Creator" content="Lixin  Song" /></meta><meta name="dc.Creator" content="Giuseppe  Terracina" /></meta><meta name="dc.Creator" content="Monica  Vicarel" /></meta><meta name="dc.Creator" content="Johannes  Voigt" /></meta><meta name="dc.Creator" content="Ruo  Xu" /></meta><meta name="dc.Creator" content="Lili  Zhang" /></meta><meta name="dc.Creator" content="Qi  Zhang" /></meta><meta name="dc.Creator" content="Zhiqiang  Zhao" /></meta><meta name="dc.Creator" content="Xiaohong  Zhu" /></meta><meta name="dc.Creator" content="Zhaoning  Zhu" /></meta><meta name="dc.Description" content="Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality. Compounds with these structural motifs were found to be metabolically stable and to possess ..." /></meta><meta name="Description" content="Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality. Compounds with these structural motifs were found to be metabolically stable and to possess ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 8, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201407j" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201407j" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201407j" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201407j" /></link>
        
    
    

<title>Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201407j" /></meta><meta property="og:title" content="Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0015.jpeg" /></meta><meta property="og:description" content="Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality. Compounds with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles. These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for reduction of central nervous system Aβ42 in various animal models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201407j"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201407j">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201407j&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201407j&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201407j&amp;href=/doi/10.1021/jm201407j" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 489-502</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2013979" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2014056" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo<a class="ref internalNav" href="#ded" aria-label=""></a></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhong-Yue++Sun">Zhong-Yue Sun</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Theodros++Asberom">Theodros Asberom</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Bara">Thomas Bara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chad++Bennett">Chad Bennett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Duane++Burnett">Duane Burnett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Inhou++Chu">Inhou Chu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Clader">John Clader</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary++Cohen-Williams">Mary Cohen-Williams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Cole">David Cole</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Czarniecki">Michael Czarniecki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Durkin">James Durkin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gioconda++Gallo">Gioconda Gallo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William++Greenlee">William Greenlee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hubert++Josien">Hubert Josien</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xianhai++Huang">Xianhai Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lynn++Hyde">Lynn Hyde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas++Jones">Nicholas Jones</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irina++Kazakevich">Irina Kazakevich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongmei++Li">Hongmei Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoxiang++Liu">Xiaoxiang Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Lee">Julie Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Malcolm++MacCoss">Malcolm MacCoss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mihir+B.++Mandal">Mihir B. Mandal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Troy++McCracken">Troy McCracken</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Amin++Nomeir">Amin Nomeir</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Mazzola">Robert Mazzola</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anandan++Palani">Anandan Palani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+M.++Parker">Eric M. Parker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dmitri+A.++Pissarnitski">Dmitri A. Pissarnitski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Qin">Jun Qin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lixin++Song">Lixin Song</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Terracina">Giuseppe Terracina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Vicarel">Monica Vicarel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johannes++Voigt">Johannes Voigt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruo++Xu">Ruo Xu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lili++Zhang">Lili Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Zhang">Qi Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhiqiang++Zhao">Zhiqiang Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaohong++Zhu">Xiaohong Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhaoning++Zhu">Zhaoning Zhu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>‡</sup>Department of Medicinal Chemistry, <sup>§</sup>Department of Neuroscience, <sup>∥</sup>Department of Structural Chemistry, <sup>⊥</sup>Department of Pharmaceutical Sciences, and <sup>#</sup>Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="corresp-info"><strong>*</strong>For Z.-Y.S.: phone, +1 917 657 6061; e-mail, <a href="/cdn-cgi/l/email-protection#9ac0c3c9cfd4acacaaababdae3fbf2f5f5b4f9f5f7"><span class="__cf_email__" data-cfemail="ca9093999f84fcfcfafbfb8ab3aba2a5a5e4a9a5a7">[email protected]</span></a>. For Z.Z.: phone, +1 732 822 7384; e-mail <a href="/cdn-cgi/l/email-protection#187277707676616262706d58756b76367b7775"><span class="__cf_email__" data-cfemail="016b6e696f6f787b7b6974416c726f2f626e6c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201407j&amp;href=/doi/10.1021%2Fjm201407j" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 489–502</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 18, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>18 October 2011</li><li><span class="item_label"><b>Published</b> online</span>8 December 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 January 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201407j" title="DOI URL">https://doi.org/10.1021/jm201407j</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D489%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhong-Yue%2BSun%252C%2BTheodros%2BAsberom%252C%2BThomas%2BBara%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D1%26contentID%3Djm201407j%26title%3DCyclic%2BHydroxyamidines%2Bas%2BAmide%2BIsosteres%253A%2BDiscovery%2Bof%2BOxadiazolines%2Band%2BOxadiazines%2Bas%2BPotent%2Band%2BHighly%2BEfficacious%2B%25CE%25B3-Secretase%2BModulators%2Bin%2BVivo%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D502%26publicationDate%3DJanuary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201407j"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3766</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201407j" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cyclic Hydroxyamidines as Amide Isosteres: Discovery of Oxadiazolines and Oxadiazines as Potent and Highly Efficacious γ-Secretase Modulators in Vivo&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhong-Yue&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Theodros&quot;,&quot;last_name&quot;:&quot;Asberom&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Bara&quot;},{&quot;first_name&quot;:&quot;Chad&quot;,&quot;last_name&quot;:&quot;Bennett&quot;},{&quot;first_name&quot;:&quot;Duane&quot;,&quot;last_name&quot;:&quot;Burnett&quot;},{&quot;first_name&quot;:&quot;Inhou&quot;,&quot;last_name&quot;:&quot;Chu&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Clader&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Cohen-Williams&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Cole&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Czarniecki&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Durkin&quot;},{&quot;first_name&quot;:&quot;Gioconda&quot;,&quot;last_name&quot;:&quot;Gallo&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;Greenlee&quot;},{&quot;first_name&quot;:&quot;Hubert&quot;,&quot;last_name&quot;:&quot;Josien&quot;},{&quot;first_name&quot;:&quot;Xianhai&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Lynn&quot;,&quot;last_name&quot;:&quot;Hyde&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;Jones&quot;},{&quot;first_name&quot;:&quot;Irina&quot;,&quot;last_name&quot;:&quot;Kazakevich&quot;},{&quot;first_name&quot;:&quot;Hongmei&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Xiaoxiang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Malcolm&quot;,&quot;last_name&quot;:&quot;MacCoss&quot;},{&quot;first_name&quot;:&quot;Mihir&quot;,&quot;last_name&quot;:&quot;B. Mandal&quot;},{&quot;first_name&quot;:&quot;Troy&quot;,&quot;last_name&quot;:&quot;McCracken&quot;},{&quot;first_name&quot;:&quot;Amin&quot;,&quot;last_name&quot;:&quot;Nomeir&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Mazzola&quot;},{&quot;first_name&quot;:&quot;Anandan&quot;,&quot;last_name&quot;:&quot;Palani&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;M. Parker&quot;},{&quot;first_name&quot;:&quot;Dmitri&quot;,&quot;last_name&quot;:&quot;A. Pissarnitski&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Qin&quot;},{&quot;first_name&quot;:&quot;Lixin&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Terracina&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Vicarel&quot;},{&quot;first_name&quot;:&quot;Johannes&quot;,&quot;last_name&quot;:&quot;Voigt&quot;},{&quot;first_name&quot;:&quot;Ruo&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Lili&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhiqiang&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Xiaohong&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Zhaoning&quot;,&quot;last_name&quot;:&quot;Zhu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;489-502&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201407j&quot;},&quot;abstract&quot;:&quot;Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality. Compounds with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles. These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for reduction of central nervous system Aβ42 in various animal models.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201407j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201407j" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201407j&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201407j" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201407j&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201407j" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201407j&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201407j&amp;href=/doi/10.1021/jm201407j" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201407j" /></input><a href="/doi/pdf/10.1021/jm201407j" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201407j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201407j%26sid%3Dliteratum%253Aachs%26pmid%3D22098494%26genre%3Darticle%26aulast%3DSun%26date%3D2012%26atitle%3DCyclic%2BHydroxyamidines%2Bas%2BAmide%2BIsosteres%253A%2BDiscovery%2Bof%2BOxadiazolines%2Band%2BOxadiazines%2Bas%2BPotent%2Band%2BHighly%2BEfficacious%2B%25CE%25B3-Secretase%2BModulators%2Bin%2BVivo%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D1%26spage%3D489%26epage%3D502%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290838" title="Carbonyls">Carbonyls</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jmcmar.2012.55.issue-1/production/jmcmar.2012.55.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0015.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality. Compounds with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles. These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for reduction of central nervous system Aβ<sub>42</sub> in various animal models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>†</span> Dedication</h4><p class="last">This paper is dedicated to Professor Ronald Breslow on the occasion of his 80th birthday.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is an ultimately fatal neurodegenerative disease that is the most common cause of age-related dementia. More than 35 million people suffer from AD worldwide, with an estimated annual cost of over $600 billion, and the AD population may increase to more than 115 million by 2050 according to a report from Alzheimers Disease International.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> A great collective effort is being made across academic and industrial laboratories to develop therapies to halt or even reverse AD. There are two distinct pathological hallmarks in the AD brains: extracellular amyloid plaques and intracellular neurofibrillary tangles. Amyloid plaques are composed of insoluble deposits of amyloid-β (Aβ), particularly Aβ<sub>42</sub>, a 42 amino acid long peptide produced from its precursor protein (APP) through sequential cleavages by BACE1<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and γ-secretase.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Aβ<sub>42</sub> and its oligomers were found to be highly toxic in cells and were proposed<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> as the root cause for AD’s pathology, leading to neurofibrillary tangle formation and eventual cell death.</div><div class="NLM_p">Aβ<sub>42</sub>, despite being the predominant component of the amyloid plaque, is produced in minor proportion (5–10%) of the total Aβ species composed of Aβ<sub>37</sub> to Aβ<sub>42</sub>. They differ at the C-terminus because of poor selectivity at the γ-secretase cleavage step. Several classes of γ-secretase inhibitors (GSIs) have been reported to effectively eliminate production of all Aβ peptides in vitro and in vivo. However, γ-secretase has a wide variety of substrates in addition to APP that are involved in diverse biological processes. One of the most notable processes is the Notch cleavage,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> producing a cell surface receptor involved in regulating cell differentiation and proliferation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> GSI’s selectivity issues against Notch and other biological pathways became a significant concern when their clinical trials identified higher incidence of skin cancer in the treatment group than in the placebo group among other known mechanism-based toxicological findings.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">In 2001, a class of small molecules was found that alter the product distribution among the known Aβ species without overall inhibition of the γ-secretase enzyme function including APP and Notch processing. GSMs selectively reduce certain Aβ species while enhancing the production of others.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> A subclass of these γ-secretase modulators (GSMs) exemplified by some nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, indomethacin, and sulindac sulfide was found to elevate the level of the shorter Aβ species (Aβ<sub>37</sub>, Aβ<sub>38</sub>, and Aβ<sub>39</sub>) while inhibiting longer and more toxic Aβ<sub>40</sub> and Aβ<sub>42</sub>. This type of GSM presents a unique approach to address the central tenet of the amyloid hypothesis (i.e., Aβ<sub>42</sub> inhibition) while effecting a gentler perturbation of Aβ natural metabolism, potentially leading to less mechanism-based toxicity involving Aβ and γ-secretase inhibition.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Therefore, it is highly attractive to identify GSMs that can selectively reduce Aβ<sub>42</sub> and elevate the Aβ<sub>40</sub>/Aβ<sub>42</sub> ratio and can be evaluated as anti-AD agents for their safety and efficacy profiles in comparison to other approaches targeting the Aβ process. Flurizan (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), the most advanced GSM developed by Myriad Genetics, failed to demonstrate statistically significant efficacy in AD patients in a phase III clinical trial. This result was not surprising given the compound’s weak in vitro activity against γ-secretase Aβ<sub>42</sub> cleavage and its poor central nervous system (CNS) penetration,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> highlighting the need for a more potent and brain penetrant GSM.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. NSAID and non-NSAID γ-secretase modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2004, a new class of non-NSAID class of GSMs was reported by scientists from Torrey Pines Therapeutics<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with impressive potency in reduction of Aβ<sub>42</sub> in cells. Compound <b>I</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) was also shown to reduce both plasma and brain Aβ<sub>42</sub> and Aβ<sub>40</sub> in Tg 2576 mice. Furthermore, chronic treatment of Tg 2576 mice with <b>I</b> lowered plaque density and amyloid load in both hippocampus and cortex.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Following this lead, a biarylcinnamide class of GSM was reported later that preserved the imidazolylphenyl group with the central aminothiazole of <b>I</b> replaced by an α,β-unsaturated amide (e.g., <b>1</b>, <b>II</b>, and <b>III</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> Compound <b>1</b> entered phase I clinical studies in 2006, but the clinical development was temporarily halted because of the finding of rat lenticular toxicity after administration of high doses for 13 weeks.<a onclick="showRef(event, 'cit8e'); return false;" href="javascript:void(0);" class="ref cit8e">(8e)</a> In our hands, E-2012 showed good in vitro potency (HEK 293<sup>Swe-Lon</sup> cell Aβ<sub>42</sub> IC<sub>50</sub> = 64 nM) and a desirable GSM profile (Aβ<sub>total</sub>/Aβ<sub>42</sub> IC<sub>50</sub> ratio of 226). It also exhibits robust rat in vivo efficacy in reducing cerebrospinal fluid (CSF) Aβ<sub>42</sub> by 55% and cortical Aβ<sub>42</sub> by 44% after a single oral dose of 30 mg/kg.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of 1,2,4-oxadiazoline as an amide isostere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Modulator Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In an effort to design novel GSMs, we decided to focus on the non-NSAID GSM class represented by compound <b>1</b> and try to further optimize its overall profile and address its lenticular toxicity issue. A survey of related patent literature indicated that the imidazolylphenyl group is a highly conserved pharmacophore across multiple subclasses of modulators from a number of research laboratories. In contrast, the middle part of the molecule, represented by the δ-lactam in <b>1</b>, can be highly variant, leaving room for exploration of a diverse range of structures. Realizing that compound <b>1</b> is a GSM with a highly optimized pharmacokinetic and pharmacodynamic profile, in our modulator design, we aimed to learn from its electronic topology while exploring significantly different chemical structures. One striking SAR point represented by the potent E-2012 analogue compound <b>III (</b>Aβ<sub>42</sub> IC<sub>50</sub> = 56 nM, compound 639 in ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>) indicates high tolerance in the enzyme environment around the quarternalized benzylic position for large structural changes on this portion of the molecule. More importantly, the steric bulkiness at this site precluded the right-hand lone electron pair of the lactam carbonyl group from interacting with any potential H-bonding donor of the enzyme. The combination of potentially high tolerance for structural change and an idling right-hand lone electron pair on the carbonyl offers an attractive opportunity to build a ring from the position of the carbonyl oxygen to the benzylic position. An imino group would be required to offer an extra valence to form the ring while still preserving the left-hand lone pair electron density as a replacement of the carbonyl group. However, an imino group seldom is a viable replacement for the carbonyl because of its high basicity and reactivity; a neutral version of the imino group therefore should be a far better choice. Hydroxylated imines such as oximes, hydroxyamidines,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and hydroxyguanidines<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> are known to be much less basic than their imine counterparts and in most cases far more stable. Therefore, a cyclized oxadiazoline or oxadiazine appeared to be a reasonable isosteric replacement of the lactam carbonyl in <b>1</b>.</div><div class="NLM_p last">Comparing the core conformations of compound <b>1</b> (gray) and oxadiazoline <b>2a</b> (red), we found that they are completely superimposible (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Molecular designs such as <b>2a</b> have minimum perturbation of electronic topology compared to <b>1</b> while offering a different molecular framework for us to further optimize its profile. However, oxadiazolines have not been explored as viable pharmacophores, and their metabolic and toxicological profiles were unknown. The monocyclic oxadiazolines seem unstable under acidic conditions,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> but some fused tricyclic oxadiazolines are stable in hot 20% HCl in MeOH.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> On the other hand, a ring expanded analogue of oxadiazoline, oxadiazine, has been explored in the context of p38 MAP kinase inhibitors, one of which was evaluated in phase II human clinic trials for cardiovascular disease.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In order to expeditiously validate the proposal of isosteric replacement of the lactam carbonyl group with cyclic hydroxyamidines, we first focused on monocyclic oxadiazolines because of their straightforward syntheses. Despite their known stability issues, the monocyclic oxadiazolines (e.g., <b>4</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) should be a suitable probe for the validity of the GSM molecular design using the in vitro cellular assay, before more resource was applied to this direction. If successful, we planned to move to bicyclic oxadiazolines (e.g., <b>2a</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) and oxadiazines (e.g., <b>2b</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) to address any druggability issues.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The monocyclic 1,2,4-oxadiazoline <b>4</b> was synthesized in three steps as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The imidazolylbenzaldehyde <b>6</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> reacted with (formylmethylene)triphenylphosphorane to form imidazolylcinnamaldehyde <b>7</b> which was subsequently converted to oxime <b>8</b>. Nitrile oxide <b>9</b>, generated in situ by treatment of <b>8</b> with <i>N</i>-chlorosuccinimide and pyridine,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> reacted with the ketimine <b>10</b> through a [3 + 2] dipolar cycloaddition to form compound <b>4</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Monocyclic Oxadiazoline <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) microwave 150 °C, 30 min, THF; (b) NH<sub>2</sub>OH·HCl, KOAc, MeOH; (c) NCS/Py, DCM; (d) Et<sub>3</sub>N, DCM.</p></p></figure><div class="NLM_p">The bicyclic oxadiazoline compounds <b>2a</b>, <b>3</b>, and <b>12</b>–<b>19</b> were prepared as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> from the key intermediate oxadiazolines (<b>31a</b>–<b>j</b>), which were synthesized from the [3 + 2] dipolar cycloaddition of the corresponding 3-bromopropylke-timines <b>30a</b>–<b>j</b> and a nitrile oxide generated from bromooxime <b>29</b> in situ.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> A potassium <i>tert</i>-butoxide mediated cyclization of <b>31a</b>–<b>j</b> led to formation of the bicyclic oxadiazoline compounds <b>32a</b>–<b>j</b>, which were finally coupled with the imidazolylbenzaldehyde <b>6</b> using Horner–Emmons conditions to give <b>2a</b>, <b>3</b>, and <b>12</b>–<b>19</b>, respectively (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5-Alkyl-5-aryl Bicyclic Oxadiazolines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, DMF; (b) Et<sub>3</sub>N, DMF; (c) <i>t</i>-BuOK, THF; (d) <i>t</i>-BuOK, THF; (e) NaBH<sub>4</sub>, THF/MeOH.</p></p></figure><div class="NLM_p">The ester group in the bicyclic oxadiazolines <b>3</b> and <b>12</b>–<b>19</b> is highly versatile in order to access alcohols and other functional groups (Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The success of the [3 + 2] cycloaddition was highly dependent on the quality of the corresponding imines, for which three synthetic methods had to be developed based on different starting amines andketones. Nonfunctionalized ketimine <b>10</b> was generated from 3-methoxypropylamine and 4-fluoroacetophenone using 3 Å molecular sieves as the dehydrating agent. Ketimine <b>30a</b> containing a 3-bromopropyl group was obtained with condensation conditions involving TiCl<sub>4</sub> and Et<sub>3</sub>N.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Formation of ketimines (<b>30b</b>–<b>j</b>) containing both ester and 3-bromopropyl groups was found to be most efficient using TMS triflate catalyzed imine synthesis from the TMS protected amine (<b>42</b>)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and the corresponding arylketoesters (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> that were obtained from the corresponding aryl bromides (<b>43</b>, <b>44</b>) and diethyl oxalate through the Grignard reaction as shown in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3-(4-Fluorophenyl)-3-hydroxymethyl or 3-Aminomethyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeMgBr, Et<sub>3</sub>N, THF; (b) (<i>S</i>)-2-methyl-CBS-oxazaborolidine in toluene, BH<sub>3</sub>·Me<sub>2</sub>S, THF; (c) NaBH<sub>4</sub>, THF/MeOH; (d) MeI, NaH, DMF; (e) Swern oxidation. (f) For <b>36</b> and <b>37</b>: NaBH(OAc)<sub>3</sub>, HOAc, the corresponding amine, DCE. For <b>38</b>: the reductive amination with 2-aminoethylbenzoate followed by hydrolysis with LiOH. (g) Acetic anhydride, Et<sub>3</sub>N, DCM; (h) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, DCM.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Ketimine <b>30b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TMSCl, Et<sub>3</sub>N, DCM; (b) TMSOTf, DCM, reflux.</p></p></figure><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Ketoesters <b>45</b> and <b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>i</i>-PrMgCl·LiCl, THF.</p></p></figure><div class="NLM_p">Compound <b>3a</b> is an enantiomer obtained by resolving the racemate <b>3</b>. The absolute structure of <b>3a</b> was determined as the <i>S</i>-configuration through its hydroxyethyl derivatives <b>11a</b> and <b>11b</b>, using the NMR spectra of their corresponding Mosher’s esters.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">As illustrated in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, oxadiazine <b>53</b> was synthesized via lactam <b>51</b> which was prepared from <b>48</b> and <b>49</b> using a similar method described in ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>. The enantiomer of amino alcohol <b>48</b> was synthesized by the Sharpless aminohydroxylation<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> from styrene <b>47</b>. By use of a Mitsunobu reaction/deprotection sequence, lactam <b>51</b> was then converted into hydroxylamine <b>52</b>, followed by cyclization using P<sub>2</sub>O<sub>5</sub> in refluxing EtOH overnight to yield oxadiazine <b>53</b> in 90% enantiomeric excess.</div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Oxadiazine <b>53</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CbzNH<sub>2</sub>, NaOH/<i>tert</i>-butyl hypochlorite, (DHQ)<sub>2</sub>PHAL, K<sub>2</sub>OsO<sub>2</sub>(OH)<sub>4</sub>, PrOH/water; (b) H<sub>2</sub>/Pd(OH)<sub>2</sub>; (c) EDCI, HOBT, DIEA, DMF; (d), NaOMe, MeOH; (e) <i>N</i>-hydroxyphthalimide, PPh<sub>3</sub>, DIAD, THF; (f) NH<sub>2</sub>NH<sub>2</sub>, EtOH; (g) P<sub>2</sub>O<sub>5</sub>, EtOH, reflux.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32603" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32603" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Racemic oxadiazoline <b>4</b>, designed based on compound <b>II</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) for the initial GSM design validation, has IC<sub>50</sub> of 187 nM for Aβ<sub>42</sub> and IC<sub>50</sub> of 2 μM for Aβ<sub>40</sub> in the cellular assays. Compared to the IC<sub>50</sub> of compound <b>II</b> of 60 nM for Aβ<sub>42</sub> reduction, these data confirm the modulator profile and the validity of oxadiazoline as an isosteric replacement of the lactam carbonyl group. Compound <b>4</b> is stable under neutral conditions, only slowly decomposing in aqueous 0.1 N HCl at room temperature over 3 h, leading to the corresponding acetophenone.</div><div class="NLM_p">A cyclized version of the oxadiazoline such as compound <b>2a</b> would further stabilize the heterocyclic ring<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and may lead to a suitable “druggable motif”.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Indeed, the active enantiomer of racemic <b>2a(α)</b> is far more stable under the same conditions, with deterioration of enantiomeric excess from 99.6% to 55.7% overnight as the only observable change. The compound has a p<i>K</i><sub>a</sub> of 6.7, a value higher than the reported p<i>K</i><sub>a</sub> for 1-phenylimidazole (p<i>K</i><sub>a</sub> = 5.1),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> indicating that the oxadiazoline core is more basic than the <i>N</i>-phenylimidazole group. Compound <b>2a(α)</b> possesses an excellent pharmacokinetic profile in all animal species examined (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) and has a low drug–drug interaction liability as evidenced by lack of inhibition of human cytochrome P450s, such as 3A4, 2D6, and 2C9, and lack of induction of human hPXR. It has a hERG ion channel IC<sub>50</sub> of 740 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) in a voltage clamp cellular assay and thus has some risk of QTc prolongation in humans. More interestingly, compound <b>2a(α)</b> demonstrates a pharmacological profile indistinguishable from E-2012 in vitro, with an IC<sub>50</sub> of 58 nM for reduction of Aβ<sub>42</sub> and an Aβ<sub>total</sub>/Aβ<sub>42</sub> IC<sub>50</sub> ratio of 237 in an HEK293 cell assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). When administered to rats, compound <b>2a(α)</b> dose dependently reduces CSF levels of Aβ<sub>42</sub> by 51% and 30% 3 h after single oral doses of 10 and 3 mg/kg, respectively, with corresponding brain exposure of 5 and 0.8 μM.</div><div class="NLM_p">The highly desirable in vitro and in vivo profile of <b>2a(α)</b> highlighted the urgency to resolve the hERG issue. A comprehensive medicinal chemistry effort was therefore launched to further optimize this series. Among many directions, we examined substitution effects on both 3-phenyl and 3-methyl groups on the oxadiazoline ring as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> with an emphasis on reduction of hydrophobicity of these compounds (see also ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a> for examples of similar approaches around E-2012). Hydroxylation of the 3-methyl group is tolerated with an eudismic ratio between the two enantiomers (<b>5a</b> and <b>5b)</b> higher than 260-fold. The <i>S</i>-configuration (<b>5a</b>) is the preferred stereochemistry, which agrees with what was reported for <b>1</b>. Additional fluorine substitution modestly improves potency with the 3,4,5-trifluorophenyl (<b>25a</b>) being the most potent (Aβ<sub>42</sub> IC<sub>50</sub> of 15 nM). Polar group incorporation into the 3-aryl group (<b>23a</b>, <b>26a</b>, and <b>27a</b>) had a negative impact on GSM potency.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Activity of 3-Aryl-3-alkyl Substituted Bicyclic Oxadiazoline Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub>,<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> nM</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Ar</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">C3 config</th><th class="colsep0 rowsep0" align="center" char=".">Aβ<sub>42</sub></th><th class="colsep0 rowsep0" align="center" char=".">Aβ<sub>total</sub></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub>(Aβ<sub>total</sub>)/IC<sub>50</sub>(Aβ<sub>42</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a(α)</b></td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">13702</td><td class="colsep0 rowsep0" align="char" char=".">237</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">14130</td><td class="colsep0 rowsep0" align="char" char=".">488</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">4-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="char" char=".">7643</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">96</td><td class="colsep0 rowsep0" align="char" char=".">3210</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">3-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">7164</td><td class="colsep0 rowsep0" align="char" char=".">280</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22a</b></td><td class="colsep0 rowsep0" align="left">2-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">10052</td><td class="colsep0 rowsep0" align="char" char=".">189</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="left">4-CN-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">117</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>171</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="left">3,5-di-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">6750</td><td class="colsep0 rowsep0" align="char" char=".">316</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25a</b></td><td class="colsep0 rowsep0" align="left">3,4,5-tri-F-Ph</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">15810</td><td class="colsep0 rowsep0" align="char" char=".">1023</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26a</b></td><td class="colsep0 rowsep0" align="left">5-F-Py-2-yl</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="char" char=".">19716</td><td class="colsep0 rowsep0" align="char" char=".">192</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27a</b></td><td class="colsep0 rowsep0" align="left">5-F-Py-3-yl</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left"><sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></sup></td><td class="colsep0 rowsep0" align="char" char=".">106</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>189</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Determined in HEK<sup>Swe-Lon</sup> 293 cells.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Active enantiomer.</p></div></div></div><div class="NLM_p">Compound <b>5b</b>, with a p<i>K</i><sub>a</sub> of 5.8, was found to be more stable compared to <b>2a(α)</b>, as it showed no sign of decomposition or deterioration of enantiomeric excess after 7 days at room temperature in 0.1 N HCl/MeOH (1:1). The excellent stability of <b>5b</b> can be attributed to the increased barrier to decomposition imposed by the inductive effect of 3-hydroxymethyl and potential stabilization from an intramolecular hydrogen bond between the hydroxyl group and the oxadiazoline oxygen.</div><div class="NLM_p">Encouraged by the tolerance to the C3-methyl modification, we further explored the scope of the SAR at this position. Replacement of the C3-methyl group with either configuration of 1-hydroxyethyl is tolerated though no improvement was seen (<b>11a</b>, <b>11b</b>). Charged groups (<b>36</b>, <b>37</b>) seem to reduce modulator potency while the less basic hydroxyethylamino group has the least impact (<b>38</b>). Small nonbasic nitrogen derivatives such as amide (<b>39</b>) and sulfonamide (<b>40</b>) are modestly tolerated (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Activity of (<i>S</i>)-3-(4-Fluorophenyl)-3-alkyl Substituted Bicyclic Oxadiazoline Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0014.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub>,<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> nM</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">Aβ<sub>42</sub></th><th class="colsep0 rowsep0" align="center" char=".">Aβ<sub>total</sub></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub>(Aβ<sub>total</sub>)/IC<sub>50</sub>(Aβ<sub>42</sub> )</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">CH(OH)Me (<i>R</i>)</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">16237</td><td class="colsep0 rowsep0" align="char" char=".">350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">CH(OH)Me (<i>S</i>)</td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>225</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OMe</td><td class="colsep0 rowsep0" align="char" char=".">122</td><td class="colsep0 rowsep0" align="char" char=".">17466</td><td class="colsep0 rowsep0" align="char" char=".">144</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>NHMe</td><td class="colsep0 rowsep0" align="char" char=".">191</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>NMe<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">196</td><td class="colsep0 rowsep0" align="char" char=".">18833</td><td class="colsep0 rowsep0" align="char" char=".">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>NHCH<sub>2</sub>CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>N(Me)COMe</td><td class="colsep0 rowsep0" align="char" char=".">199</td><td class="colsep0 rowsep0" align="char" char=".">>20000</td><td class="colsep0 rowsep0" align="char" char=".">>101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>N(Me)SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">19308</td><td class="colsep0 rowsep0" align="char" char=".">269</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Determined in HEK<sup>Swe-Lon</sup> 293 cells.</p></div></div></div><div class="NLM_p">With the full validation of five-membered cyclic hydroxyamidines as lactam carbonyl isosteric replacement, we further explored other variations of this concept by first examining oxadiazines with a choice of trifluorophenyl group as exemplified by compound <b>25a</b>. Compound <b>53</b> displays two p<i>K</i><sub>a</sub> values of 7.4 and 2.7, indicating that the oxadiazine ring is modestly more basic than oxadiazolines. This weak basicity gives <b>53</b> a highly desirable aqueous solubility of greater than 100 mM at pH 3.5 as an HCl salt, despite the fact that its measured log <i>D</i>(5.29 at pH 7.4) suggested a molecule with a rather hydrophobic nature. Its nominal basicity notwithstanding, compound <b>53</b> is a very potent GSM in vitro, indicating an excellent isosteric replacement of the carbonyl group (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">The GSM characteristics of <b>5a</b> and <b>53</b> were further confirmed by the changes they induce in the Aβ species produced by HEK293<sup>Swe-Lon</sup> cells in vitro as assessed by mass spectrometry. Incubation of HEK293<sup>Swe-Lon</sup> with 10 μM <b>53</b> selectively reduced Aβ<sub>42</sub>, Aβ<sub>40</sub>, and Aβ<sub>39</sub> while profoundly increasing production of Aβ<sub>37</sub> and Aβ<sub>38</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). A similar modulator profile was also observed for <b>5a</b>.<figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mass spectrometric analysis of Aβ peptides generated from HEK293<sup>Swe-Lon</sup> cells after treatment with vehicle (DMSO) or 10 μM <b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_p">Compounds <b>5a</b> and <b>53</b> are highly permeable in a Caco-2 membrane permeability assay and do not appear to be substrates for PGP efflux (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> These two compounds possess excellent pharmacokinetic profiles typical of their structural classes in dog, rat, and monkey (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Both compounds displayed a better overall hERG profile than compound <b>2a(α)</b> because both reduced potency for blocking the hERG channel and decreased exposure at the effective doses (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Neither compound affected QTc intervals in dogs at sufficient exposure multiples over exposures required for pharmacological effect (data not shown).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Profiles of <b>2a(α)</b>, <b>5a</b>, and <b>53</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>2a(α)</b></th><th class="colsep0 rowsep0" align="center"><b>5a</b></th><th class="colsep0 rowsep0" align="center"><b>53</b></th><th class="colsep0 rowsep0" align="center"><b>1</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ<sub>42</sub> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">64</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ<sub>40</sub> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">267</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">2300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ<sub>total</sub> IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">14000</td><td class="colsep0 rowsep0" align="left">14130</td><td class="colsep0 rowsep0" align="left">>20000</td><td class="colsep0 rowsep0" align="left">14000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Notch IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left">>50000</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">740</td><td class="colsep0 rowsep0" align="left">3300</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">1200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>a-b</sub> <a class="ref internalNav" href="#t3fn3" aria-label="c">c</a>(nm/s)</td><td class="colsep0 rowsep0" align="left">346</td><td class="colsep0 rowsep0" align="left">302</td><td class="colsep0 rowsep0" align="left">246</td><td class="colsep0 rowsep0" align="left">579</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>b-a</sub>/<i>P</i><sub>a-b</sub> <a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">determined in HEK293<sup>Swe-Lon</sup> cells.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">determined using a voltage-clamp method.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">P<sub>a-b</sub> is the permeability when applied to the apical side, while P<sub>b-a</sub> is the permeability when applied to the basolateral side in a Caco-2 membrane assay (nm/s). The ratio of these two values is a measure of Pgp efflux, while the P<sub>a-b</sub> value is a measure of permeability.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PK Parameters in Rat, Dog, and Monkey<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">species<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">AUC <a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (μM·h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> <a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center">BA <a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (%)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> <a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> (h)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>dss</sub> <a class="ref internalNav" href="#t4fn4" aria-label="d">d</a>(L/kg)</th><th class="colsep0 rowsep0" align="center">CL <a class="ref internalNav" href="#t4fn4" aria-label="d">d</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a(α)</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">78</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">6.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">7.5</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">8.8</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">265</td><td class="colsep0 rowsep0" align="left">19.8</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">10 mg/kg for po; 3 mg/kg for iv in rat, dog, and monkey.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">AUC (area under the curve) and <i>C</i><sub>max</sub> (maximal drug concentration) obtained with po administration.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">BA: bioavalability.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last"><i>T</i><sub>1/2</sub> (half-life), <i>V</i><sub>dss</sub> (steady state volume of distribution), and CL (in vivo clearance) obtained with iv administration.</p></div></div></div><div class="NLM_p">Compounds <b>5a</b> and <b>53</b> did not inhibit APP processing (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) in vitro as indicated by a lack of substrate accumulation of C89 and C100, the cleavage products of preceding α-secretase and BACE1 cleavages. Nor did they affect Notch processing in HEK293 cells expressing the human Notch1 protein at concentrations up to 50 μM. The shift in specificity of APP cleavage (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) rather than a reduction in overall γ-secretase activity and the resulting lack of changes in substrate accumulation and Notch processing confirm that both compounds are potent GSMs. There was no evidence of Notch-related side effects or biomarker changes following repeated administration of the highest tolerable doses of <b>5a</b> and <b>53</b> to rats. Neither compound produced goblet cell meta/hyperplasia in the ileum, nor did they decrease thymus size or dramatically affect body weight, all of which are common side effects of γ-secretase inhibitors that reduce Notch cleavage. In addition, HES-1 and adipsin expression, biomarkers for Notch activity, were unaffected in the jejunum of treated rats.</div><div class="NLM_p">Compound <b>53</b> (3 mg/kg, orally) reduces cortical Aβ<sub>42</sub> to 63% of the level seen after vehicle administration, while <b>5a</b>(10 mg/kg, orally) reduces cortical Aβ<sub>42</sub> levels to 37% (Table 5). Compounds <b>5a</b> and <b>53</b> were also found to dose-dependently reduce Aβ<sub>42</sub> preferentially over Aβ<sub>total</sub> and Aβ<sub>40</sub> upon acute administration to rat (Figure 4). Similar results were observed after sub-chronic (6 day) dosing in rat (data not shown). Four hours after a single dose of 30 mg/kg to cynomolgous monkeys (<i>n</i> = 3), <b>53</b> reduces Aβ<sub>42</sub> in the cortex and CSF to 44% and 70% of the values seen after vehicle administration (Figure 5). The corresponding plasma exposure of <b>53</b> 4 h after administration to the monkeys was ∼6 μM, while the average brain/plasma ratio in the monkeys was determined to be 1.4.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo Profile of <b>5a</b> and <b>53</b> in Rat</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">CSF Aβ (%)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">cortex Aβ (%)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="3" align="center">plasma Aβ (%)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">po (mg/kg)</th><th class="colsep0 rowsep0" align="center">plasma (μM)</th><th class="colsep0 rowsep0" align="center"><i>B</i>/<i>P</i> ratio</th><th class="colsep0 rowsep0" align="center">Aβ<sub>42</sub></th><th class="colsep0 rowsep0" align="center">Aβ<sub>40</sub></th><th class="colsep0 rowsep0" align="center">Aβ<sub>total</sub></th><th class="colsep0 rowsep0" align="center">Aβ<sub>42</sub></th><th class="colsep0 rowsep0" align="center">Aβ<sub>40</sub></th><th class="colsep0 rowsep0" align="center">Aβ<sub>42</sub></th><th class="colsep0 rowsep0" align="center">Aβ<sub>40</sub></th><th class="colsep0 rowsep0" align="center">Aβ<sub>total</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">104</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">37<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">41<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">44 <a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0.49</td><td class="colsep0 rowsep0" align="left">65</td><td class="colsep0 rowsep0" align="left">74</td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">84</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">86</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Expressed as % vehicle in CSF, cortex, and plasma at 3 h after dosing.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last"><i>p</i> < 0.05 vs vehicle-treated rats (ANOVA on raw values followed by Dunnett’s post hoc <i>t</i> test comparing each treatment group to vehicle).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Results for <b>53</b> are average of data from several studies; see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> for data and variance.</p></div></div></div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Aβ<sub>total</sub>, Aβ<sub>40</sub>, and Aβ<sub>42</sub> in plasma (left), CSF (middle), and cortex (right) from rats treated acutely with various single oral doses of <b>53</b>(1–30 mg/kg). Data are the mean ± standard error of the mean averaged from several studies, expressed as % vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Aβ<sub>total</sub>, Aβ<sub>40</sub>, and Aβ<sub>42</sub> in plasma, CSF, and cortex from monkeys treated with <b>53</b> orally at 30 mg/kg at 4 h. Data are expressed as a percent of the predose value from the same animals (plasma) or as a percent of the control (vehicle)-treated monkeys (CSF and cortex).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Summary and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50058" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50058" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Cyclic hydroxyamidines were designed as novel isosteric replacements of amide with a consideration of hydrogen bonding characteristics and lack of strong basicity. Both five-membered oxadiazolines and six-membered oxadiazines were found to be ideal replacements for a lactam group. Importantly, these novel druggable motifs were found to possess highly desirable pharmacokinetic and toxicological profiles, offering excellent opportunities for exploration of amide bond replacement, a frequently encountered but potentially difficult task in drug discovery. Most valuable of all, both scaffolds were found to be modestly basic, enabling salt formation for rapid dissolution with an appropriate formulation while maintaining amide characteristics at physiological pH. The successful and expeditious validation of these novel amide isosteres led to GSMs that are highly efficacious in vitro and in vivo in a number of animal models. Further exploration of these compounds as potential drugs to fight Alzheimer’s disease is underway and will be subjects of additional publications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Cell Based γ-Secretase Assay</h3><div class="NLM_p last">Human embryonic kidney (HEK) 293 cells stably transfected with a human APP cDNA with both the Swedish and London familial AD mutations in the pcDNA3.1 vector (Invitrogen, HEK293<sup>Swe-Lon</sup> cells) were treated with GSM compounds for 5 h. Aβ in conditioned medium was measured using MesoScale Discovery (MSD) technology-based sandwich immunoassays. Aβ<sub>42</sub> was measured using a pair of labeled antibodies TAG-G2-11 and biotin-4G8. Aβ<sub>40</sub> was measured using the antibody pair of TAG-G2-10 and biotin-4G8; total Aβ was measured using TAG-W02 and biotin-4G8. In some cases, a cell based γ-secretase assay was also carried out in HEK293 cells stably coexpressing a C99 expression construct and PS1ΔE9, a familial Alzheimer's disease mutant form presenilin.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Aβ in conditioned medium was measured using the same methods described above.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Mass Spectrometric Analysis of Aβ Profiles</h3><div class="NLM_p last">The Aβ profile in conditioned medium was analyzed using surface enhanced laser desorption/ionization (SELDI) mass spectrometry as described previously.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The γ-secretase mixture of 50 μL was applied on a PS20 protein chip array (BioRad) that had been precoated with 1 μg of antibody W02. The array was incubated overnight at 4 °C. Nonspecific protein binding to the array was removed by washing three times in phosphate buffered saline (PBS) with 0.2% Tween 20 followed by three times in PBS. The array was rinsed briefly with water and air-dried before being analyzed on BioRad.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Notch Assay</h3><div class="NLM_p last">HEK293 cells stably expressing a human Notch protein with a truncated extracellular EGF repeat domain (NΔE)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> were treated with GSI or GSM compounds. Production of the Notch intracellular domain (NICD) in cell lysates was measured using a MSD-based sandwich immunoassay with Notch antibodies (Cell Signaling).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> CSF and Brain Aβ Assays</h3><div class="NLM_p last">CSF Aβ<sub>42</sub> was measured using AlphaLISA Aβ<sub>1–42</sub> and Aβ<sub>1–40</sub> kits (Perkin-Elmer) according to the manufacturer’s instructions. CSF total Aβ was measured using MesoScale Discovery technology with biotinylated antibody 4G8 (Signet) and S-tag labeled antibody W02. Aβ from rat and monkey brain was enriched by solid phase extraction using an Oasis HLB LP 96-well plate (Waters Corp.) and analyzed using AlphaLISA Aβ<sub>1–42</sub> and Aβ<sub>1–40</sub> kits.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Drug Treatment in Animals</h3><div class="NLM_p">Male CD rats (∼100 g, Crl:CD(SD); Charles River Laboratories, Kingston, NY) were group housed and acclimated to the vivarium for 5–7 days prior to use in a study. Compounds were formulated in 20% hydroxypropyl-β-cyclodextrin and administered orally with a dosing volume of 5 mL/kg. Three hours after drug administration, rats were euthanized with excess CO<sub>2</sub>. Immediately following euthanasia, CSF was collected from the cisterna magna and quickly frozen on dry ice. Only visibly clear CSF samples were analyzed. Blood was collected from the vena cava, and plasma was isolated using heparin as an anticoagulant. Finally, the brain was removed from the skull and immediately frozen on dry ice. All tissues were stored at −70 °C until Aβ quantification.</div><div class="NLM_p last">Adult male purpose bred cynomolgous monkeys (<i>Macaca fascicularis</i>), weighing between 6 and 8 kg, were used. Monkeys were fasted overnight prior to orogastric gavage tube administration of compound (formulated in 0.4% MC with 1–2 equiv of tartrate acid as an excipient) in a 1 mL/kg dosing volume. Three hours after drug administration, monkeys were given an intramuscular injection of ketamine HCl, a blood sample was collected from the femoral vein, and the animals were euthanized by an intravenous dose of sodium pentobarbital. CSF was collected from the cisterna magna immediately following euthanasia, and then the brain was removed and frozen on dry ice.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Chemistry</h3><div class="NLM_p last"><sup>1</sup>H NMR spectra were measured on a Varian Oxford 400 or Bruker 500 UltraShield spectrometer. Chemical shifts δ are reported relative to CDCl<sub>3</sub> at 7.26 ppm as an internal standard. LCMS spectra were obtained on a Shimadzu VP-Sciex API 150EX system. HPLC spectra were obtained on a Shimadzu VP system. Normal phase column chromatography was performed on prepacked silica gel columns using ISCO CombiFlash system. Reverse phase column chromatography was performed on Phenomenex Luna 10 μm C18 columns using Alltech 627 HPLC pump or Varian SD-1 HPLC system. Chiral columns were from Chiral Technologies. The purity of final compounds was analyzed on two independent reverse phase HPLC systems with different gradient. LC–electrospray mass spectrometry with a C-18 column using a gradient of 5–95% MeCN in water as the mobile phase was used to determine the molecular mass and retention time. The purity of the samples was assessed using a mass detector and a UV detector at 254 nm. An additional analytical reverse phase HPLC system was used to assess the purity of final compounds using a UV detector monitored at both 219 and 254 nm and an ELSD detector. All compounds have purity greater than 95%.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>E</i>)-3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-3-methyl-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridine (<b>2a</b>) and Its Enantiomers (<b>2a(α)</b> and <b>2a(β)</b>)</h3><div class="NLM_p last"><b>2a</b>, <b>2a(α)</b>, and <b>2a(β)</b> were prepared from <b>30a</b> similar to the method for <b>3</b>, <b>3a</b>, and <b>3b</b>. Compound <b>2a</b> was resolved on an OD column, eluting with 50% isopropanol in hexanes containing 0.1% Et<sub>2</sub>NH to give <b>2a(α)</b> and <b>2a(β)</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.81 (1H, s), 7.58–7.55 (2H, m), 7.51 (1H, s), 7.26–7.24 (1H, d), 7.10–7.06 (2H, t), 7.02–7.00 (1H, d), 6.98 (1H, s), 6.94 (1H, s), 3.85 (3H, s), 3.17–3.12 (1H, m), 2.87–2.78 (1H, m), 2.78–2.69 (1H, m), 2.69–2.60 (1H, m), 2.32 (3H, s), 1.97–1.78 (2H, m), 1.89 (3H, s). LCMS for <b>2a(α)</b>: <i>m</i>/<i>z</i> 433 [M + 1]<sup>+</sup>, 100% purity. LCMS for <b>2a(β)</b>: <i>m</i>/<i>z</i> 433 [M + 1]<sup>+</sup>, 99.9% purity.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>E</i>)-Ethyl 3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridine-3-carboxylate (<b>3</b>), and Its <i>S</i>-enantiomer (<b>3a</b>) and <i>R</i>-Enantiomer (<b>3b</b>)</h3><div class="NLM_p last">Under N<sub>2</sub> protection, a solution of potassium <i>t</i>-BuOK (22.3 g, 199.5 mmol) in anhydrous THF (200 mL) was added slowly to a solution of <b>32b</b> (81.3 g, 190.0 mmol) and 3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzaldehyde (<b>6</b>) (39.0 g, 180.5 mmol) in anhydrous THF (1900 mL) at −78 °C. The reaction mixture was stirred at −78 °C for 45 min, allowed to warm to −20 °C over a period of 30 min, diluted with brine, and extracted with EtOAc. The combined organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to give <b>3</b> (91 g, crude). This product (88 g) was resolved in an AS column, eluting with 55% isopropanol in hexanes containing 0.1% Et<sub>2</sub>NH to give the <i>S</i>-enantiomer <b>3a</b> (30.6 g, 34.8% yield) and the <i>R</i>-enantiomer <b>3b</b>. Analytical data for <b>3a</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.70 (1H, s), 7.53–7.47 (3H, m), 7.24–7.22 (1H, d), 7.13–7.09 (2H, t), 7.00–6.98 (1H, d), 6.96 (1H, s), 6.91 (1H, s), 4.40–4.28 (2H, m), 3.83 (1H, s), 3.58–3.55 (1H, m), 2.88–2.85 (1H, m), 2.76–2.63 (2H, m), 2.28 (3, s), 1.99–1.91 (1H, m), 1.73–1.69 (1H, m), 1.35–1.31 (3H, t). LCMS <i>m</i>/<i>z</i> 491 [M + 1]<sup>+</sup>, 100% ee. <b>3b</b>: LCMS <i>m</i>/<i>z</i> 491 [M + 1]<sup>+</sup>, 99% ee.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>E</i>)-5-(4-Fluorophenyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)styryl)-4-(3-methoxypropyl)-5-methyl-4,5-dihydro-1,2,4-oxadiazole (<b>4</b>)</h3><div class="NLM_p last">A mixture of 4-fluoroacetophenone (1.36 g, 9.9 mmol), 3-methoxypropylamine (1.76 g, 19.8 mmol), 3 Å molecular sieves, and 18 mL of DCM in a sealed tube was heated at 50 °C for 3 h and then was at room temperature for several days. The filtrate was concentrated under reduced pressure to give <b>10</b> (1.03 g). A mixture of <b>8</b> (100 mg, 0.39 mmol), NCS (51.9 mg, 0.39 mmol), and pyridine (7.8 mg, 0.1 mmol) in DCM (1.2 mL) was stirred at room temperature for 10 min, followed by additions of <b>10</b> (98 mg, 0.39 mmol) and Et<sub>3</sub>N (0.8 mL). The reaction mixture was stirred overnight, diluted with DCM, washed with water, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude was purified on a silica gel column MeOH containing 2% Et<sub>3</sub>N/DCM with a gradient from 0% to 5%, followed by purification on a C18 column, eluting with MeCN/water containing 0.1% formic acid to give <b>4</b> (27 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.80 (1H, br s), 7.59–7.54 (2H, m), 7.48–7.44 (1H, d), 7.27–7.25 (1H, d), 7.18–7.16 (1H, d) 7.12 (1H, s), 7.08–7.04 (2H, t), 6.94 (1H, br s), 6.58–6.54 (1H, d). LCMS <i>m</i>/<i>z</i> 465 [M + 1]<sup>+</sup>, 97.7% purity.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>,<i>E</i>)-(3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>5a</b>) and (<i>R</i>,<i>E</i>)-(3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>5b</b>)</h3><div id="sec4_10_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Method a</h4><div class="NLM_p last">Sodium borohydride (1.3 g, 34. mmol) was added to a solution of <b>3a</b> (11.4 g, 23.2 mmol) in anhydrous THF (116 mL) in an ice bath, followed by slow addition of anhydrous MeOH. The reaction mixture was stirred at room temperature for 2 h, quenched with a mixture of ice and brine, and extracted with EtOAc. The combined organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude was purified on a silica gel column, eluting with MeCN containing 5% Et<sub>3</sub>N/EtOAc with a gradient from 0% to 100% to give <b>5a</b> (8.1 g, 77.7% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.72 (1H, s), 7.52–7.48 (2H, m), 7.45 (1H, s), 7.26–7.23 (1H, d), 7.16–7.08 (2H, t), 7.03–6.96 (2H, m), 6.92 (1H, s), 4.23–4.19 (1H, d), 4.09–4.05 (1H, d), 3.84 (3H, m), 3.36–3.32(1H, m), 2.99–2.75 (1H, m), 2.75–2.68 (2H, m), 2.60 (1H, br s), 2.29 (3H, s), 2.04–1.92 (1H, m), 1.92–1.80 (1H, m). LCMS <i>m</i>/<i>z</i> 449 [M + 1]<sup>+</sup>, 99.0% purity. Compound <b>5b</b> was prepared from <b>3b</b> by the same method. HPLC: 96.8% purity.</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Method b</h4><div class="NLM_p last">Compound <b>3</b> (3 g, crude) was reduced according to method a to give <b>5</b> (2.8 g, crude). This product (500 mg) was resolved on an AD column, eluting with 65% isopropanol in hexanes containing 0.1% Et<sub>2</sub>NH to give <b>5a</b> (183 mg, 36.6%) and <b>5b</b>.</div></div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>E</i>)-3-(3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)acrylaldehyde (<b>7</b>)</h3><div class="NLM_p last">A solution of 3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzaldehyde (<b>6</b>) (1.00 g, 4.6 mmol) and (formylmethylene)triphenylphosphorane (1.83 g, 6.0 mmol) in THF was heated at 150 °C in a microwave reactor for 30 min. Solvent was evaporated under reduced pressure, and the residue was purified on a silica gel column, eluting with EtOAc/hexanes in a gradient from 0% to 100% to give <b>7</b> (1.05 g), which was used without further purification in the preparation of <b>8</b>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl)acrylaldehyde Oxime (<b>8</b>)</h3><div class="NLM_p last">Hydroxylamine hydrochloride (2.35 g, 33.8 mmol) was added portionwise to a solution of <b>7</b> (6.3 g,26.0 mmol) and potassium acetate in MeOH (300 mL) in an ice bath. The reaction mixture was stirred at 0 °C for 90 min and then at room temperature for 30 min. Solvent was evaporated under reduced pressure. The residue was partitioned in EtOAc and brine, and aqueous NaHCO<sub>3</sub> was added to adjust the pH to 8. The aqueous phase was extracted with EtOAc, and the combined organic phase was washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude was briefly purified on a C18 column, eluting with MeCN/water containing 0.02% concentrated HCl. The collected fraction was concentrated under reduced pressure to remove MeCN, neutralized with aqueous NaHCO<sub>3</sub>, and extracted with EtOAc to give <b>8</b> (2.48 g). LCMS <i>m</i>/<i>z</i> 258 [M + 1]<sup>+</sup>. It was used without further purification in the preparation of <b>4</b>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>R</i>)-1-((<i>S</i>,<i>E</i>)-3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)ethanol (<b>11a</b>) and (<i>S</i>)-1-((<i>S</i>,<i>E</i>)-3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)ethanol (<b>11b</b>)</h3><div class="NLM_p last">Under N<sub>2</sub> protection, a 1 M solution of (<i>S</i>)-2-methyl-CBS-oxazaborolidine (4.1 mL, 4.1 mmol) in toluene was added to a solution of the crude <b>33</b> (2.2 g, 4.9 mmol) in anhydrous THF (15 mL) at room temperature, followed by slow addition of 2 M solution of BH<sub>3</sub>·Me<sub>2</sub>S (3.7 mL, 7.3 mmol) in THF. The reaction solution was stirred for 2 h, quenched with a mixture of brine and ice, and extracted with EtOAc. The combined organic phase was washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude was purified on a silica gel column, eluting with EtOAc/hexanes from 0% to 100%. The desired fraction was concentrated under reduced pressure. The resulting residue (1.3 g) was dissolved in THF (27 mL), treated with concentrated hydrochloride (0.45 mL, 5.5 mmol) at room temperature for 1 h, neutralized with aqueous NaHCO<sub>3</sub>, concentrated under reduced pressure, diluted with brine, and extracted with EtOAc. The combined organic phase was washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude was purified on a C18 column, eluting with MeCN/water containing 0.1% TFA. The desired fractions were neutralized with aqueous NaHCO<sub>3</sub>, concentrated under reduced pressure, and extracted with EtOAc to give <b>11a</b> (0.56 g, 25.3% yield) and <b>11b</b> (0.12 g, 5.4% yield). Analytical data for <b>11a</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94 (1H, s), 7.50–7.46 (2H, m), 7.42 (1H, s), 7.23–7.21 (1H, d), 7.11–7.07 (2H, t), 6.97–6.91 (3H, m), 4.53–4.49 (1H, q), 3.82 (3H, s), 3.42–3.37 (1H, m), 2.99–2.95 (1H, m), 2.79–2.71 (1H, m), 2.54–2.48 (1H, m), 2.30 (3H, s), 1.95–1.76 (2H, m), 1.15–1.13 (3H, d); LCMS <i>m</i>/<i>z</i> 463 [M + H]<sup>+</sup>, 97.8% purity. <b>11b</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (1H, s), 7.63–7.59 (2H, m), 7.44 (1H, s), 7.24–7.22 (1H, d), 7.10–7.06 (2H, t), 6.98–6.92 (3H, m), 4.58–4.53 (1H, q), 3.83 (3H, s), 3.27–3.22 (1H, m), 2.88–2.84 (1H, m), 2.75–2.71 (1H, m), 2.55–2.49 (1H, m), 2.31 (3H, s), 1.86–1.79 (2H, m), 1.37–1.35 (3H, d). LCMS <i>m</i>/<i>z</i> 463 [M + H]<sup>+</sup>, 99.0% purity.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>E</i>)-(8-(3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-3-phenyl-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>20</b>) and Its Enantiomer (<b>20a</b>)</h3><div class="NLM_p last"><b>20</b> and <b>20a</b> were prepared from <b>30c</b>, similar to the procedure for <b>5a</b> in method b. The racemate <b>20</b> was resolved on an OJ column, eluting with 65% isopropanol in hexanes to give <b>20a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71 (1H, s), 7.52–7.49 (2H, m), 7.46–7.39 (4H, m), 7.26–7.23 (1H, d), 7.00–6.97 (1H, d), 6.96 (1H, s), 6.92 (1H, s), 4.25–4.22 (1H, d), 4.10–4.07 (1H, d), 3.84 (3H, s), 3.39–3.33 (1H, m), 3.05–3.00 (1H, m,), 2.73–2.70 (2H, m), 2.29 (3H, s), 2.00–1.84 (2H, m). LCMS <i>m</i>/<i>z</i> 431 [M + 1]<sup>+</sup>, 100% purity.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>E</i>)-(3-(3-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>21</b>) and Its Enantiomers (<b>21a</b>)</h3><div class="NLM_p last"><b>21</b> and <b>21a</b> were prepared from <b>30d</b>, similar to the procedure for <b>5a</b> in method b. Analytical data for <b>21a</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.73 (1H, s), 7.46 (1H, s), 7.43–7.38 (1H, m), 7.26–7.24 (3H, m), 7.12–7.07 (1H, m), 7.01–6.98 (1H, d), 6.97 (1H, s), 6.93 (1H,s), 4.22–4.19 (1H, d), 4.07–4.03 (1H, d), 3.85 (3H, s), 3.40–3.34 (1H, m), 3.06–3.01 (1H, m), 2.74–2.71 (2H, m), 2.30 (3H, s), 2.01–1.84 (2H, m). LCMS <i>m</i>/<i>z</i> 449 [M + 1]<sup>+</sup>, 96.0% purity.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>E</i>)-(3-(2-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>22</b>) and Its Enantiomers (<b>22a</b>)</h3><div class="NLM_p last"><b>22</b> and <b>22a</b> were prepared from <b>30e</b>, similar to the procedure for <b>5a</b> in method b. Analytical data for <b>22a</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.75–7.71 (2H, m), 7.44 (1H, s), 7.41–7.35 (1H, m), 7.25–7.21 (2H, m), 7.12–7.07 (1H, m), 6.99–6.92 (3H, m), 4.44–4.41 (1H, d), 4.06–4.03 (1H, d), 3.84 (3H, s), 3.52–3.47 (1H, m), 3.15–3.10 (1H, m), 2.83–2.75 (1H, m), 2.63–2.55 (1H, m) 2.29 (3H, s), 1.97–1.88 (2H, m). LCMS <i>m</i>/<i>z</i> 449 [M + 1]<sup>+</sup>, 97.0% purity.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>E</i>)-4-(3-(Hydroxymethyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)benzonitrile (<b>23</b>) and Its Enantiomer (<b>23a</b>)</h3><div class="NLM_p last"><b>23</b> and <b>23a</b> were prepared from <b>30f</b>, similar to the procedure for <b>5a</b> in method b. Analytical data for <b>23a</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.74–7.72 (3H, m), 7.65–7.63 (2H, d), 7.45 (1H, s), 7.26–7.24 (1H, d), 7.01–6.98 (1H, d), 6.96 (1H, s), 6.93 (1H, s), 4.24–4.21 (1H, d), 4.07–4.04 (1H, d), 3.85 (3H, s), 3.43–3.37 (1H, m), 3.05–2.99 (1H, m), 2.75–2.71 (2H, m), 2.30 (3H, s), 2.04–1.84 (2H, m). LCMS <i>m</i>/<i>z</i> 456 [M + 1]<sup>+</sup>, 95.3% purity.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>E</i>)-(3-(3,5-Difluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>24</b>) and Its Enantiomer (<b>24a</b>)</h3><div class="NLM_p last"><b>24</b> and <b>24a</b> were prepared from <b>30g</b>, similar to the procedure for <b>5a</b> in method b. The racemate <b>24</b> was resolved on an OD-H column by SFC using IPA as a cosolvent to give <b>24a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72 (1H, s), 7.45 (1H, s), 7.26–7.25 (1H, d), 7.06–7.04 (2H, m), 7.00–6.98 (1H, d), 6.96 (1H, s), 6.93 (1H, d), 6.87–6.82 (1H, m), 4.18–4.15 (1H, d),), 4.04–4.01 (1H, d), 3.85 (3H, s), 3.43–3.37 (1H, m), 3.10–3.03 (1H, m), 2.74–2.71 (2H, m), 2.30 (3H, s), 2.00–1.85 (2H, m). LCMS <i>m</i>/<i>z</i> 467 [M + 1]<sup>+</sup>, 100% purity.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>E</i>)-(8-(3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-3-(3,4,5-trifluorophenyl)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>25</b>) and Its Enantiomer (<b>25a</b>)</h3><div class="NLM_p last"><b>25</b> and <b>25a</b> were prepared from <b>30h</b>, similar to the procedure for <b>5a</b> in method b. Analytical data for <b>25a</b>: <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.76 (1H, s), 7.46 (1H, s), 7.30–7.20 (3H, m), 7.01–6.96 (3H, m), 4.18–4.16 (1H, d), 4.10–4.08 (1H, d), 3.86 (3H, s), 3.46–3.40 (1H, m), 3.10–3.04 (1H, m), 2.80–2.60 (2H, m), 2.31 (3H, s), 2.00–1.95 (1H, m), 1.95–1.88 (1H, m). LCMS <i>m</i>/<i>z</i> 485 [M + 1]<sup>+</sup>, 96.0% purity.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>E</i>)-(3-(5-Fluoropyridin-2-yl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>26</b>) and Its Enantiomer (<b>26a</b>)</h3><div class="NLM_p last"><b>26</b> and <b>26a</b> were prepared according to the similar procedure for <b>5a</b> in method b from <b>30i</b> which was made from <b>45</b> according to the procedure for <b>30b</b>. The racemate <b>26</b> was resolved on an OJ column, eluting with 40% isopropanol in hexanes to give <b>26a</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.41 (1H, m), 7.84–7.81 (1H, m), 7.72 (1H, s), 7.53–7.48 (1H, m), 7.46 (1H, s), 7.26–7.23 (1H, d), 7.00–6.97 (1H, d), 6.96 (1H, s), 6.92 (1H, s), 4.45–4.42 (1H, d), 4.05–4.02 (1H, d), 3.84 (3H, s), 3.54–3.48 (1H, m), 3.19–3.14 (1H, m), 2.73–2.63 (2H, m), 2.29 (3H, s), 1.97–1.89 (1H, m), 1.83–1.75 (1H, m). LCMS <i>m</i>/<i>z</i> 450 [M + H]<sup>+</sup>, 91.4% purity.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>E</i>)-(3-(5-Fluoropyridin-3-yl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methanol (<b>27</b>) and Its Enantiomer (<b>27a</b>)</h3><div class="NLM_p last"><b>27</b> and <b>27a</b> were prepared according to the similar procedure for <b>5a</b> in method b from <b>30j</b> which was made from <b>46</b> according to the procedure for <b>30b</b>. Analytical data for <b>27a</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55–8.51 (2H, m), 7.72 (1H, s), 7.68–7.65 (1H, m), 7.46 (1H, s), 7.26–7.24 (1H, d), 7.00–6.93 (3H, m), 4.25–4.22 (1H, d), 4.10–4.07 (1H, d), 3.84 (3H, s), 3.46–3.40 (1H, m), 3.09–3.04 (1H, m), 2.75–2.70 (2H, m), 2.29 (3H, s), 2.05–1.85 (2H, m). LCMS <i>m</i>/<i>z</i> 450 [M + H]<sup>+</sup>, 95% purity.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-Bromo-<i>N</i>-(1-(4-fluorophenyl)ethylidene)propan-1-amine (<b>30a</b>)</h3><div class="NLM_p last">Under N<sub>2</sub> protection, Et<sub>3</sub>N (40 mL, 29.0 mmol) was added slowly to a solution of 4-fluoroacetophenone (5 g, 36.2 mmol) and 3-bromopropan-1-amine hydrobromide (<b>41</b>) (10.3 g, 47.1 mmol) in anhydrous DMF (35 mL) and DCM (10 mL) while vigorously stirring. A solution of TiCl<sub>4</sub> (6.2 g, 32.6 mmol) in DCM (29 mL) was added dropwise at 0 °C. The reaction suspension was vigorously stirred at room temperature overnight. The reaction mixture was diluted with ether and filtered to remove solid. The filtrate was washed with ice cold brine 4 times and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> to give <b>30a</b> (6.8 g, 73.0% yield). The product was used without further purification in the preparation of <b>1</b>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Ethyl 2-(3-Bromopropylimino)-2-(4-fluorophenyl)acetate (<b>30b</b>)</h3><div class="NLM_p last">Under N<sub>2</sub> protection, the reaction solution of <b>42</b> (306.8 g, 1.1 mol), ethyl 2-(4-fluorophenyl)-2-oxoacetate (209 g, 1.1 mol), and trimethylsilyl trifluoromethanesulfonate (11.8 g, 0.05 mol) in DCM (1500 mL) was refluxed for 4 days, cooled to room temperature, washed with cold aqueous NaHCO<sub>3</sub> and brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> to give <b>30b</b> (332 g, 98.6% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.71–7.67 (2H, m), 7.24–7.05 (2H, m), 4.45–4.39 (2H, q), 3.66–3.62 (2H, t), 3.55–3.52 (2H, t), 2.28–2.2.25 (2H, m), 1.41–1.37 (3H, t).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Ethyl 4-(3-Bromopropyl)-3-((diethoxyphosphoryl)methyl)-5-(4-fluorophenyl)-4,5-dihydro-1,2,4-oxadiazole-5-carboxylate (<b>31b</b>)</h3><div class="NLM_p last">Under N<sub>2</sub> protection, NBS (101.3 g, 569 mmol) in DMF (240 mL) was added dropwise to a solution of diethyl 2-(hydroxyimino)ethylphosphonate (<b>28) (</b>111 g, 569 mmol) in DMF (470 mL) at −30 °C. The cooling bath was removed, and the reaction mixture was stirred for about 1 h to give <b>29</b> in DMF solution. This solution was slowly mixed with <b>30b</b> (178.8 g, 569 mmol) in DMF (400 mL) at −10 °C, followed by dropwise addition of Et<sub>3</sub>N (39.5 mL, 285 mmol) in DMF (250 mL) in an ice bath. The resulting reaction mixture was stirred at room temperature overnight. Additional 39.5 mL of Et<sub>3</sub>N in DMF (250 mL) was added dropwise in an ice bath, and the reaction mixture was stirred at room temperature for 4 h. Then an additional 1 equiv of <b>29</b> was made as described above and added dropwise to the reaction mixture in an ice bath, followed by slow addition of Et<sub>3</sub>N (79 mL) in two portions using the procedure described above. The reaction mixture was diluted with 70% EtOAc in hexanes and half-saturated NaCl in water. The aqueous phase was extracted with 70% EtOAc in hexanes. The combined organic phase was washed with a mixture of NaHCO<sub>3</sub> and NaCl in water, with half-saturated NaCl in water, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude was purified on a silica gel column, eluting with EtOAc/hexanes in a gradient from 0% to 70% to give <b>31b</b> (122.6 g, 42.6% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.49–7.46 (2H, m), 7.12–7.07 (2H, m), 4.33–4.27 (2H, m), 4.21–4.16 (4H, m), 3.54–3.46 (1H, m), 3.42–3.34 (1H, m) 3.22–3.18 (2H, m), 2.99–2.93(2H, m), 1.81–1.70 (1H, m), 1.62–1.51 (1H, m), 1.36–1.26 (9H, m).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Ethyl 8-(Diethoxyphosphoryl)-3-(4-fluorophenyl)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridine-3-carboxylate (<b>32b</b>)</h3><div class="NLM_p last">Under N<sub>2</sub> protection, <i>t</i>-BuOK (29.7 g, 265.0 mmol) in anhydrous THF (265 mL) was added dropwise to a solution of <b>31b</b> (122.6 g, 240.9 mmol) in anhydrous THF (2400 mL) at −70 °C. The reaction mixture was allowed to warm to 12 °C over a period of 2 h, diluted with brine, and extracted with EtOAc. The combined organic phase was washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude was purified on a silica gel column, eluting with EtOAc/hexanes in a gradient from 0% to 100% to give <b>32b</b> (82.6 g, 80.1% yield), a mixture of diastereomers A and B. The analytical diastereomer samples were obtained by purification on silica gel column again. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), diastereomer A: δ 7.45–7.41 (2H, m), 7.08–7.04 (2H, m), 4.30–4.12 (6H, m), 3.33–3.28 (1H, m), 3.13–3.05 (1H, tt), 2.79–2.74 (1H, m), 2.13–1.75 (4H, m), 1.34–1.26 (9H, m). Diastereomer B: δ 7.45–7.41 (2H, m), 7.10–7.05 (2H, m), 4.33–4.14 (6H, m), 3.42–3.37 (1H, m), 3.15–3.06 (1H, tt), 2.62–2.56 (1H, m), 2.18–2.08 (2H, m), 1.92–1.78 (1H, m), 1.68–1.57 (1H, m), 1.36–1.27 (9H, m).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>S</i>,<i>E</i>)-1-(3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)ethanone (<b>33</b>)</h3><div class="NLM_p last">A solution of 3 M MeMgBr in ether (3.4 mL, 10.3 mmol) and Et<sub>3</sub>N (4.3 mL, 31 mmol) in THF (6.8 mL) was added dropwise to a stirred solution of <b>3a</b> (2.5 g, 5.2 mmol) in 15.6 mL of THF at −60 °C under nitrogen atmosphere. The reaction mixture was allowed to warm to 10 °C over a period of 5 h, stirred for an additional 1 h at room temperature, quenched with a mixture of brine and ice, diluted with EtOAc, filtered through a Celite pad, and extracted with EtOAc. The combined organic phase was washed with brine and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The crude was purified on a silica gel column, eluting with EtOAc/hexanes from 0% to 75% to give a crude of <b>33</b> (1.7 g) containing 50% of <b>3a</b>. This crude was used without further purification in the preparation of <b>11a</b> and <b>11b</b>. The analytical sample was purified on a C18 column, eluting with MeCN/water containing 0.1% formic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.67 (1H, s), 7.47–7.43 (3H, m), 7.21–7.19 (1H, d), 7.12–7.08 (2H, t), 6.96–6.94 (1H, d), 6.92 (1H, s), 6.88 (1H, s), 3.80 (3H, s), 3.58–3.53 (1H, m), 2.83–2.77 (1H, m), 2.70–2.59 (2H, m), 2.25–2.24 (6H, ss),1.92–1.87 (1H, m), 1.72–1.66 (1H, m).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>S</i>,<i>E</i>)-3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridine-3-carbaldehyde (<b>34</b>)</h3><div class="NLM_p last">Under N<sub>2</sub> protection, DMSO (0.16 mL, 2.2 mmol) was added dropwise to a solution of oxalyl dichloride (0.11 mL, 1.3 mmol) in anhydrous DCM (11.1 mL) at −78 °C, followed by dropwise addition of <b>5a</b> (500 mg, 1.1 mmol) in anhydrous DCM (1.5 mL). After the mixture was stirred at −78 °C for 1 h, Et<sub>3</sub>N (0.62 mL, 4.5 mmol) was added dropwise. The reaction mixture was stirred for 30 min, allowed to warm to room temperature, diluted with cold brine, and extracted with DCM. The combined organic phase was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure to give <b>34</b> (507 mg), which was used without further purification in the preparations of <b>36</b>, <b>37</b>, and <b>38</b>. MS <i>m</i>/<i>z</i> 447.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>S</i>,<i>E</i>)-3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-3-(methoxymethyl)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridine (<b>35</b>)</h3><div class="NLM_p last">Sodium hydride (2 mg, 60% in mineral oil) and methyl iodide (16.6 mg, 0.12 mmol)) were added to a stirred solution of <b>5a</b> (7.5 mg, 0.017 mmol) in anhydrous DMF (0.2 mL) at room temperature under nitrogen atmosphere. The reaction mixture was stirred for 15 min, quenched with iced brine, and extracted with EtOAc. The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude was purified on a C18 column with MeCN/water containing 0.1% formic acid. The desired fraction was neutralized with aqueous NaHCO<sub>3</sub>, concentrated under reduced pressure to remove MeCN, and extracted with EtOAc to give <b>35</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.05 (1H, s), 7.55–7.51 (2H, m), 7.46 (1H, s), 7.26–7.24 (1H, d), 7.11–7.06 (2H, t), 7.02–6.93 (3H, m), 4.04–4.01 (1H, d), 3.96–3.93 (1H, d), 3.84 (3H, s), 3.50 (3H, s), 3.29–3.26 (1H, m), 2.97–2.94 (1H, m), 2.71–2.68 (2H, m), 2.33 (3H, s), 1.95–1.85 (1H, m), 1.85–1.75 (1H, m). LCMS <i>m</i>/<i>z</i>463 [M + H]<sup>+</sup>, 98.5% purity.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>S</i>,<i>E</i>)-1-(3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)-<i>N</i>-methylmethanamine (<b>36</b>)</h3><div class="NLM_p last">Sodium triacetoxy borohydride (252 mg, 1.2 mmol) was slowly added to a stirred reaction mixture of <b>34</b> (200 mg, 0.45 mmol), 2 M solution methylamine in THF (0.5 mL, 1 mmol), and acetic acid (0.051 mL, 0.9 mmol) in DCE (12 mL) at 0 °C under nitrogen atmosphere. The reaction mixture was stirred at room temperature overnight, quenched with aqueous NaHCO<sub>3</sub>, and extracted with EtOAc. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated under reduced pressure. The crude was purified on a C18 column with MeCN/water containing 0.1% formic acid. The desired fraction was neutralized with aqueous NaHCO<sub>3</sub>, concentrated under reduced pressure, and extracted with EtOAc to give <b>36</b> (87.9 mg, 42.5% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.15 (1H, s), 7.44–7.36 (3H, m), 7.13–7.09 (2H, t), 7.05 (1H, s), 6.94 (1H, s), 6.79 (1H, s), 6.73–6.71 (1H, d), 3.99–3.95 (1H, d), 3.82 (3H, s), 3.72–3.69 (1H, d), 3.44–3.38 (1H, m), 2.93 (3H, s), 2.76–2.67 (2H, m), 2.44 (3H, s), 2.39–2.32 (1H, m), 1.99–1.87 (1H, m), 1.73–1.61 (1H, m). LCMS <i>m</i>/<i>z</i> 462 [M + H]<sup>+</sup>, 99.9% purity.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>S</i>,<i>E</i>)-1-(3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)-<i>N</i>,<i>N</i>-dimethylmethanamine (<b>37</b>)</h3><div class="NLM_p last"><b>37</b> was made from <b>34</b> and dimethylamine according to the procedure for <b>36</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.69 (1H, s), 7.54–7.50 (2H, m), 7.46 (1H, s), 7.22–7.20 (1H, d), 7.09–7.05 (3H, t), 6.97–6.95 (1H, d), 6.94 (1H, s), 6.91 (1H, s), 3.82 (3H, s), 3.23–3.18 (1H, m), 3.09–3.05 (1H, d), 2.95–2.91 (1H, d), 2.85–2.79 (1H, m), 2.76–2.70 (1H, m), 2.60–2.52 (1H, m), 2.50 (6H, s), 2.28 (3H, s), 1.90–1.79 (2H, m). LCMS <i>m</i>/<i>z</i> 476 [M + H]<sup>+</sup>, 98.1% purity.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>S</i>,<i>E</i>)-2-((3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methylamino)ethanol (<b>38</b>)</h3><div class="NLM_p last"><b>38</b> was made from <b>34</b> and 2-aminoethyl benzoate according to the procedure for <b>36</b>, followed by hydrolysis of the benzoate with lithium hydroxide. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.03 (1H, s), 7.45–7.41 (2H, m), 7.35–7.33 (1H, d), 7.15–7.09 (3H, m), 7.05 (1H, s), 6.88 (1H, s), 6.81–6.79 (1H, d), 4.20–4.17 (1H, d), 4.02–3.97 (2H, m), 3.85 (3H, s), 3.66–3.63 (1H, d), 3.46–3.43 (2H, m), 3.39–3.35 (1H, m), 2.76–2.70 (2H, m), 2.45 (3H, s), 2.37–2.29 (1H, m), 1.94–1.86 (1H, m), 1.75–1.69 (1H, m). LCMS <i>m</i>/<i>z</i> 492 [M + H]<sup>+</sup>, 99.4% purity.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>S</i>,<i>E</i>)-<i>N</i>-((3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methyl)-<i>N</i>-methylacetamide (<b>39</b>)</h3><div class="NLM_p last">Acetic anhydride (5.3 mg, 0.052 mmol) in DCM (0.1 mL) was added dropwise to a stirred reaction mixture of <b>36</b> (20 mg, 0.043 mmol) and Et<sub>3</sub>N (0.02 mL) in anhydrous DCM (0.4 mL) at 0 °C under nitrogen atmosphere. The reaction mixture was stirred for 30 min, allowed to warm to room temperature, quenched with water, concentrated to remove DCM, and purified on a C18 column, eluting with MeCN/water containing 0.1% formic acid. The desired fraction was neutralized with aqueous NaHCO<sub>3</sub>, concentrated under reduced pressure, and extracted with EtOAc to give <b>39</b> (9.4 mg, 43.1%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.69 (1H, s), 7.58–7.55 (2H, m), 7.44 (1H, s), 7.23–7.21 (1H, d), 7.11–7.07 (2H, t), 6.98–6.94 (2H, m), 6.90 (1H, s), 4.86–4.82 (1H, d), 3.82 (3H, s), 3.53–3.49 (1H, m), 3.47–3.43 (1H, d), 3.22 (3H, s), 2.79–2.72 (1H, m), 2.63–2.57 (1H, m), 2.45–2.37 (1H, m), 2.28 (3H, s), 2.09 (3H, s), 1.80–1.70 (2H, m). LCMS <i>m</i>/<i>z</i> 504 [M + H]<sup>+</sup>, 100% purity.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>S</i>,<i>E</i>)-<i>N</i>-((3-(4-Fluorophenyl)-8-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-5,6,7,8-tetrahydro-3<i>H</i>-[1,2,4]oxadiazolo[4,3-<i>a</i>]pyridin-3-yl)methyl)-<i>N</i>-methylmethanesulfonamide (<b>40</b>)</h3><div class="NLM_p last"><b>40</b> was made from methanesulfonyl chloride according to the procedure for <b>39</b> in 46.6% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.94 (1H, s), 7.54–7.51 (2H, m), 7.45 (1H, s), 7.24–7.22 (1H, d), 7.13–7.09 (2H, t), 6.99–6.96 (2H, m), 6.93 (1H, s), 4.28–4.24 (1H, d), 3.84 (3H, s), 3.47–3.43 (1H, d), 3.43–3.39 (1H, m), 3.11 (3H, s), 2.84 (3H, s), 2.82–2.78 (1H, m), 2.73–2.66 (1H, m), 2.45–2.39 (1H, m), 2.32 (3H, s), 1.90–1.80 (2H, m). LCMS <i>m</i>/<i>z</i> 540 [M + H]<sup>+</sup>, 96.0% purity.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(3-Bromopropyl)-<i>N</i>,<i>N</i>-bis(trimethylsilyl)amine (<b>42</b>)</h3><div class="NLM_p last">Chlorotrimethylsilane (273 g, 2.5 mol) was added to a suspension of <b>41</b> in anhydrous DCM (3000 mL) in an ice bath, followed by slow addition of Et<sub>3</sub>N (525 mL, 3.8 mol). The reaction mixture was stirred at room temperature overnight and filtered to remove white solid. The filtrate was concentrated under reduced pressure, diluted with ether, filtered, and concentrated again to give <b>42</b> (306.8 g, 95.1% yield). The product was used without further purification in the preparation of <b>30b</b>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Ethyl 2-(5-Fluoropyridin-2-yl)-2-oxoacetate (<b>45</b>)</h3><div class="NLM_p last">Isopropylmagnesium chloride–lithium chloride complex (1.3 M in THF) (131 mL, 170.5 mmol) was added slowly to a solution of 2-bromo-5-fluoropyridine (<b>43</b>) (25 g, 142.1 mmol) in 200 mL of THF over 20 min at 0 °C. The resulting mixture was allowed to warm to room temperature over 1 h and stirred at room temperature for 30 min. The prepared organometallic solution was added to a solution of diethyl oxalate (22.7 g, 135 mmol) in 100 mL of THF at −78 °C slowly via cannulation. The reaction mixture was allowed to warm to room temperature overnight, quenched with saturated NH<sub>4</sub>Cl, and extracted with ether. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness. The residue was purified on a silica gel column, eluting with EtOAc/hexanes in a gradient from 0% to 100% to give <b>45</b> (13 g, 47% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.57 (1H, m), 8.19–8.15 (1H, m), 7.62–7.57 (1H, m), 4.50–4.45 (2H, q), 1.42–1.38 (3H, t).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Ethyl 2-(5-Fluoropyridin-3-yl)-2-oxoacetate (<b>46</b>)</h3><div class="NLM_p last"><b>46</b> was prepared from 3-bromo-5-fluoropyridine (<b>44</b>) according to the procedure for <b>45</b>. The product was used without further purification in the preparation of <b>30j</b>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>S</i>)-2-Amino-2-(3,4,5-trifluorophenyl)ethanol (<b>48</b>)</h3><div class="NLM_p last">Sodium hydroxide (8.2 g, 205 mmol) in water (300 mL) was added to a solution of CbzNH<sub>2</sub> (31.5 g, 208 mmol) in PrOH (300 mL). The mixture was stirred for 3 min, followed by dropwise addition of <i>tert</i>-butyl hypochlorite (23.5 mL, 205 mmol). After this mixture was stirred for another 6 min, a solution of (DHQ)<sub>2</sub>PHAL (600 mg, 0.75 mmol) and 1,2,3-trifluoro-5-vinylbenzene <b>47</b> (100 mmol) in PrOH (150 mL) was added, followed by addition of K<sub>2</sub>OsO<sub>2</sub>(OH)<sub>4</sub> (380 mg, 1.0 mmol). The resulting mixture turned green immediately. Stirring was continued for 2 h, upon which the solution turned light yellow. The reaction was quenched by stirring the mixture with an excess of Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> for 2 h. The PrOH layer was then separated and concentrated in vacuum. The solid residue was dissolved in EtOAc, which was passed through a silica gel pad, and concentrated. The residue was treated with 15% EtOAc/hexanes to remove solid CbzNH<sub>2</sub>. The filtrate was reconcentrated and crystallized in EtOAc/hexanes to give an undesired regioisomer (3 g). The filtrate was concentrated again to provide a solid mixture (18 g) with the desired Cbz-protected regioisomer as the major component (>70%). This mixture was directly subjected to hydrogenation catalyzed with Pd(OH)<sub>2</sub>/C (9 g, 50% water, 20% Pd on dry basis) in MeOH (250 mL) for 1 h. The reaction mixture was filtered through Celite and concentrated to give <b>48</b> (8.6 g, 45.0% yield), which was used without further purification in the preparation of <b>51</b>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>S</i>,<i>E</i>)-1-(2-Hydroxy-1-(3,4,5-trifluorophenyl)ethyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)piperidin-2-one (<b>51</b>)</h3><div class="NLM_p last"><b>51</b> was prepared from <b>48</b> and (<i>E</i>)-5-chloro-2-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)pentanoic acid TFA salt (<b>49</b>) using a similar method described in the ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.82 (1H, s), 7.70 (1H, s), 7.24–7.22 (1H, d), 7.00–6.91 (4H, m), 6.92 (1H, s), 5.78–5.76 (1H, m), 4.2–4.05 (2H, m), 3.84 (3H, s), 3.42–3.35 (1H, m), 3.20–3.12 (1H, m), 2.88–2.76 (2H, m), 2.28 (3H, s), 1.90–1.70 (2H, m). LCMS <i>m</i>/<i>z</i> 472 [M + H]<sup>+</sup>, 96.8% purity.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>S</i>,<i>E</i>)-1-(2-(Aminooxy)-1-(3,4,5-trifluorophenyl)ethyl)-3-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)piperidin-2-one (<b>52</b>)</h3><div class="NLM_p last">Under N<sub>2</sub> protection, DIAD (3.0 g, 15 mmol) was added dropwise to a mixture of <b>51</b> (4.7 g, 10 mmol), PPh<sub>3</sub> (3.9 g, 15 mmol), and <i>N</i>-hydroxylphthalimide (2.4 g, 15 mmol) in anhydrous THF (100 mL) at −10 °C. The mixture was allowed to warm to room temperature and stirred for 30 min. After evaporation of THF, the residue was dissolved in EtOAc, washed with aqueous NaHCO<sub>3</sub>, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was then treated with NH<sub>2</sub>NH<sub>2</sub> monohydrate (1.0 g, 20 mmol) in EtOH (100 mL) overnight. After evaporation of EtOH, the residue was dissolved in DCM, washed consecutively with water and brine, and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The DCM was then removed and the residue was purified on a silica gel column, eluting with MeOH/DCM containing 0.1% Et<sub>3</sub>N to afford <b>52</b> (3.5 g, 72.2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.86 (1H, br s), 7.71 (1H, s), 7.25–7.23 (1H, m), 7.05–7.02 (2H, m), 6.95–6.92 (3H, m), 6.33–6.28 (1H, br t), 5.70 (2H, br s), 4.13–4.10 (2H, m), 3.84 (3H, s), 3.32–3.25 (1H, m), 3.07–3.02 (1H, m), 2.92–2.75 (2 H, m), 2.28 (3H, s), 1.92–1.85 (1H, m), 1.78–1.70 (1H, m).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>S</i>,<i>E</i>)-9-(3-Methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)benzylidene)-4-(3,4,5-trifluorophenyl)-3,4,6,7,8,9-hexahydropyrido[2,1-<i>c</i>][1,2,4]oxadiazine (<b>53</b>)</h3><div class="NLM_p last">A solution of <b>52</b> (2.7 g, 5.5 mmol) in EtOH (30 mL) was added to a mixture of P<sub>2</sub>O<sub>5</sub> (7.5 g, 52.8 mmol) in EtOH (35 mL). The resulting mixture was then stirred at 80 °C overnight, cooled to room temperature, and diluted with DCM and water. Aqueous K<sub>2</sub>CO<sub>3</sub> was added to adjust the pH to ∼9–10. The organic layer was then collected and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After the DCM was evaporated, the residue was purified on a silica gel column, eluting with MeOH/DCM containing 0.1% Et<sub>3</sub>N to afford <b>53</b> (2.2 g, 84.6% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.69 (1H, s), 7.51 (1H, br s), 7.24–7.21 (1H, m), 7.00–6.95 (4H, m), 6.91 (1H, s), 4.26–4.24 (1H, m), 4.04–4.02 (2H, m), 3.83 (3H, s), 3.18–3.03 (2H, m), 2.86–2.79 (1H, m), 2.75–2.68 (1H, m), 2.28 (3H, s), 1.93–1.75 (2H, m). LCMS <i>m</i>/<i>z</i> 469 [M + H]<sup>+</sup>, 96.6% purity, 90% ee.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm201407j" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhong-Yue Sun</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a8f2f1fbfde69e9e989999e8d1c9c0c7c786cbc7c588c2c7c0c6c6d1d2d2c0dde8c5dbc686cbc7c5"><span class="__cf_email__" data-cfemail="e6bcbfb5b3a8d0d0d6d7d7a69f878e8989c885898b">[email protected]</span> <span class="__cf_email__" data-cfemail="caa0a5a2a4a4b3b0b0a2bf8aa7b9a4e4a9a5a7">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhaoning Zhu</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#03595a50564d3535333232437a626b6c6c2d606c6e23696c6b6d6d7a79796b76436e706d2d606c6e"><span class="__cf_email__" data-cfemail="84deddd7d1cab2b2b4b5b5c4fde5ecebebaae7ebe9">[email protected]</span> <span class="__cf_email__" data-cfemail="c7ada8afa9a9bebdbdafb287aab4a9e9a4a8aa">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theodros Asberom</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Bara</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chad Bennett</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Duane Burnett</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Inhou Chu</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Clader</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Cohen-Williams</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Cole</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Czarniecki</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Durkin</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gioconda Gallo</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William Greenlee</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hubert Josien</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianhai Huang</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lynn Hyde</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas Jones</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irina Kazakevich</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongmei Li</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoxiang Liu</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Lee</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Malcolm MacCoss</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mihir B. Mandal</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Troy McCracken</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amin Nomeir</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Mazzola</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anandan Palani</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric M. Parker</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dmitri A. Pissarnitski</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Qin</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lixin Song</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Terracina</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Vicarel</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johannes Voigt</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruo Xu</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lili Zhang</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Zhang</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiqiang Zhao</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaohong Zhu</span> - <span class="hlFld-Affiliation affiliation">‡Department
of Medicinal Chemistry, §Department of Neuroscience, ∥Department of Structural Chemistry, ⊥Department of Pharmaceutical
Sciences, and #Department of Drug Metabolism and Pharmacokinetics, Schering Plough Research Institute, 2015 Galloping
Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack" id="ACK-d437e4685-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Mary Humphries, Matthew Nienart, and Kathryn Galvin for conducting the in life portion of the cynomolgous study; Alexei Buevich, Rebecca Osterman, Mary Senior, and Tze-Ming Chan for NMR structural analysis; Steve Sorota for all hERG cellular data; and Jessy Wong, Xian Liang, Yan Jin, Teresa Andreani, Yang Cao, and Michael Starks for scale-up and chiral separation.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51268" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51268" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">After this paper was published online December 8, 2011, a correction was made to the straddle heading structure of Table 5. The corrected version was published December 14, 2011.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i63" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i63"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i64" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i64"> Abbreviations Used</h2><tr><td class="NLM_term">GSM</td><td class="NLM_def"><p class="first last">γ-secretase modulator</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">GSI</td><td class="NLM_def"><p class="first last">γ-secretase inhibitor</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">NSAID</td><td class="NLM_def"><p class="first last">nonsteroidal anti-inflammatory drug</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid β</p></td></tr><tr><td class="NLM_term">BACE</td><td class="NLM_def"><p class="first last">β-site amyloid cleaving enzyme</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebral spinal fluid</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney cell</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wimo, A.; Prince, M.</span><span> </span><span class="NLM_article-title">World Alzheimer Report 2010: The Global Economic Impact of Dementia</span>; <span class="NLM_publisher-name">Alzheimer’s Disease International (ADI)</span>: <span class="NLM_publisher-loc">London, U.K.</span>, September<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wimo%2C+A.%3B+Prince%2C+M.+World+Alzheimer+Report+2010%3A+The+Global+Economic+Impact+of+Dementia%3B+Alzheimer%E2%80%99s+Disease+International+%28ADI%29%3A+London%2C+U.K.%2C+September+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWimo%26aufirst%3DA.%26atitle%3DWorld%2520Alzheimer%2520Report%25202010%253A%2520The%2520Global%2520Economic%2520Impact%2520of%2520Dementia%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%2520%2528ADI%2529%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashler, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase specificity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520specificity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.-C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljs2gcyoEZ4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as beta-secretase.</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+beta-secretase."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0lik5ZGXdQAVdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520beta-secretase.%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, J.</span><span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=J.+Varghese&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DVarghese%26aufirst%3DJ.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleó, A.</span><span> </span><span class="NLM_article-title">γ-Secretase as a therapeutic target in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.2174%2F138945010790980349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=20015011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvV2jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=506-517&author=C.+Guardia-Laguartaauthor=M.+Peraauthor=A.+Lle%C3%B3&title=%CE%B3-Secretase+as+a+therapeutic+target+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase as a therapeutic target in Alzheimer's disease</span></div><div class="casAuthors">Guardia-Laguarta, C.; Pera, M.; Lleo, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">506-517</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is an intramembranous multi-protein complex that cleaves many type-1 proteins with crit. roles in neuronal function.  In Alzheimer's disease (AD) interest in γ-secretase comes, in part, from the fact that this complex is responsible for the last cleavage step of the amyloid precursor protein (APP) that generates the amyloid-β peptide (Aβ).  Aβ represents the primary component of the amyloid plaque, one of the main pathol. hallmarks of AD.  Over the last years, considerable efforts have been made to develop drugs to reduce Aβ prodn. with the aim to slow AD progression.  Many inhibitors of this protease have been identified, although the clin. use has been limited by concerns about the possible toxicity of these compds.  γ-Secretase inhibitors have been shown to reduce Aβ in vitro and in vivo, but interference with Notch proteolysis causes immunol. and gastrointestinal toxicity in animal models.  The observation that some nonsteroidal anti-inflammatory drug (NSAID) derivs. are able to specifically lower Aβ42 and the development of inhibitors with Notch-sparing selectivity has revived the interest in γ-secretase as an attractive target for drug intervention in AD.  Despite the fact that all clin. trials with NSAIDs or γ-secretase modulators in AD have failed to show clin. benefit thus far, the main concern is that the Aβ-lowering potency of the tested compds. may be too low.  Active efforts are being made to develop compds. able to penetrate into the brain to lower Aβ at physiol. doses without interfering with the cleavage and function of other crit. γ-secretase substrates.  These novel inhibitors and modulators may soon offer hope in the Alzheimer's fight.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrzBNbV0vJrbVg90H21EOLACvtfcHk0lik5ZGXdQAVdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvV2jtrw%253D&md5=5deb524a552dc54e9b7ed72df9904838</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F138945010790980349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945010790980349%26sid%3Dliteratum%253Aachs%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DPera%26aufirst%3DM.%26aulast%3DLle%25C3%25B3%26aufirst%3DA.%26atitle%3D%25CE%25B3-Secretase%2520as%2520a%2520therapeutic%2520target%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2010%26volume%3D11%26spage%3D506%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problem on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problem+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problem%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Aβ oligomers: a decade of discovery</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A%CE%B2+oligomers%3A+a+decade+of+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lgQ3jjGYcyjAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%25CE%25B2%2520oligomers%253A%2520a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Artavanis-Tsakonas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rand, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, R. J.</span><span> </span><span class="NLM_article-title">Notch signaling: cell fate control and signal integration in development</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1999&pages=770-776&author=S.+Artavanis-Tsakonasauthor=M.+D.+Randauthor=R.+J.+Lake&title=Notch+signaling%3A+cell+fate+control+and+signal+integration+in+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArtavanis-Tsakonas%26aufirst%3DS.%26aulast%3DRand%26aufirst%3DM.%2BD.%26aulast%3DLake%26aufirst%3DR.%2BJ.%26atitle%3DNotch%2520signaling%253A%2520cell%2520fate%2520control%2520and%2520signal%2520integration%2520in%2520development%26jtitle%3DScience%26date%3D1999%26volume%3D284%26spage%3D770%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hüll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M.</span><span> </span><span class="NLM_article-title">Disease-modifying therapies in Alzheimer’s disease</span> <span class="citation_source-journal">Drug</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">2075</span><span class="NLM_x">–</span> <span class="NLM_lpage">2093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.2165%2F00003495-200666160-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=17112302" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=2075-2093&author=M.+H%C3%BCllauthor=M.+Bergerauthor=M.+Heneka&title=Disease-modifying+therapies+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2165%2F00003495-200666160-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200666160-00004%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCll%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DHeneka%26aufirst%3DM.%26atitle%3DDisease-modifying%2520therapies%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrug%26date%3D2006%26volume%3D66%26spage%3D2075%26epage%3D2093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Siemers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsteinsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulnouni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span> </span><span class="NLM_article-title">Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=602-604&author=E.+R.+Siemersauthor=J.+F.+Quinnauthor=J.+Kayeauthor=M.+R.+Farlowauthor=A.+Porsteinssonauthor=P.+Tariotauthor=P.+Zoulnouniauthor=J.+E.+Galvinauthor=D.+M.+Holtzmanauthor=D.+S.+Knopmanauthor=J.+Satterwhiteauthor=C.+Gonzalesauthor=R.+A.+Deanauthor=P.+C.+May&title=Effects+of+a+%CE%B3-secretase+inhibitor+in+a+randomized+study+of+patients+with+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DPorsteinsson%26aufirst%3DA.%26aulast%3DTariot%26aufirst%3DP.%26aulast%3DZoulnouni%26aufirst%3DP.%26aulast%3DGalvin%26aufirst%3DJ.%2BE.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DSatterwhite%26aufirst%3DJ.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMay%26aufirst%3DP.%2BC.%26atitle%3DEffects%2520of%2520a%2520%25CE%25B3-secretase%2520inhibitor%2520in%2520a%2520randomized%2520study%2520of%2520patients%2520with%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26spage%3D602%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fleisher, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becerra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskind, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowell, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span> </span><span class="NLM_article-title">Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1001%2Farchneur.65.8.1031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=18695053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A280%3ADC%252BD1crht1eitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=1031-1038&author=A.+S.+Fleisherauthor=R.+Ramanauthor=E.+R.+Siemersauthor=L.+Becerraauthor=C.+M.+Clarkauthor=R.+A.+Deanauthor=M.+R.+Farlowauthor=J.+E.+Galvinauthor=E.+R.+Peskindauthor=J.+F.+Quinnauthor=A.+Sherzaiauthor=B.+B.+Sowellauthor=P.+S.+Aisenauthor=L.+J.+Thal&title=Phase+2+safety+trial+targeting+amyloid+%CE%B2+production+with+a+%CE%B3-secretase+inhibitor+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease</span></div><div class="casAuthors">Fleisher Adam S; Raman Rema; Siemers Eric R; Becerra Lida; Clark Christopher M; Dean Robert A; Farlow Martin R; Galvin James E; Peskind Elaine R; Quinn Joseph F; Sherzai Abdullah; Sowell B Brooke; Aisen Paul S; Thal Leon J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1031-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the safety, tolerability, and amyloid beta (Abeta) response to the gamma-secretase inhibitor LY450139 in Alzheimer disease.  DESIGN:  Multicenter, randomized, double-blind, dose-escalation, placebo-controlled trial.  SETTING:  Community-based clinical research centers.  Patients Fifty-one individuals with mild to moderate Alzheimer disease were randomized to receive placebo (n=15) or LY450139 (100 mg [n=22] or 140 mg [n=14]), with 43 completing the treatment phase.  Intervention The LY450139 groups received 60 mg/d for 2 weeks, then 100 mg/d for 6 weeks, and then either 100 or 140 mg/d for 6 additional weeks.  MAIN OUTCOME MEASURES:  Primary outcome measures were adverse events, plasma and cerebrospinal fluid Abeta levels, vital signs, electrocardiographic data, and laboratory safety test results.  Secondary outcome measures included the Alzheimer's Disease Assessment Scale cognitive subscale and the Alzheimer's Disease Cooperative Study Activities of Daily Living Scale.  RESULTS:  Group differences were seen in skin and subcutaneous tissue concerns (P=.05), including 3 possible drug rashes and 3 reports of hair color change in the treatment groups.  There were 3 adverse event-related discontinuations, including 1 transient bowel obstruction.  The plasma Abeta(40) concentration was reduced by 58.2% for the 100-mg group and 64.6% for the 140-mg group (P<.001).  No significant reduction was seen in cerebrospinal fluid Abeta levels.  No group differences were seen in cognitive or functional measures.  CONCLUSIONS:  LY450139 was generally well tolerated at doses of up to 140 mg/d for 14 weeks, with several findings indicating the need for close clinical monitoring in future studies.  Decreases in plasma Abeta concentrations were consistent with inhibition of gamma-secretase.  Trial Registration clinicaltrials.gov Identifier: NCT00244322.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqalGl_MMc4JotVjB3IRIyfW6udTcc2eaL_Cq0q-Q_Gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crht1eitw%253D%253D&md5=629a70ec00cd620952cd78c83617e152</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1001%2Farchneur.65.8.1031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.65.8.1031%26sid%3Dliteratum%253Aachs%26aulast%3DFleisher%26aufirst%3DA.%2BS.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DBecerra%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DGalvin%26aufirst%3DJ.%2BE.%26aulast%3DPeskind%26aufirst%3DE.%2BR.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DSowell%26aufirst%3DB.%2BB.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26atitle%3DPhase%25202%2520safety%2520trial%2520targeting%2520amyloid%2520%25CE%25B2%2520production%2520with%2520a%2520%25CE%25B3-secretase%2520inhibitor%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2008%26volume%3D65%26spage%3D1031%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ness, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span> </span><span class="NLM_article-title">Safety, tolerability, and changes in amyloid β concentrations after administration of a γ-secretase inhibitor in volunteers</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=126-132&author=E.+Siemersauthor=M.+Skinnerauthor=R.+A.+Deanauthor=C.+Gonzalesauthor=J.+Satterwhiteauthor=M.+Farlowauthor=D.+Nessauthor=P.+C.+May&title=Safety%2C+tolerability%2C+and+changes+in+amyloid+%CE%B2+concentrations+after+administration+of+a+%CE%B3-secretase+inhibitor+in+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DSkinner%26aufirst%3DM.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DSatterwhite%26aufirst%3DJ.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DNess%26aufirst%3DD.%26aulast%3DMay%26aufirst%3DP.%2BC.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520changes%2520in%2520amyloid%2520%25CE%25B2%2520concentrations%2520after%2520administration%2520of%2520a%2520%25CE%25B3-secretase%2520inhibitor%2520in%2520volunteers%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2007%26volume%3D28%26spage%3D126%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bateman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawuenyega, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarasheski, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMattos, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span> </span><span class="NLM_article-title">A γ-secretase inhibitor decreases amyloid-β production in the central nervous system</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1002%2Fana.21623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=19360898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWju7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=48-64&author=R.+J.+Batemanauthor=E.+R.+Siemersauthor=K.+G.+Mawuenyegaauthor=G.+Wenauthor=K.+R.+Browningauthor=W.+C.+Sigurdsonauthor=K.+E.+Yarasheskiauthor=S.+W.+Friedrichauthor=R.+B.+DeMattosauthor=P.+C.+Mayauthor=S.+M.+Paulauthor=D.+M.+Holtzman&title=A+%CE%B3-secretase+inhibitor+decreases+amyloid-%CE%B2+production+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">A γ-secretase inhibitor decreases amyloid-β production in the central nervous system</span></div><div class="casAuthors">Bateman, Randall J.; Siemers, Eric R.; Mawuenyega, Kwasi G.; Wen, Guolin; Browning, Karen R.; Sigurdson, Wendy C.; Yarasheski, Kevin E.; Friedrich, Stuart W.; De Mattos, Ronald B.; May, Patrick C.; Paul, Steven M.; Holtzman, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-54</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: Accumulation of amyloid-β (Aβ) by overprodn. or underclearance in the central nervous system (CNS) is hypothesized to be a necessary event in the pathogenesis of Alzheimer's disease.  However, previously, there has not been a method to det. drug effects on Aβ prodn. or clearance in the human CNS.  The objective of this study was to det. the effects of a γ-secretase inhibitor on the prodn. of Aβ in the human CNS.  Methods: We utilized a recently developed method of stable-isotope labeling combined with cerebrospinal fluid sampling to directly measure Aβ prodn. during treatment of a γ-secretase inhibitor, LY450139.  We assessed whether this drug could decrease CNS Aβ prodn. in healthy men (age range, 21-50 years) at single oral doses of 100, 140, or 280mg (n = 5 per group).  Results: LY450139 significantly decreased the prodn. of CNS Aβ in a dose-dependent fashion, with inhibition of Aβ generation of 47, 52, and 84% over a 12-h period with doses of 100, 140, and 280mg, resp.  There was no difference in Aβ clearance.  Interpretation: Stable isotope labeling of CNS proteins can be utilized to assess the effects of drugs on the prodn. and clearance rates of proteins targeted as potential disease-modifying treatments for Alzheimer's disease and other CNS disorders.  Results from this approach can assist in making decisions about drug dosing and frequency in the design of larger and longer clin. trials for diseases such as Alzheimer's disease, and may accelerate effective drug validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcrw_WczwGLVg90H21EOLACvtfcHk0liUSXHC38Z2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWju7fM&md5=8f950c978d6fc83d0436ab1138227dd6</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1002%2Fana.21623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21623%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DMawuenyega%26aufirst%3DK.%2BG.%26aulast%3DWen%26aufirst%3DG.%26aulast%3DBrowning%26aufirst%3DK.%2BR.%26aulast%3DSigurdson%26aufirst%3DW.%2BC.%26aulast%3DYarasheski%26aufirst%3DK.%2BE.%26aulast%3DFriedrich%26aufirst%3DS.%2BW.%26aulast%3DDeMattos%26aufirst%3DR.%2BB.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26atitle%3DA%2520%25CE%25B3-secretase%2520inhibitor%2520decreases%2520amyloid-%25CE%25B2%2520production%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D66%26spage%3D48%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Carlson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estergard, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barakos, J.</span><span> </span><span class="NLM_article-title">Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1016%2Fj.jalz.2011.05.2353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=21784350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1Oqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=396-401&author=C.+Carlsonauthor=W.+Estergardauthor=J.+Ohauthor=J.+Suhyauthor=C.+R.+Jackauthor=E.+Siemersauthor=J.+Barakos&title=Prevalence+of+asymptomatic+vasogenic+edema+in+pretreatment+Alzheimer%E2%80%99s+disease+study+cohorts+from+phase+3+trials+of+semagacestat+and+solanezumab"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab</span></div><div class="casAuthors">Carlson, Christopher; Estergard, Wahiba; Oh, Joonmi; Suhy, Joyce; Jack, Clifford R., Jr.; Siemers, Eric; Barakos, Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">396-401</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Cerebral vasogenic edema (VE) has been reported to occur during antiamyloid immunotherapy.  VE may be assocd. with central nervous system pathol. with blood-brain barrier disruptions; however, less is known about the prevalence of naturally occurring VE in patients with Alzheimer's disease (AD).  Methods: Fluid-attenuated inversion recovery imaging sequences were obtained from four ongoing multicenter, randomized, double-blind, placebo-controlled, phase 3 trials in patients with mild-to-moderate AD.  The first set of baseline scans was from patients in volumetric magnetic resonance imaging addenda in the Interrupting Alzheimer's Dementia by EvaluatiNg Treatment of Amyloid PaThol. (IDENTITY) studies examg. semagacestat, a γ-secretase inhibitor (cohort 1, n = 621).  The second set of baseline scans was from the EXPanding alzhEimer's Disease InvestigaTIONs (EXPEDITION) studies examg. solanezumab, an anti-Aβ monoclonal antibody (cohort 2, n = 2141).  Readers were blinded to patient-identifying information and future treatment.  A third set of baseline scans was from the first 700 patients who underwent protocol-specified magnetic resonance imaging before randomization in the EXPEDITION studies (cohort 3).  The anal. used three neuroradiologists: two performed independent primary interpretations and the third was the adjudicator.  Readers were blinded to patient information, treatment, protocol, and time point.  Results: Four cases of asymptomatic VE were detected at baseline/screening.  Two VE cases were due to underlying extra-axial mass lesions.  The third VE case was assocd. with numerous microhemorrhages in keeping with cerebral amyloid angiopathy-related inflammation or Aβ-related angiitis.  The final VE case demonstrated localized sulcal fluid-attenuated inversion recovery imaging hyperintensity.  No VE was detected in cohort 3 by readers blinded to patient baseline status.  Conclusions: VE seems to be rare at baseline in patients with AD in clin. trials, 2 of 2762 assocd. with AD.  Addnl. cohorts should be evaluated to support these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8b79pO8a-grVg90H21EOLACvtfcHk0liUSXHC38Z2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1Oqtb8%253D&md5=7ab127032d186ee51237e1260c127344</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.05.2353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.05.2353%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DC.%26aulast%3DEstergard%26aufirst%3DW.%26aulast%3DOh%26aufirst%3DJ.%26aulast%3DSuhy%26aufirst%3DJ.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DBarakos%26aufirst%3DJ.%26atitle%3DPrevalence%2520of%2520asymptomatic%2520vasogenic%2520edema%2520in%2520pretreatment%2520Alzheimer%25E2%2580%2599s%2520disease%2520study%2520cohorts%2520from%2520phase%25203%2520trials%2520of%2520semagacestat%2520and%2520solanezumab%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D396%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saqi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterlingk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1038%2F35102591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=11700559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFahsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+Eriksenauthor=P.+Dasauthor=S.+A.+Saqiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingkauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+NSAIDs+lower+amyloidogenic+A%CE%B242+independently+of+cyclooxygenase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity</span></div><div class="casAuthors">Weggen, Sascha; Eriksen, Jason L.; Das, Pritam; Sagl, Sarah A.; Wang, Rong; Pletrzik, Claus U.; Findlay, Kirk A.; Smith, Tawnya E.; Murphy, Michael P.; Bulter, Thomas; Kang, David E.; Marquez-Steriling, Numa; Golde, Todd E.; Koo, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6860</span>),
    <span class="NLM_cas:pages">212-216</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epidemiol. studies have documented a reduced prevalence of Alzheimer's disease among users of nonsteroidal anti-inflammatory drugs (NSAIDs).  It has been proposed that NSAIDs exert their beneficial effects in part by reducing neurotoxic inflammatory responses in the brain, although this mechanism has not been proved.  Here we report that the NSAIDs ibuprofen, indomethacin and sulindac sulfide preferentially decrease the highly amyloidogenic Aβ42 peptide (the 42-residue isoform of the amyloid-β peptide) produced from a variety of cultured cells by as much as 80%.  This effect was not seen in all NSAIDs and seems not to be mediated by inhibition of cyclooxygenase (COX) activity, the principal pharmacol. target of NSAIDs.  Furthermore, short-term administration of ibuprofen to mice that produce mutant β-amyloid precursor protein (APP) lowered their brain levels of Aβ42.  In cultured cells, the decrease in Aβ42 secretion was accompanied by an increase in the Aβ(1-38) isoform, indicating that NSAIDs subtly alter γ-secretase activity without significantly perturbing other APP processing pathways or Notch cleavage.  Our findings suggest that NSAIDs directly affect amyloid pathol. in the brain by reducing Aβ42 peptide levels independently of COX activity and that this Aβ42-lowering activity could be optimized to selectively target the pathogenic Aβ42 species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVOE6e2axj77Vg90H21EOLACvtfcHk0liUSXHC38Z2LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFahsLc%253D&md5=134200e7533409c6f6ad5092f680be70</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2F35102591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102591%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSaqi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterlingk%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520NSAIDs%2520lower%2520amyloidogenic%2520A%25CE%25B242%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kukar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kache, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasiadis, P. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1038%2Fnm1235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=15834426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=545-550&author=T.+Kukarauthor=M.+P.+Murphyauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=S.+Weggenauthor=T.+E.+Smithauthor=T.+Laddauthor=M.+A.+Khanauthor=R.+Kacheauthor=J.+Beardauthor=M.+Dodsonauthor=S.+Meritauthor=V.+V.+Ozolsauthor=P.+Z.+Anastasiadisauthor=P.+Dasauthor=A.+Fauqauthor=E.+H.+Kooauthor=T.+E.+Golde&title=Diverse+compounds+mimic+Alzheimer+disease-causing+mutations+by+augmenting+A%CE%B242+production"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production</span></div><div class="casAuthors">Kukar, Thomas; Murphy, Michael Paul; Eriksen, Jason L.; Sagi, Sarah A.; Weggen, Sascha; Smith, Tawnya E.; Ladd, Thomas; Khan, Murad A.; Kache, Rajashaker; Beard, Jenny; Dodson, Mark; Merit, Sami; Ozols, Victor V.; Anastasiadis, Panos Z.; Das, Pritam; Fauq, Abdul; Koo, Edward H.; Golde, Todd E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-550</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Increased Aβ42 prodn. has been linked to the development of Alzheimer disease.  We now identify a no. of compds. that raise Aβ42.  Among the more potent Aβ42-raising agents identified are fenofibrate, an antilipidemic agent, and celecoxib, a COX-2-selective NSAID.  Many COX-2-selective NSAIDs tested raised Aβ42, including multiple COX-2-selective derivs. of two Aβ42-lowering NSAIDs.  Compds. devoid of COX activity and the endogenous isoprenoids FPP and GGPP also raised Aβ42.  These compds. seem to target the γ-secretase complex, increasing γ-secretase-catalyzed prodn. of Aβ42 in vitro.  Short-term in vivo studies show that two Aβ42-raising compds. increase Aβ42 levels in the brains of mice.  The elevations in Aβ42 by these compds. are comparable to the increases in Aβ42 induced by Alzheimer disease-causing mutations in the genes encoding amyloid β protein precursor and presenilins, raising the possibility that exogenous compds. or naturally occurring isoprenoids might increase Aβ42 prodn. in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtRxKDIW3Gh7Vg90H21EOLACvtfcHk0ljv5Nbu1K3OOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOls78%253D&md5=78e435c12ca6f7c6af227cd38bffe131</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fnm1235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1235%26sid%3Dliteratum%253Aachs%26aulast%3DKukar%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DLadd%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BA.%26aulast%3DKache%26aufirst%3DR.%26aulast%3DBeard%26aufirst%3DJ.%26aulast%3DDodson%26aufirst%3DM.%26aulast%3DMerit%26aufirst%3DS.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DAnastasiadis%26aufirst%3DP.%2BZ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDiverse%2520compounds%2520mimic%2520Alzheimer%2520disease-causing%2520mutations%2520by%2520augmenting%2520A%25CE%25B242%2520production%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D545%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-226&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators%3A+a+review+of+patents+from+2008+to+2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0ljv5Nbu1K3OOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%253A%2520a%2520review%2520of%2520patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Czirr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">γ-Secretase modulation with Aβ42-lowering nonsteroidal anti-inflammatory drugs and derived compounds</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1159%2F000095270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=17047371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2hu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=298-304&author=E.+Czirrauthor=S.+Weggen&title=%CE%B3-Secretase+modulation+with+A%CE%B242-lowering+nonsteroidal+anti-inflammatory+drugs+and+derived+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase modulation with Aβ42-lowering nonsteroidal anti-inflammatory drugs and derived compounds</span></div><div class="casAuthors">Czirr, Eva; Weggen, Sascha</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">298-304</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The amyloid-β (Aβ) peptides and specifically the highly amyloidogenic isoform Aβ42 appear to be key agents in the pathogenesis of familial and sporadic forms of Alzheimer's disease (AD).  The final step in the generation of Aβ from the amyloid precursor protein is catalyzed by the multiprotein complex γ-secretase, which constitutes a prime drug target for prevention and therapy of the disease.  However, highly potent γ-secretase inhibitors that block formation of all Aβ peptides have provoked troubling side effects in preclin. animal models of AD.  This toxicity can be readily explained by the promiscuous substrate specificity of γ-secretase and its essential role in the NOTCH signaling pathway.  For that reason and because of the crucial role of Aβ42 in the pathogenesis of the disease, selective inhibition of Aβ42 prodn. would seem to be a more promising alternative to complete inhibition of γ-secretase activity.  This theor. concept has edged much closer to clin. reality with the surprising finding that certain nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, and derived compds. display preferential Aβ42-lowering activity.  In contrast to γ-secretase inhibitors, these γ-secretase modulators effectively suppress Aβ42 prodn. while sparing processing of NOTCH and other γ-secretase substrates.  Although not fully resolved on the mol. level, the mechanism of action of Aβ42-lowering NSAIDs is independent of cyclooxygenase inhibition and most likely involves direct interaction with components of the γ-secretase complex or its substrates.  Current efforts to improve the pharmacol. shortcomings of available γ-secretase modulators will hopefully lead to the development of clin. useful Aβ42-lowering compds. in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq74m9n6Jxoi7Vg90H21EOLACvtfcHk0ljv5Nbu1K3OOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2hu7nK&md5=e6d31bb9f7a939b823b7df568b761905</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1159%2F000095270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000095270%26sid%3Dliteratum%253Aachs%26aulast%3DCzirr%26aufirst%3DE.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3D%25CE%25B3-Secretase%2520modulation%2520with%2520A%25CE%25B242-lowering%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520and%2520derived%2520compounds%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2006%26volume%3D3%26spage%3D298%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J.-C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">γ-Secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.-C+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-Secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.-C%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span> </span><span class="NLM_article-title">Secretase inhibitors and modulators for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=27-47&author=R.+E.+Olsonauthor=L.+R.+Marcin&title=Secretase+inhibitors+and+modulators+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26atitle%3DSecretase%2520inhibitors%2520and%2520modulators%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D27%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardina, G. A. M.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors and modulators for the treatment of Alzheimer’s disease: disappointments and hopes</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.2174%2F156802611795860942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=21510832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFOrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1555-1570&author=B.+P.+Imbimboauthor=G.+A.+M.+Giardina&title=%CE%B3-Secretase+inhibitors+and+modulators+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+disappointments+and+hopes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8gR"><div class="casContent"><span class="casTitleNuber">8g</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes</span></div><div class="casAuthors">Imbimbo, Bruno P.; Giardina, Giuseppe A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1555-1570</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  According to the β-amyloid (Aβ) hypothesis, compds. that inhibit or modulate γ-secretase, the pivotal enzyme that generates Aβ, are potential therapeutics for Alzheimer's disease (AD).  Studies in both transgenic and non-transgenic animal models of AD have indicated that γ-secretase inhibitors, administered by the oral route, are able to lower brain Aβ concns.  However, scanty data are available on the effects of these compds. on brain Aβ deposition after chronic administration.  Behavioral studies are also scarce with only one study indicating pos. cognitive effects of a peptidomimetic compd. acutely administered (DAPT).  γ-Secretase inhibitors may cause abnormalities in the gastrointestinal tract, thymus, spleen, and skin in exptl. animals and in man.  These toxic effects are likely due to inhibition of Notch cleavage, a transmembrane receptor involved in regulating cell-fate decisions.  Some non-steroidal anti-inflammatory drugs (NSAIDs) and other small org. mols. were found to modulate γ-secretase shifting its cleavage activity from longer to shorter β-amyloid species without affecting Notch cleavage.  Long-term histopathol. and behavioral animal studies are available with these NSAIDs (mainly ibuprofen) but it is unclear if the obsd. in vivo effects on Aβ brain pathol. and learning depend on their activity on γ-secretase or on other biol. targets.  The most studied γ-secretase inhibitor, semagacestat (LY-450139), was shown to dose-dependently decrease the generation of Aβ in the cerebrospinal fluid of healthy humans.  Unfortunately, 2 large Phase 3 clin. trials of semagacestat in mild-to-moderate AD patients were prematurely interrupted because of the observation of detrimental effects on cognition and functionality in patients receiving the drug compared to those receiving placebo.  These detrimental effects were mainly ascribed to the inhibition of Notch processing and to the accumulation of the neurotoxic precursor of Aβ (the carboxy-terminal fragment of APP, or CTFβ) resulting from the block of the γ-secretase cleavage activity on APP.  Two large Phase 3 studies in mild AD patients with tarenflurbil (R-flurbiprofen), a putative γ-secretase modulator, were also completely neg.  The failure of tarenflurbil was ascribed to low potency and brain penetration.  New Notch-sparing γ-secretase inhibitors and more potent, more brain penetrant γ-secretase modulators are being developed with the hope of overcoming the previous setbacks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4MVK1ienYPrVg90H21EOLACvtfcHk0liaSH7mIpOJ0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFOrurw%253D&md5=316bdea0acc108a062a1015894b77c88</span></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.2174%2F156802611795860942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795860942%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DGiardina%26aufirst%3DG.%2BA.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520and%2520modulators%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520disappointments%2520and%2520hopes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D1555%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larbig, G.</span><span> </span><span class="NLM_article-title">Inhibitors and modulators of β- and γ-secretase</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.2174%2F156802606776287027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=16611149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVahsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=377-392&author=B.+Schmidtauthor=S.+Baummanauthor=H.+A.+Braunauthor=G.+Larbig&title=Inhibitors+and+modulators+of+%CE%B2-+and+%CE%B3-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8h</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors and modulators of β- and γ-secretase</span></div><div class="casAuthors">Schmidt, Boris; Baumann, Stefanie; Braun, Hannes A.; Larbig, Gregor</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-392</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Most gene mutations assocd. with Alzheimer's disease point to the metab. of amyloid precursor protein as potential cause.  The β- and γ-secretases are 2 executioners of amyloid precursor protein processing resulting in amyloid β.  Significant progress was made in the selective inhibition of both proteases, regardless of structural information for γ-secretase.  Several peptidic and non-peptidic leads were identified and first drug candidates are in clin. trials.  This review focuses on the development since 2003.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdqvWbXNyBs7Vg90H21EOLACvtfcHk0lg_PL0L1zwduQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVahsbs%253D&md5=f7dee5bf60dcb32f1e3d0c22defb6489</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.2174%2F156802606776287027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776287027%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DBaumman%26aufirst%3DS.%26aulast%3DBraun%26aufirst%3DH.%2BA.%26aulast%3DLarbig%26aufirst%3DG.%26atitle%3DInhibitors%2520and%2520modulators%2520of%2520%25CE%25B2-%2520and%2520%25CE%25B3-secretase%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D377%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kounnas, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyree, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleynet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digregorio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauderman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Modulation of γ-secretase reduces β-amyloid deposition in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=S.+Chengauthor=C.+Tyreeauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comerauthor=L.+Maoauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.-M+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+%CE%B3-secretase+reduces+%CE%B2-amyloid+deposition+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DTyree%26aufirst%3DC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DComer%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.-M%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520%25CE%25B3-secretase%2520reduces%2520%25CE%25B2-amyloid%2520deposition%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onstead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwizinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span> </span><span class="NLM_article-title">Aβ40 inhibits amyloid deposition in vivo</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1523%2FJNEUROSCI.4849-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=17234594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=627-633&author=J.+Kimauthor=L.+Onsteadauthor=S.+Randleauthor=R.+Priceauthor=L.+Smithsonauthor=C.+Zwizinskiauthor=D.+W.+Dicksonauthor=T.+Goldeauthor=E.+McGowan&title=A%CE%B240+inhibits+amyloid+deposition+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ40 inhibits amyloid deposition in vivo</span></div><div class="casAuthors">Kim, Jungsu; Onstead, Luisa; Randle, Suzanne; Price, Robert; Smithson, Lisa; Zwizinski, Craig; Dickson, Dennis W.; Golde, Todd; McGowan, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">627-633</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Numerous studies have established a pivotal role for Aβ42 in Alzheimer's disease (AD) pathogenesis.  In contrast, although Aβ40 is the predominant form of amyloid β (Aβ) produced and accumulates to a variable degree in the human AD brain, its role in AD pathogenesis has not been established.  It has generally been assumed that an increase in Aβ40 would accelerate amyloid plaque formation in vivo.  We have crossed BRI-Aβ40 mice that selectively express high levels of Aβ40 with both Tg2576 (APPswe, K670N + M671L) mice and BRI-Aβ42A mice expressing Aβ42 selectively and analyzed parenchymal and cerebrovascular Aβ deposition in the bitransgenic mice compared with their singly transgenic littermates.  In the bitransgenic mice, the increased steady-state levels of Aβ40 decreased Aβ deposition by 60-90%.  These results demonstrate that Aβ42 and Aβ40 have opposing effects on amyloid deposition: Aβ42 promotes amyloid deposition but Aβ40 inhibits it.  In addn., increasing Aβ40 levels protected BRI-Aβ40/Tg2576 mice from the premature-death phenotype obsd. in Tg2576 mice.  The protective properties of Aβ40 with respect to amyloid deposition suggest that strategies that preferentially target Aβ40 may actually worsen the disease course and that selective increases in Aβ40 levels may actually reduce the risk for development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBkk_HKSaW0bVg90H21EOLACvtfcHk0lhY4FGp5HwArg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSkurg%253D&md5=503d71263bf85911413a264fe360490a</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4849-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4849-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DOnstead%26aufirst%3DL.%26aulast%3DRandle%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DR.%26aulast%3DSmithson%26aufirst%3DL.%26aulast%3DZwizinski%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DMcGowan%26aufirst%3DE.%26atitle%3DA%25CE%25B240%2520inhibits%2520amyloid%2520deposition%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D627%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, C.</span><span> </span><span class="NLM_article-title">Aβ40 promotes neuronal cell fate in neural progenitor cells</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1038%2Fcdd.2008.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=18566600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=386-394&author=Y.+Chenauthor=C.+Dong&title=A%CE%B240+promotes+neuronal+cell+fate+in+neural+progenitor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ40 promotes neuronal cell fate in neural progenitor cells</span></div><div class="casAuthors">Chen, Y.; Dong, C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-394</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sequential cleavage of the amyloid precursor protein (APP) by β- and then γ- secretase gives rise to Aβ1-40 (Aβ40), a major species of Aβ (β-amyloid) produced by neurons under physiol. conditions.  Aβ1-42 (Aβ42), a minor species of Aβ, is also produced by a similar but less understood mechanism of the γ-secretase.  The physiol. functions of these Aβ species remain to be defined.  In this report, we demonstrate that freshly prepd. sol. Aβ40 significantly promotes neurogenesis in primary neural progenitor cells (NPCs).  First, Aβ40 increases neuronal markers as detd. by NeuN expression and Tuj1 promoter activity, differing from Aβ42, which induces astrocyte markers in NPCs.  Second, Aβ40 induces neuronal differentiation at the end of S-phase in the cell cycle.  Third, Aβ40 promotes NPC entry into S-phase, playing a role in NPC self-renewal.  Interestingly, Aβ40 does not significantly increase apoptotic indexes such as DNA condensation and DNA fragmentation.  In addn., Aβ40 does not augment caspase-3 activation in NeuN+ or nestin+ cells.  Collectively, this report provides strong evidence that Aβ40 is a neurogenic factor and suggests that the debilitated function of Aβ40 in neurogenesis may account for the shortage of neurons in Alzheimer's disease.  Cell Death and Differentiation (2009) 16, 386-394; doi:10.1038/cdd.2008.94; published online 20 June 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6f495t2azg7Vg90H21EOLACvtfcHk0lhY4FGp5HwArg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wktbg%253D&md5=c25316bc3e0442b1ebecf7a4dc1f41c8</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2008.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2008.94%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DA%25CE%25B240%2520promotes%2520neuronal%2520cell%2520fate%2520in%2520neural%2520progenitor%2520cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2009%26volume%3D16%26spage%3D386%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Abramov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolev, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccotosto, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slutsky, I.</span><span> </span><span class="NLM_article-title">Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1038%2Fnn.2433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=19935655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=1567-1576&author=E.+Abramovauthor=I.+Dolevauthor=H.+Fogelauthor=G.+D.+Ciccotostoauthor=E.+Ruffauthor=I.+Slutsky&title=Amyloid-%CE%B2+as+a+positive+endogenous+regulator+of+release+probability+at+hippocampal+synapses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses</span></div><div class="casAuthors">Abramov, Efrat; Dolev, Iftach; Fogel, Hilla; Ciccotosto, Giuseppe D.; Ruff, Eyal; Slutsky, Inna</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1567-1576</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulation of cerebral amyloid-β peptide (Aβ) is essential for developing synaptic and cognitive deficits in Alzheimer's disease.  However, the physiol. functions of Aβ, as well as the primary mechanisms that initiate early Aβ-mediated synaptic dysfunctions, remain largely unknown.  Here we examine the acute effects of endogenously released Aβ peptides on synaptic transfer at single presynaptic terminals and synaptic connections in rodent hippocampal cultures and slices.  Increasing extracellular Aβ by inhibiting its degrdn. enhanced release probability, boosting ongoing activity in the hippocampal network.  Presynaptic enhancement mediated by Aβ was found to depend on the history of synaptic activation, with lower impact at higher firing rates.  Notably, both elevation and redn. in Aβ levels attenuated short-term synaptic facilitation during bursts in excitatory synaptic connections.  These observations suggest that endogenous Aβ peptides have a crucial role in activity-dependent regulation of synaptic vesicle release and might point to the primary pathol. events that lead to compensatory synapse loss in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvuRVsAXup4LVg90H21EOLACvtfcHk0lhY4FGp5HwArg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlur%252FP&md5=ae3f09cc8ddec7dcb30876535a76051d</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1038%2Fnn.2433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2433%26sid%3Dliteratum%253Aachs%26aulast%3DAbramov%26aufirst%3DE.%26aulast%3DDolev%26aufirst%3DI.%26aulast%3DFogel%26aufirst%3DH.%26aulast%3DCiccotosto%26aufirst%3DG.%2BD.%26aulast%3DRuff%26aufirst%3DE.%26aulast%3DSlutsky%26aufirst%3DI.%26atitle%3DAmyloid-%25CE%25B2%2520as%2520a%2520positive%2520endogenous%2520regulator%2520of%2520release%2520probability%2520at%2520hippocampal%2520synapses%26jtitle%3DNat.%2520Neurosci.%26date%3D2009%26volume%3D12%26spage%3D1567%26epage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span> </span><span class="NLM_article-title">Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">15330</span><span class="NLM_x">–</span> <span class="NLM_lpage">15336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=15330-15336&author=R.+Wangauthor=B.+Wangauthor=W.+Heauthor=H.+Zheng&title=Wild-type+presenilin+1+protects+against+Alzheimer+disease+mutation-induced+amyloid+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DWild-type%2520presenilin%25201%2520protects%2520against%2520Alzheimer%2520disease%2520mutation-induced%2520amyloid%2520pathology%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D15330%26epage%3D15336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Why did tarenflurbil fail in Alzheimer’s disease?</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=19542625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVChsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=757-760&author=B.+P.+Imbimbo&title=Why+did+tarenflurbil+fail+in+Alzheimer%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Why Did Tarenflurbil Fail in Alzheimer's Disease?</span></div><div class="casAuthors">Imbimbo, Bruno P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">757-760</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  There has been a lot of disappointment surrounding the recent failure of the largest ever study in patients with Alzheimer's disease (AD) with tarenflurbil, a compd. believed to modulate the activity of γ-secretase, the pivotal enzyme that generates the amyloid-β (Aβ) peptide from the amyloid-β protein precursor.  What are the reasons for this setback after the previous apparently encouraging results in a Phase II study A straightforward explanation of this failure is that the γ-secretase is not the right target for therapy or that, in general, blocking Aβ does not produce clin. benefits in AD.  If one still accepts a physiopathol. role of Aβ in AD, tarenflurbil could not be the right compd. because of its weak pharmacol. activity as an Aβ1-42 lowering agent and its poor brain penetration.  In addn., based on previous neg. results with several anti-inflammatory drugs in AD, it is hypothesized that the residual anti-inflammatory activity of tarenflurbil may have a detrimental effect on disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoZkD60p6dMbVg90H21EOLACvtfcHk0lhne7s7Y0b_Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVChsbc%253D&md5=a825d380c2734cb1645f70bc09605891</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DWhy%2520did%2520tarenflurbil%2520fail%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2009%26volume%3D17%26spage%3D757%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=440-449&author=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=T.+E.+Smithauthor=S.+Weggenauthor=P.+Dasauthor=D.+C.+McLendonauthor=V.+V.+Ozolsauthor=K.+W.+Jessingauthor=K.+H.+Zavitzauthor=E.+H.+Kooauthor=T.+E.+Golde&title=NSAIDs+and+enantiomers+of+flurbiprofen+target+%CE%B3-secretase+and+lower+A%CE%B242+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DMcLendon%26aufirst%3DD.%2BC.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DJessing%26aufirst%3DK.%2BW.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DNSAIDs%2520and%2520enantiomers%2520of%2520flurbiprofen%2520target%2520%25CE%25B3-secretase%2520and%2520lower%2520A%25CE%25B242%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26spage%3D440%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cheng, S.; Comer, D. D.; Mao, L.; Balow, G. P.; Pleynet, D.</span><span> </span><span class="NLM_article-title">Aryl Compounds and Uses Thereof in Modulating Amyloid β</span>. WO 2004110350,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Cheng&author=D.+D.+Comer&author=L.+Mao&author=G.+P.+Balow&author=D.+Pleynet&title=Aryl+Compounds+and+Uses+Thereof+in+Modulating+Amyloid+%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26atitle%3DAryl%2520Compounds%2520and%2520Uses%2520Thereof%2520in%2520Modulating%2520Amyloid%2520%25CE%25B2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Shin, K.; Miyagawa, T.; Kaneko, T.; Ito, K.; Takaishi, M.; Sasaki, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Cinnamide Compound</span>. US 20060004013,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Cinnamide+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DCinnamide%2520Compound%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Takaishi, M.; Ito, K.; Kaneko, T.; Sasaki, T.; Sato, N.; Miyagawa, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Morpholine Type Cinnamide Compound</span>. US20070117798,<span class="NLM_x"> </span><span class="NLM_year">2007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=M.+Takaishi&author=K.+Ito&author=T.+Kaneko&author=T.+Sasaki&author=N.+Sato&author=T.+Miyagawa&author=H.+Hagiwara&title=Morpholine+Type+Cinnamide+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DMorpholine%2520Type%2520Cinnamide%2520Compound%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gustafsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyström, J.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyzander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, K.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungell, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sörensen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Någård, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylund, R.</span><span> </span><span class="NLM_article-title">The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1016%2FS0049-3848%2800%2900399-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=11228340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsVKmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=171-181&author=D.+Gustafssonauthor=J.-E.+Nystr%C3%B6mauthor=S.+Carlssonauthor=U.+Bredbergauthor=U.+Erikssonauthor=E.+Gyzanderauthor=M.+Elgauthor=T.+Antonssonauthor=K.-J.+Hoffmannauthor=A.-L.+Ungellauthor=H.+S%C3%B6rensenauthor=S.+N%C3%A5g%C3%A5rdauthor=A.+Abrahamssonauthor=R.+Bylund&title=The+direct+thrombin+inhibitor+melagatran+and+its+oral+prodrug+H+376%2F95%3A+intestinal+absorption+properties%2C+biochemical+and+pharmacodynamic+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects</span></div><div class="casAuthors">Gustafsson, D.; Nystrom, J.-E.; Carlsson, S.; Bredberg, U.; Eriksson, U.; Gyzander, E.; Elg, M.; Antonsson, T.; Hoffmann, K.-J.; Ungell, A.-L.; Sorensen, H.; Nagard, S.; Abrahamsson, A.; Bylund, R.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-181</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Suboptimal gastrointestinal absorption is a problem for many direct thrombin inhibitors.  The studies presented herein describe the new oral direct thrombin inhibitor H 376/95, a prodrug with 2 protecting residues added to the direct thrombin inhibitor melagatran.  Absorption properties in vitro: H 376/95 is uncharged at intestinal pH while melagatran is charged.  H 376/95 is 170 times more lipophilic (octanol water partition coeff.) than melagatran.  As a result, the permeability coeff. across cultured epithelial Caco-2 cells is 80 times higher for H 376/95 than for melagtran.  Pharmacokinetic studies in healthy volunteers: H 376/95 is converted to melagatran in man.  Oral bioavailability, measured as melagatran in plasma, is about 20% after oral administration of H 376/95, which is 2.7-5.5 times higher than after oral administration of melagatran.  The variability in the area under the drug plasma concn. vs. time curve (AUC) is much smaller with oral H 376/95 (coeff. of variation 20%) than with oral melagatran (coeff. of variation 38%).  Pharmacodynamic properties: H 376/95 is inactive towards human α-thrombin compared with melagatran [inhibition const. (Ki) ratio, 185 times], a potential advantage for patients with silent gastrointestinal bleeding.  In an exptl. thrombosis model in the rat, oral H 376/95 was more effective than the s.c. low mol. wt. heparin dalteparin in preventing thrombosis.  Conclusion: By the use of the prodrug principle, H 376/95 endows the direct thrombin inhibitor melagatran with pharmacokinetic properties required for oral administration without compromising the promising pharmacodynamic properties of melagatran.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_S2pHMWUQ9rVg90H21EOLACvtfcHk0ljzQ-hzYwvvFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsVKmurw%253D&md5=63260995e92c84cd2a2f753b1513bb9f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0049-3848%2800%2900399-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0049-3848%252800%252900399-6%26sid%3Dliteratum%253Aachs%26aulast%3DGustafsson%26aufirst%3DD.%26aulast%3DNystr%25C3%25B6m%26aufirst%3DJ.-E.%26aulast%3DCarlsson%26aufirst%3DS.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DEriksson%26aufirst%3DU.%26aulast%3DGyzander%26aufirst%3DE.%26aulast%3DElg%26aufirst%3DM.%26aulast%3DAntonsson%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DK.-J.%26aulast%3DUngell%26aufirst%3DA.-L.%26aulast%3DS%25C3%25B6rensen%26aufirst%3DH.%26aulast%3DN%25C3%25A5g%25C3%25A5rd%26aufirst%3DS.%26aulast%3DAbrahamsson%26aufirst%3DA.%26aulast%3DBylund%26aufirst%3DR.%26atitle%3DThe%2520direct%2520thrombin%2520inhibitor%2520melagatran%2520and%2520its%2520oral%2520prodrug%2520H%2520376%252F95%253A%2520intestinal%2520absorption%2520properties%252C%2520biochemical%2520and%2520pharmacodynamic%2520effects%26jtitle%3DThromb.%2520Res.%26date%3D2001%26volume%3D101%26spage%3D171%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tomczuk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedde, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crysler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisennagel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R.</span><span> </span><span class="NLM_article-title">Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1495-1498&author=B.+Tomczukauthor=T.+Luauthor=R.+M.+Sollauthor=C.+Feddeauthor=A.+Wangauthor=L.+Murphyauthor=C.+Cryslerauthor=M.+Dasguptaauthor=S.+Eisennagelauthor=J.+Spurlinoauthor=R.+Bone&title=Oxyguanidines%3A+application+to+non-peptidic+phenyl-based+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomczuk%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DFedde%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DCrysler%26aufirst%3DC.%26aulast%3DDasgupta%26aufirst%3DM.%26aulast%3DEisennagel%26aufirst%3DS.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DBone%26aufirst%3DR.%26atitle%3DOxyguanidines%253A%2520application%2520to%2520non-peptidic%2520phenyl-based%2520thrombin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1495%26epage%3D1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gandolfi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grünanger, P.</span><span> </span><span class="NLM_article-title">1,3-Dipolar cycloaddition of nitrile oxides to 8-azaheptafulvenes</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1995&pages=619-638&author=R.+Gandolfiauthor=A.+Gambaauthor=P.+Gr%C3%BCnanger&title=1%2C3-Dipolar+cycloaddition+of+nitrile+oxides+to+8-azaheptafulvenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGandolfi%26aufirst%3DR.%26aulast%3DGamba%26aufirst%3DA.%26aulast%3DGr%25C3%25BCnanger%26aufirst%3DP.%26atitle%3D1%252C3-Dipolar%2520cycloaddition%2520of%2520nitrile%2520oxides%2520to%25208-azaheptafulvenes%26jtitle%3DHeterocycles%26date%3D1995%26volume%3D40%26spage%3D619%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Malamdou-Xenikaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutouli-Argyropoulou, E.</span><span> </span><span class="NLM_article-title">Preparation and catalytic hydrogenation of 1,2,4-oxadiazolo[4,5-<i>a</i>]indolines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">7865</span><span class="NLM_x">–</span> <span class="NLM_lpage">7872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1990&pages=7865-7872&author=E.+Malamdou-Xenikakiauthor=E.+Coutouli-Argyropoulou&title=Preparation+and+catalytic+hydrogenation+of+1%2C2%2C4-oxadiazolo%5B4%2C5-a%5Dindolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalamdou-Xenikaki%26aufirst%3DE.%26aulast%3DCoutouli-Argyropoulou%26aufirst%3DE.%26atitle%3DPreparation%2520and%2520catalytic%2520hydrogenation%2520of%25201%252C2%252C4-oxadiazolo%255B4%252C5-a%255Dindolines%26jtitle%3DTetrahedron%26date%3D1990%26volume%3D46%26spage%3D7865%26epage%3D7872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_contrib-group">Kabakov, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budagova, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malyutina, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latchman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csermely, P.</span><span> </span><span class="NLM_article-title">Pharmacological attenuation of apoptosis in re-oxygenated endothelial cells</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3076</span><span class="NLM_x">–</span> <span class="NLM_lpage">3086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1007%2Fs00018-004-4204-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=3076-3086&author=A.+E.+Kabakovauthor=K.+R.+Budagovaauthor=Y.+V.+Malyutinaauthor=D.+S.+Latchmanauthor=P.+Csermely&title=Pharmacological+attenuation+of+apoptosis+in+re-oxygenated+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1007%2Fs00018-004-4204-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-004-4204-y%26sid%3Dliteratum%253Aachs%26aulast%3DKabakov%26aufirst%3DA.%2BE.%26aulast%3DBudagova%26aufirst%3DK.%2BR.%26aulast%3DMalyutina%26aufirst%3DY.%2BV.%26aulast%3DLatchman%26aufirst%3DD.%2BS.%26aulast%3DCsermely%26aufirst%3DP.%26atitle%3DPharmacological%2520attenuation%2520of%2520apoptosis%2520in%2520re-oxygenated%2520endothelial%2520cells%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2005%26volume%3D61%26spage%3D3076%26epage%3D3086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Azizian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souzangarzadeh, S.</span><span> </span><span class="NLM_article-title">One-pot synthesis of novel derivatives of spiro-[6<i>H</i>-indolo[2,1-<i>b</i>]quinazoline-6,3′-[1,2,4]oxadiazoline]</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1081%2FSCC-200050932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFaju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=765-768&author=J.+Azizianauthor=M.+Madaniauthor=S.+Souzangarzadeh&title=One-pot+synthesis+of+novel+derivatives+of+spiro-%5B6H-indolo%5B2%2C1-b%5Dquinazoline-6%2C3%E2%80%B2-%5B1%2C2%2C4%5Doxadiazoline%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">One-pot synthesis of novel derivatives of spiro-[6H-indolo [2,1-b]quinazoline-6,3'-[1,2,4]oxadiazoline]</span></div><div class="casAuthors">Azizian, Javad; Madani, Masoud; Souzangarzadeh, Saeid</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">765-768</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Novel spiro-indoles I (R = H, Br; R1 = H, Cl; R2 = H, Cl, Br) are prepd. via a one-pot 1,3-dipolar cycloaddn. reaction of nitrile oxide with tryptanthrine imines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodDZgbOeAw0bVg90H21EOLACvtfcHk0lik_2MhyfYxsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFaju74%253D&md5=47378403b79324eb7ec320fd22546052</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1081%2FSCC-200050932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-200050932%26sid%3Dliteratum%253Aachs%26aulast%3DAzizian%26aufirst%3DJ.%26aulast%3DMadani%26aufirst%3DM.%26aulast%3DSouzangarzadeh%26aufirst%3DS.%26atitle%3DOne-pot%2520synthesis%2520of%2520novel%2520derivatives%2520of%2520spiro-%255B6H-indolo%255B2%252C1-b%255Dquinazoline-6%252C3%25E2%2580%25B2-%255B1%252C2%252C4%255Doxadiazoline%255D%26jtitle%3DSynth.%2520Commun.%26date%3D2005%26volume%3D35%26spage%3D765%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tsuge, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanemasa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, N.</span><span> </span><span class="NLM_article-title">Synthesis of 2-(1-phosphorylalkyl)acetonitrile oxide and its cycloaddition to olefins. Synthetic applications to 3,5-disubstituted 2-isoxazolines</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2463</span><span class="NLM_x">–</span> <span class="NLM_lpage">2473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1987&pages=2463-2473&author=O.+Tsugeauthor=S.+Kanemasaauthor=H.+Sugaauthor=N.+Nakagawa&title=Synthesis+of+2-%281-phosphorylalkyl%29acetonitrile+oxide+and+its+cycloaddition+to+olefins.+Synthetic+applications+to+3%2C5-disubstituted+2-isoxazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuge%26aufirst%3DO.%26aulast%3DKanemasa%26aufirst%3DS.%26aulast%3DSuga%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DN.%26atitle%3DSynthesis%2520of%25202-%25281-phosphorylalkyl%2529acetonitrile%2520oxide%2520and%2520its%2520cycloaddition%2520to%2520olefins.%2520Synthetic%2520applications%2520to%25203%252C5-disubstituted%25202-isoxazolines%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1987%26volume%3D60%26spage%3D2463%26epage%3D2473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Selva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tundo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marques, C. A.</span><span> </span><span class="NLM_article-title">A simple one-port synthesis of functionalized ketimines from ketones and amine hydrochloride salts</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1080%2F00397919508011368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADyaK2MXjsVyrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=369-378&author=M.+Selvaauthor=P.+Tundoauthor=C.+A.+Marques&title=A+simple+one-port+synthesis+of+functionalized+ketimines+from+ketones+and+amine+hydrochloride+salts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A simple one-pot synthesis of functionalized ketimines from ketones and amine hydrochloride salts</span></div><div class="casAuthors">Selva, Maurizio; Tundo, Pietro; Marques, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-78</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">Functionalized ketimines R1R2C:NCH2R [R = CN, CH2Cl, CO2Me; R1 = Ph, R2 = Me, Et, Ph, R1 = R2 = Pr or R1R2 = (CH2)5] have been prepd. by condensation of ketones with primary amine hydrochloride salts H2NCH2R.HCl.  The reaction proceeds in DMF with TiCl4 as drying agent in a single step without isolation of the free amine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBfmLcoCoa9bVg90H21EOLACvtfcHk0lhYUjgb6eIRlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsVyrtL8%253D&md5=c1925e613cc636f610a2b905f0e3e47d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F00397919508011368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919508011368%26sid%3Dliteratum%253Aachs%26aulast%3DSelva%26aufirst%3DM.%26aulast%3DTundo%26aufirst%3DP.%26aulast%3DMarques%26aufirst%3DC.%2BA.%26atitle%3DA%2520simple%2520one-port%2520synthesis%2520of%2520functionalized%2520ketimines%2520from%2520ketones%2520and%2520amine%2520hydrochloride%2520salts%26jtitle%3DSynth.%2520Commun.%26date%3D1995%26volume%3D25%26spage%3D369%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. O.</span><span> </span><span class="NLM_article-title">Practical synthesis of aminoethyl-<i>o</i>-carboranes</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/om020803q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=445-449&author=J.-D.+Leeauthor=Y.-J.+Leeauthor=H.-J.+Jeongauthor=J.+S.+Leeauthor=C.-H.+Leeauthor=J.+Koauthor=S.+O.+Kang&title=Practical+synthesis+of+aminoethyl-o-carboranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fom020803q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom020803q%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DLee%26aufirst%3DY.-J.%26aulast%3DJeong%26aufirst%3DH.-J.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BO.%26atitle%3DPractical%2520synthesis%2520of%2520aminoethyl-o-carboranes%26jtitle%3DOrganometallics%26date%3D2003%26volume%3D22%26spage%3D445%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Morimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiya, M.</span><span> </span><span class="NLM_article-title">A convenient synthetic method for Schiff bases. The trimethyl trifluoromethanesulfonate-catalyzed reaction of <i>N</i>,<i>N</i>-bis(trimethylsilyl)amines with aldehydes and ketones</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">1371</span><span class="NLM_x">–</span> <span class="NLM_lpage">1372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=1371-1372&author=T.+Morimotoauthor=M.+Sekiya&title=A+convenient+synthetic+method+for+Schiff+bases.+The+trimethyl+trifluoromethanesulfonate-catalyzed+reaction+of+N%2CN-bis%28trimethylsilyl%29amines+with+aldehydes+and+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DT.%26aulast%3DSekiya%26aufirst%3DM.%26atitle%3DA%2520convenient%2520synthetic%2520method%2520for%2520Schiff%2520bases.%2520The%2520trimethyl%2520trifluoromethanesulfonate-catalyzed%2520reaction%2520of%2520N%252CN-bis%2528trimethylsilyl%2529amines%2520with%2520aldehydes%2520and%2520ketones%26jtitle%3DChem.%2520Lett.%26date%3D1985%26spage%3D1371%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ohtani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakisawa, H.</span><span> </span><span class="NLM_article-title">High-field FT NMR application of Mosher’s method. The absolute configurations of marine terpenoids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">4092</span><span class="NLM_x">–</span> <span class="NLM_lpage">4096</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00011a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=4092-4096&author=I.+Ohtaniauthor=T.+Kusumiauthor=Y.+Kashmanauthor=H.+Kakisawa&title=High-field+FT+NMR+application+of+Mosher%E2%80%99s+method.+The+absolute+configurations+of+marine+terpenoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja00011a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00011a006%26sid%3Dliteratum%253Aachs%26aulast%3DOhtani%26aufirst%3DI.%26aulast%3DKusumi%26aufirst%3DT.%26aulast%3DKashman%26aufirst%3DY.%26aulast%3DKakisawa%26aufirst%3DH.%26atitle%3DHigh-field%2520FT%2520NMR%2520application%2520of%2520Mosher%25E2%2580%2599s%2520method.%2520The%2520absolute%2520configurations%2520of%2520marine%2520terpenoids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D4092%26epage%3D4096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Reddy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">From styrenes to enantiopure <i>R</i>-arylglycines in two steps</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">1207</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9728177" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=1207-1217&author=K.+L.+Reddyauthor=K.+B.+Sharpless&title=From+styrenes+to+enantiopure+R-arylglycines+in+two+steps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja9728177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9728177%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DK.%2BL.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DFrom%2520styrenes%2520to%2520enantiopure%2520R-arylglycines%2520in%2520two%2520steps%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D1207%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">We propose to use the term “druggable motif” to describe some of the well understood pharmacophores that have proven records for achieving good pharmacokinetic, pharmacodynamic, and toxicological profiles. Deliberate attention to suitable “druggable motifs” would help medicinal chemists achieve a balanced approach in evaluating SAR directions. Detailed discussions will be the subject of another publication.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pozharskii, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitkina, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegolya, T. N.</span><span> </span><span class="NLM_article-title">Nature of the interaction of phenyl and imidazole rings in <i>N</i>-arylimidazoles. IV. Derivatives of <i>N</i>-phenylimidazole with substituents on the benzene ring</span> <span class="citation_source-journal">Khim. Geterotsikl. Soedin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1970&pages=209-213&author=A.+F.+Pozharskiiauthor=L.+M.+Sitkinaauthor=A.+M.+Simonovauthor=T.+N.+Chegolya&title=Nature+of+the+interaction+of+phenyl+and+imidazole+rings+in+N-arylimidazoles.+IV.+Derivatives+of+N-phenylimidazole+with+substituents+on+the+benzene+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPozharskii%26aufirst%3DA.%2BF.%26aulast%3DSitkina%26aufirst%3DL.%2BM.%26aulast%3DSimonov%26aufirst%3DA.%2BM.%26aulast%3DChegolya%26aufirst%3DT.%2BN.%26atitle%3DNature%2520of%2520the%2520interaction%2520of%2520phenyl%2520and%2520imidazole%2520rings%2520in%2520N-arylimidazoles.%2520IV.%2520Derivatives%2520of%2520N-phenylimidazole%2520with%2520substituents%2520on%2520the%2520benzene%2520ring%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1970%26volume%3D6%26spage%3D209%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rubas, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jezyk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, G. M.</span><span> </span><span class="NLM_article-title">Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=113-118&author=W.+Rubasauthor=N.+Jezykauthor=G.+M.+Grass&title=Comparison+of+the+permeability+characteristics+of+a+human+colonic+epithelial+%28Caco-2%29+cell+line+to+colon+of+rabbit%2C+monkey%2C+and+dog+intestine+and+human+drug+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubas%26aufirst%3DW.%26aulast%3DJezyk%26aufirst%3DN.%26aulast%3DGrass%26aufirst%3DG.%2BM.%26atitle%3DComparison%2520of%2520the%2520permeability%2520characteristics%2520of%2520a%2520human%2520colonic%2520epithelial%2520%2528Caco-2%2529%2520cell%2520line%2520to%2520colon%2520of%2520rabbit%252C%2520monkey%252C%2520and%2520dog%2520intestine%2520and%2520human%2520drug%2520absorption%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D113%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Makhey, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinko, P. J.</span><span> </span><span class="NLM_article-title">Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=1160-1167&author=V.+D.+Makheyauthor=A.+Guoauthor=D.+A.+Norrisauthor=P.+Huauthor=J.+Yanauthor=P.+J.+Sinko&title=Characterization+of+the+regional+intestinal+kinetics+of+drug+efflux+in+rat+and+human+intestine+and+in+Caco-2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMakhey%26aufirst%3DV.%2BD.%26aulast%3DGuo%26aufirst%3DA.%26aulast%3DNorris%26aufirst%3DD.%2BA.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DSinko%26aufirst%3DP.%2BJ.%26atitle%3DCharacterization%2520of%2520the%2520regional%2520intestinal%2520kinetics%2520of%2520drug%2520efflux%2520in%2520rat%2520and%2520human%2520intestine%2520and%2520in%2520Caco-2%2520cells%26jtitle%3DPharm.%2520Res.%26date%3D1998%26volume%3D15%26spage%3D1160%26epage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerfass, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forstl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandbrink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyreuther, K.</span><span> </span><span class="NLM_article-title">Analysis of heterogeneous Aβ42 peptide in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">22908</span><span class="NLM_x">–</span> <span class="NLM_lpage">22914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22908-22914&author=N.+Idaauthor=T.+Hartmannauthor=J.+Pantelauthor=J.+Schroderauthor=R.+Zerfassauthor=H.+Forstlauthor=R.+Sandbrinkauthor=C.+L.+Mastersauthor=K.+Beyreuther&title=Analysis+of+heterogeneous+A%CE%B242+peptide+in+human+cerebrospinal+fluid+and+blood+by+a+newly+developed+sensitive+Western+blot+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIda%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DPantel%26aufirst%3DJ.%26aulast%3DSchroder%26aufirst%3DJ.%26aulast%3DZerfass%26aufirst%3DR.%26aulast%3DForstl%26aufirst%3DH.%26aulast%3DSandbrink%26aufirst%3DR.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBeyreuther%26aufirst%3DK.%26atitle%3DAnalysis%2520of%2520heterogeneous%2520A%25CE%25B242%2520peptide%2520in%2520human%2520cerebrospinal%2520fluid%2520and%2520blood%2520by%2520a%2520newly%2520developed%2520sensitive%2520Western%2520blot%2520assay%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D22908%26epage%3D22914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasikumar, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4973</span><span class="NLM_x">–</span> <span class="NLM_lpage">4980</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi200026m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4973-4980&author=J.+Leeauthor=L.+Songauthor=G.+Terracinaauthor=T.+Baraauthor=H.+Josienauthor=T.+Asberomauthor=T.+K.+Sasikumarauthor=D.+A.+Burnettauthor=J.+Claderauthor=E.+M.+Parkerauthor=L.+Zhang&title=Identification+of+presenilin+1-selective+%CE%B3-secretase+inhibitors+with+reconstituted+%CE%B3-secretase+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi200026m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200026m%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DSasikumar%26aufirst%3DT.%2BK.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520presenilin%25201-selective%2520%25CE%25B3-secretase%2520inhibitors%2520with%2520reconstituted%2520%25CE%25B3-secretase%2520complexes%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D4973%26epage%3D4980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulet, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinzon-Ortiz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span> </span><span class="NLM_article-title">Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">12876</span><span class="NLM_x">–</span> <span class="NLM_lpage">12882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=12876-12882&author=G.+T.+Wongauthor=D.+Manfraauthor=F.+M.+Pouletauthor=Q.+Zhangauthor=H.+Josienauthor=T.+Baraauthor=L.+Engstromauthor=M.+Pinzon-Ortizauthor=J.+S.+Fineauthor=H.-J.+J.+Leeauthor=L.+Zhangauthor=G.+A.+Higginsauthor=E.+M.+Parker&title=Chronic+treatment+with+the+%CE%B3-secretase+inhibitor+LY-411%2C575+inhibits+%CE%B2-amyloid+peptide+production+and+alters+lymphopoiesis+and+intestinal+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DG.%2BT.%26aulast%3DManfra%26aufirst%3DD.%26aulast%3DPoulet%26aufirst%3DF.%2BM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DEngstrom%26aufirst%3DL.%26aulast%3DPinzon-Ortiz%26aufirst%3DM.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DH.-J.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DChronic%2520treatment%2520with%2520the%2520%25CE%25B3-secretase%2520inhibitor%2520LY-411%252C575%2520inhibits%2520%25CE%25B2-amyloid%2520peptide%2520production%2520and%2520alters%2520lymphopoiesis%2520and%2520intestinal%2520cell%2520differentiation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D12876%26epage%3D12882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c','cit2d'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f','cit8g','cit8h'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':[],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ángel Santiago, Dulce C. Guzmán-Ocampo, Rodrigo Aguayo-Ortiz, <span class="NLM_string-name hlFld-ContribAuthor">Laura Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the Chemical Space of γ-Secretase Inhibitors and Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (15)
                                     , 2765-2775. <a href="https://doi.org/10.1021/acschemneuro.1c00313" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00313%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DCharacterizing%252Bthe%252BChemical%252BSpace%252Bof%252B%2525CE%2525B3-Secretase%252BInhibitors%252Band%252BModulators%26aulast%3DSantiago%26aufirst%3D%25C3%2581ngel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21052021%26date%3D09072021%26date%3D22072021%26volume%3D12%26issue%3D15%26spage%3D2765%26epage%3D2775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Alexei Buevich, John P. Caldwell, Lynn Hyde, Xianhai Huang, Xiaoxiang Liu, Brian McKittrick, Robert D. Mazzola, Dmitri Pissarnitski, Anandan Palani, Lili Zhang, Eric Parker, Li Xiao, Diane Rindgen, <span class="NLM_string-name hlFld-ContribAuthor">Zhaoning Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Leads for γ-Secretase Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8216-8230. <a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252BLeads%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D04082020%26date%3D27072020%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Dmitri A.  Pissarnitski</span>, <span class="hlFld-ContribAuthor ">Xianhai  Huang</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Lixin  Song</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, and <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1002-1006. <a href="https://doi.org/10.1021/acsmedchemlett.7b00178" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00178%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BTetrahydrobenzisoxazole%252BSeries%252Bof%252B%2525CE%2525B3-Secretase%252BModulators%26aulast%3DZhao%26aufirst%3DZhiqiang%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D23042017%26date%3D19092017%26date%3D26092017%26date%3D12102017%26date%3D19092017%26volume%3D8%26issue%3D10%26spage%3D1002%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew G.  Bursavich</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Harrison</span>, <span class="hlFld-ContribAuthor ">Raksha  Acharya</span>, <span class="hlFld-ContribAuthor ">Donald E.  Costa</span>, <span class="hlFld-ContribAuthor ">Emily A.  Freeman</span>, <span class="hlFld-ContribAuthor ">Hilliary E.  Hodgdon</span>, <span class="hlFld-ContribAuthor ">Lori A.  Hrdlicka</span>, <span class="hlFld-ContribAuthor ">Hong  Jin</span>, <span class="hlFld-ContribAuthor ">Sudarshan  Kapadnis</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Moffit</span>, <span class="hlFld-ContribAuthor ">Deirdre A.  Murphy</span>, <span class="hlFld-ContribAuthor ">Scott  Nolan</span>, <span class="hlFld-ContribAuthor ">Holger  Patzke</span>, <span class="hlFld-ContribAuthor ">Cuyue  Tang</span>, <span class="hlFld-ContribAuthor ">Melody  Wen</span>, <span class="hlFld-ContribAuthor ">Gerhard  Koenig</span>, <span class="hlFld-ContribAuthor ">Jean-François  Blain</span>, and <span class="hlFld-ContribAuthor ">Duane A.  Burnett</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Evaluation of a Novel Series of Oxadiazine Gamma Secretase Modulators for Familial Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (6)
                                     , 2383-2400. <a href="https://doi.org/10.1021/acs.jmedchem.6b01620" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01620%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BOxadiazine%252BGamma%252BSecretase%252BModulators%252Bfor%252BFamilial%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBursavich%26aufirst%3DMatthew%2BG.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D22112016%26date%3D10032017%26date%3D23032017%26date%3D23022017%26volume%3D60%26issue%3D6%26spage%3D2383%26epage%3D2400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven P.  Miller</span>, <span class="hlFld-ContribAuthor ">William J.  Morris</span>, <span class="hlFld-ContribAuthor ">Robert K.  Orr</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Eckert</span>, <span class="hlFld-ContribAuthor ">Jay  Milan</span>, <span class="hlFld-ContribAuthor ">Mathew  Maust</span>, <span class="hlFld-ContribAuthor ">Cameron  Cowden</span>, and <span class="hlFld-ContribAuthor ">Jian  Cui</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of the γ-Secretase Modulator MK-8428. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (6)
                                     , 2957-2964. <a href="https://doi.org/10.1021/acs.joc.6b02979" title="DOI URL">https://doi.org/10.1021/acs.joc.6b02979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.6b02979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.6b02979%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bthe%252B%2525CE%2525B3-Secretase%252BModulator%252BMK-8428%26aulast%3DMiller%26aufirst%3DSteven%2BP.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D13122016%26date%3D06032017%26date%3D17032017%26volume%3D82%26issue%3D6%26spage%3D2957%26epage%3D2964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew G.  Bursavich</span>, <span class="hlFld-ContribAuthor ">Bryce A.  Harrison</span>, and <span class="hlFld-ContribAuthor ">Jean-François  Blain</span>  . </span><span class="cited-content_cbyCitation_article-title">Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7389-7409. <a href="https://doi.org/10.1021/acs.jmedchem.5b01960" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01960%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGamma%252BSecretase%252BModulators%25253A%252BNew%252BAlzheimer%2525E2%252580%252599s%252BDrugs%252Bon%252Bthe%252BHorizon%25253F%26aulast%3DBursavich%26aufirst%3DMatthew%2BG.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D18122015%26date%3D05042016%26date%3D25082016%26date%3D23032016%26volume%3D59%26issue%3D16%26spage%3D7389%26epage%3D7409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Subramanyam</span>, <span class="hlFld-ContribAuthor ">Kelly R.  Bales</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Benjamin A.  Fish</span>, <span class="hlFld-ContribAuthor ">Michael E.  Green</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Patrick B.  Mullins</span>, <span class="hlFld-ContribAuthor ">Thayalan  Navaratnam</span>, <span class="hlFld-ContribAuthor ">Subas M.  Sakya</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Tuan P.  Tran</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Liming  Zhang</span>, <span class="hlFld-ContribAuthor ">Leslie R.  Pustilnik</span>, <span class="hlFld-ContribAuthor ">Beth C.  Vetelino</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Wood</span>, <span class="hlFld-ContribAuthor ">Nikolay  Pozdnyakov</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Evaluation of a Novel Series of Pyridopyrazine-1,6-dione γ-Secretase Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 1046-1062. <a href="https://doi.org/10.1021/jm401782h" title="DOI URL">https://doi.org/10.1021/jm401782h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401782h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401782h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BEvaluation%252Bof%252Ba%252BNovel%252BSeries%252Bof%252BPyridopyrazine-1%25252C6-dione%252B%2525CE%2525B3-Secretase%252BModulators%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D17112013%26date%3D28012014%26date%3D13022014%26date%3D15012014%26volume%3D57%26issue%3D3%26spage%3D1046%26epage%3D1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christina J.  Crump</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, and <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Development and Mechanism of γ-Secretase Modulators for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2013,</strong> <em>52 </em>
                                    (19)
                                     , 3197-3216. <a href="https://doi.org/10.1021/bi400377p" title="DOI URL">https://doi.org/10.1021/bi400377p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi400377p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi400377p%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DDevelopment%252Band%252BMechanism%252Bof%252B%2525CE%2525B3-Secretase%252BModulators%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DCrump%26aufirst%3DChristina%2BJ.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D22032013%26date%3D23042013%26date%3D02052013%26date%3D14052013%26date%3D24042013%26volume%3D52%26issue%3D19%26spage%3D3197%26epage%3D3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Lian  Wu</span>, <span class="hlFld-ContribAuthor ">Martin  Domalski</span>, <span class="hlFld-ContribAuthor ">Duane A.  Burnett</span>, <span class="hlFld-ContribAuthor ">Hubert  Josien</span>, <span class="hlFld-ContribAuthor ">Thomas  Bara</span>, <span class="hlFld-ContribAuthor ">Murali  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Ruo  Xu</span>, <span class="hlFld-ContribAuthor ">John  Clader</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Andrew  Brunskill</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Robert A.  Del Vecchio</span>, <span class="hlFld-ContribAuthor ">Mary E.  Cohen-Williams</span>, <span class="hlFld-ContribAuthor ">Lixin  Song</span>, <span class="hlFld-ContribAuthor ">Julie  Lee</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Amin  Nomeir</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, and <span class="hlFld-ContribAuthor ">Lili  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of SCH 900229, a Potent Presenilin 1 Selective γ-Secretase Inhibitor for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (11)
                                     , 892-896. <a href="https://doi.org/10.1021/ml300044f" title="DOI URL">https://doi.org/10.1021/ml300044f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300044f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300044f%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BSCH%252B900229%25252C%252Ba%252BPotent%252BPresenilin%252B1%252BSelective%252B%2525CE%2525B3-Secretase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DWu%26aufirst%3DWen-Lian%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D21022012%26date%3D09042012%26date%3D18042012%26date%3D08112012%26date%3D09042012%26volume%3D3%26issue%3D11%26spage%3D892%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianhai  Huang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaoxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Hongmei  Li</span>, <span class="hlFld-ContribAuthor ">George  Sun</span>, <span class="hlFld-ContribAuthor ">Mihirbaran  Mandal</span>, <span class="hlFld-ContribAuthor ">Monica  Vicarel</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Zhu</span>, <span class="hlFld-ContribAuthor ">Chad  Bennett</span>, <span class="hlFld-ContribAuthor ">Troy  McCraken</span>, <span class="hlFld-ContribAuthor ">Dmitri  Pissarnitski</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">David  Cole</span>, <span class="hlFld-ContribAuthor ">Gioconda  Gallo</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>, <span class="hlFld-ContribAuthor ">Robert  Aslanian</span>, <span class="hlFld-ContribAuthor ">John  Clader</span>, <span class="hlFld-ContribAuthor ">Michael  Czarniecki</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Duane  Burnett</span>, <span class="hlFld-ContribAuthor ">Mary  Cohen-Williams</span>, <span class="hlFld-ContribAuthor ">Lynn  Hyde</span>, <span class="hlFld-ContribAuthor ">Lixin  Song</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Inhou  Chu</span>, and <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (11)
                                     , 931-935. <a href="https://doi.org/10.1021/ml300209g" title="DOI URL">https://doi.org/10.1021/ml300209g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300209g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300209g%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252BStudies%252Bof%252BFused%252BOxadiazines%252Bas%252B%2525CE%2525B3-Secretase%252BModulators%252Bfor%252BTreatment%252Bof%252BAlzheimer%252527s%252BDisease%26aulast%3DHuang%26aufirst%3DXianhai%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D22072012%26date%3D04092012%26date%3D18102012%26date%3D08112012%26date%3D04092012%26volume%3D3%26issue%3D11%26spage%3D931%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joana L.S.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Júlio C.A.V.  Soares</span>, <span class="hlFld-ContribAuthor ">Gisele B.  Portapilla</span>, <span class="hlFld-ContribAuthor ">Maiara V.  Providello</span>, <span class="hlFld-ContribAuthor ">Camilo H.S.  Lima</span>, <span class="hlFld-ContribAuthor ">Estela M.F.  Muri</span>, <span class="hlFld-ContribAuthor ">Sérgio  de Albuquerque</span>, <span class="hlFld-ContribAuthor ">Luiza R.S.  Dias</span>. </span><span class="cited-content_cbyCitation_article-title">Trypanocidal activity of new 1,6-diphenyl-1H-pyrazolo[3,4-b]pyridine derivatives: Synthesis, in vitro and in vivo studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>29 </em>, 115855. <a href="https://doi.org/10.1016/j.bmc.2020.115855" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115855</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115855%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DTrypanocidal%252Bactivity%252Bof%252Bnew%252B1%25252C6-diphenyl-1H-pyrazolo%25255B3%25252C4-b%25255Dpyridine%252Bderivatives%25253A%252BSynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bstudies%26aulast%3DRibeiro%26aufirst%3DJoana%2BL.S.%26date%3D2021%26volume%3D29%26spage%3D115855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepa  Nair</span>, <span class="hlFld-ContribAuthor ">Mamta  Dadwal</span>, <span class="hlFld-ContribAuthor ">Namrata  Rastogi</span>, <span class="hlFld-ContribAuthor ">Irishi N.N.  Namboothiri</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,4-Oxadiazines and 1,2,4-Thiadiazines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00090-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00090-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00090-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00090-1%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C2%25252C4-Oxadiazines%252Band%252B1%25252C2%25252C4-Thiadiazines%26aulast%3DNair%26aufirst%3DDeepa%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shekar  Mekala</span>, <span class="hlFld-ContribAuthor ">Grady  Nelson</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments of small molecule γ-secretase modulators for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (9)
                                     , 1003-1022. <a href="https://doi.org/10.1039/D0MD00196A" title="DOI URL">https://doi.org/10.1039/D0MD00196A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00196A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00196A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopments%252Bof%252Bsmall%252Bmolecule%252B%2525CE%2525B3-secretase%252Bmodulators%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DMekala%26aufirst%3DShekar%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D9%26spage%3D1003%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinyue  Liu</span>, <span class="hlFld-ContribAuthor ">Weiming  Xia</span>, <span class="hlFld-ContribAuthor ">Yingkai  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunyu  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2020,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnmol.2020.00137" title="DOI URL">https://doi.org/10.3389/fnmol.2020.00137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2020.00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2020.00137%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DTargeting%252BAmyloidogenic%252BProcessing%252Bof%252BAPP%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DZhao%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nalini  Schaduangrat</span>, <span class="hlFld-ContribAuthor ">Veda  Prachayasittikul</span>, <span class="hlFld-ContribAuthor ">Saowapak  Choomwattana</span>, <span class="hlFld-ContribAuthor ">Prapimpun  Wongchitrat</span>, <span class="hlFld-ContribAuthor ">Kamonrat  Phopin</span>, <span class="hlFld-ContribAuthor ">Wilasinee  Suwanjang</span>, <span class="hlFld-ContribAuthor ">Aijaz Ahmad  Malik</span>, <span class="hlFld-ContribAuthor ">Bruno  Vincent</span>, <span class="hlFld-ContribAuthor ">Chanin  Nantasenamat</span>. </span><span class="cited-content_cbyCitation_article-title">Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1730-1778. <a href="https://doi.org/10.1002/med.21563" title="DOI URL">https://doi.org/10.1002/med.21563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21563%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMultidisciplinary%252Bapproaches%252Bfor%252Btargeting%252Bthe%252Bsecretase%252Bprotein%252Bfamily%252Bas%252Ba%252Btherapeutic%252Broute%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DSchaduangrat%26aufirst%3DNalini%26date%3D2019%26date%3D2019%26volume%3D39%26issue%3D5%26spage%3D1730%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoyi  Sun</span>, <span class="hlFld-ContribAuthor ">Qi  Jia</span>, <span class="hlFld-ContribAuthor ">Zaihui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of amide isosteres in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2535-2550. <a href="https://doi.org/10.1016/j.bmcl.2019.07.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplications%252Bof%252Bamide%252Bisosteres%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DSun%26aufirst%3DShaoyi%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2535%26epage%3D2550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Martins  Silva</span>, <span class="hlFld-ContribAuthor ">Mariana Pegrucci  Barcelos</span>, <span class="hlFld-ContribAuthor ">João Gabriel Curtolo  Poiani</span>, <span class="hlFld-ContribAuthor ">Lorane Izabel da Silva  Hage‐Melim</span>, <span class="hlFld-ContribAuthor ">Carlos Henrique Tomich de Paula  da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (16)
                                     , 1467-1483. <a href="https://doi.org/10.1002/cmdc.201900299" title="DOI URL">https://doi.org/10.1002/cmdc.201900299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900299%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DAllosteric%252BModulators%252Bof%252BPotential%252BTargets%252BRelated%252Bto%252BAlzheimer%252527s%252BDisease%25253A%252Ba%252BReview%26aulast%3DSilva%26aufirst%3DGuilherme%2BMartins%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D16%26spage%3D1467%26epage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vineet Kumar  Soni</span>, <span class="hlFld-ContribAuthor ">Jun  Kim</span>, <span class="hlFld-ContribAuthor ">Eun Jin  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalytic Oxidative Cyclization of Amidoximes for the Synthesis of 1,2,4‐Oxadiazolines. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (14)
                                     , 2626-2631. <a href="https://doi.org/10.1002/adsc.201800238" title="DOI URL">https://doi.org/10.1002/adsc.201800238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800238%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DOrganocatalytic%252BOxidative%252BCyclization%252Bof%252BAmidoximes%252Bfor%252Bthe%252BSynthesis%252Bof%252B1%25252C2%25252C4%2525E2%252580%252590Oxadiazolines%26aulast%3DSoni%26aufirst%3DVineet%2BKumar%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D14%26spage%3D2626%26epage%3D2631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Devendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Ankit  Ganeshpurkar</span>, <span class="hlFld-ContribAuthor ">Dileep  Kumar</span>, <span class="hlFld-ContribAuthor ">Gyan  Modi</span>, <span class="hlFld-ContribAuthor ">Sanjeev Kumar  Gupta</span>, <span class="hlFld-ContribAuthor ">Sushil Kumar  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>148 </em>, 436-452. <a href="https://doi.org/10.1016/j.ejmech.2018.02.035" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.035%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSecretase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252BLong%252Broad%252Bahead%26aulast%3DKumar%26aufirst%3DDevendra%26date%3D2018%26volume%3D148%26spage%3D436%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Yue-Ming  Li</span>, <span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Peter H.  St George-Hyslop</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Chemical Biology of Presenilin Complexes. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Medicine</span><span> <strong>2017,</strong> <em>7 </em>
                                    (12)
                                     , a024067. <a href="https://doi.org/10.1101/cshperspect.a024067" title="DOI URL">https://doi.org/10.1101/cshperspect.a024067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a024067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a024067%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Medicine%26atitle%3DStructural%252Band%252BChemical%252BBiology%252Bof%252BPresenilin%252BComplexes%26aulast%3DJohnson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D12%26spage%3Da024067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton A.  Shetnev</span>, <span class="hlFld-ContribAuthor ">Fedor I.  Zubkov</span>. </span><span class="cited-content_cbyCitation_article-title">The latest advances in chemistry of 1,2,4-oxadiazines (microreview). </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (5)
                                     , 495-497. <a href="https://doi.org/10.1007/s10593-017-2081-1" title="DOI URL">https://doi.org/10.1007/s10593-017-2081-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-017-2081-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-017-2081-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DThe%252Blatest%252Badvances%252Bin%252Bchemistry%252Bof%252B1%25252C2%25252C4-oxadiazines%252B%252528microreview%252529%26aulast%3DShetnev%26aufirst%3DAnton%2BA.%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D5%26spage%3D495%26epage%3D497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pankaj D.  Mehta</span>, <span class="hlFld-ContribAuthor ">Jean-Francois  Blain</span>, <span class="hlFld-ContribAuthor ">Emily A.  Freeman</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Patrick</span>, <span class="hlFld-ContribAuthor ">Marc  Barshatzky</span>, <span class="hlFld-ContribAuthor ">Lori A.  Hrdlicka</span>, <span class="hlFld-ContribAuthor ">Sangita P.  Mehta</span>, <span class="hlFld-ContribAuthor ">Janusz  Frackowiak</span>, <span class="hlFld-ContribAuthor ">Bozena  Mazur-Kolecka</span>, <span class="hlFld-ContribAuthor ">Jerzy  Wegiel</span>, <span class="hlFld-ContribAuthor ">Holger  Patzke</span>, <span class="hlFld-ContribAuthor ">David L.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Generation and Partial Characterization of Rabbit Monoclonal Antibody to Amyloid-β Peptide 1–37 (Aβ37). </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2017,</strong> <em>57 </em>
                                    (1)
                                     , 135-145. <a href="https://doi.org/10.3233/JAD-161207" title="DOI URL">https://doi.org/10.3233/JAD-161207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-161207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-161207%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DGeneration%252Band%252BPartial%252BCharacterization%252Bof%252BRabbit%252BMonoclonal%252BAntibody%252Bto%252BAmyloid-%2525CE%2525B2%252BPeptide%252B1%2525E2%252580%25259337%252B%252528A%2525CE%2525B237%252529%26aulast%3DMehta%26aufirst%3DPankaj%2BD.%26date%3D2017%26volume%3D57%26issue%3D1%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Martin  Pettersson</span>. </span><span class="cited-content_cbyCitation_article-title">γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 87-118. <a href="https://doi.org/10.1007/7355_2016_19" title="DOI URL">https://doi.org/10.1007/7355_2016_19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2016_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2016_19%26sid%3Dliteratum%253Aachs%26atitle%3D%2525CE%2525B3-Secretase%252BModulators%252Bas%252BA%2525CE%2525B242-Lowering%252BPharmacological%252BAgents%252Bto%252BTreat%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DJohnson%26aufirst%3DDouglas%2BS.%26date%3D2017%26date%3D2017%26spage%3D87%26epage%3D118%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%252BII%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2017%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">A.I.  Velter</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting γ-Secretase for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 280-325. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13789-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13789-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13789-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13789-8%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B3-Secretase%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D280%26epage%3D325%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyun Ah  Jung</span>, <span class="hlFld-ContribAuthor ">Md. Yousof  Ali</span>, <span class="hlFld-ContribAuthor ">Hee Jin  Jung</span>, <span class="hlFld-ContribAuthor ">Hyong Oh  Jeong</span>, <span class="hlFld-ContribAuthor ">Hae Young  Chung</span>, <span class="hlFld-ContribAuthor ">Jae Sue  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2016,</strong> <em>191 </em>, 152-160. <a href="https://doi.org/10.1016/j.jep.2016.06.037" title="DOI URL">https://doi.org/10.1016/j.jep.2016.06.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2016.06.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2016.06.037%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3DInhibitory%252Bactivities%252Bof%252Bmajor%252Banthraquinones%252Band%252Bother%252Bconstituents%252Bfrom%252BCassia%252Bobtusifolia%252Bagainst%252B%2525CE%2525B2-secretase%252Band%252Bcholinesterases%26aulast%3DJung%26aufirst%3DHyun%2BAh%26date%3D2016%26volume%3D191%26spage%3D152%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.E.  Golde</span>, <span class="hlFld-ContribAuthor ">C.B.  Lessard</span>, <span class="hlFld-ContribAuthor ">Y.  Ran</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Targeting of Aβ42. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 77-96. <a href="https://doi.org/10.1016/B978-0-12-802173-6.00005-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-802173-6.00005-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802173-6.00005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802173-6.00005-8%26sid%3Dliteratum%253Aachs%26atitle%3DTherapeutic%252BTargeting%252Bof%252BA%2525CE%2525B242%26aulast%3DGolde%26aufirst%3DT.E.%26date%3D2016%26spage%3D77%26epage%3D96%26pub%3DElsevier%26atitle%3DDeveloping%252BTherapeutics%252Bfor%252BAlzheimer%252527s%252BDisease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johan  J. N. Veerman</span>, <span class="hlFld-ContribAuthor ">Matthew  G. Bursavich</span>, <span class="hlFld-ContribAuthor ">Yorik  B. Bruseker</span>, <span class="hlFld-ContribAuthor ">Bart  C. J. van Esseveldt</span>, <span class="hlFld-ContribAuthor ">Rebecca  Glen</span>, <span class="hlFld-ContribAuthor ">Bryce  A. Harrison</span>, <span class="hlFld-ContribAuthor ">Erik  H. Heijne</span>, <span class="hlFld-ContribAuthor ">Andrew  J. McRiner</span>, <span class="hlFld-ContribAuthor ">Tommi  M. Meulemans</span>, <span class="hlFld-ContribAuthor ">Peter  van Rijnsbergen</span>, <span class="hlFld-ContribAuthor ">Wim  Zonneveld</span>, <span class="hlFld-ContribAuthor ">Duane  A. Burnett</span>. </span><span class="cited-content_cbyCitation_article-title">Strategic and Tactical Approaches to the Synthesis of 5,6-Dihydro-[1,2,4]oxadiazines. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2016,</strong> <em>92 </em>
                                    (12)
                                     , 2166. <a href="https://doi.org/10.3987/COM-16-13570" title="DOI URL">https://doi.org/10.3987/COM-16-13570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-16-13570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-16-13570%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DStrategic%252Band%252BTactical%252BApproaches%252Bto%252Bthe%252BSynthesis%252Bof%252B5%25252C6-Dihydro-%25255B1%25252C2%25252C4%25255Doxadiazines%26aulast%3DJ.%2BN.%2BVeerman%26aufirst%3DJohan%26date%3D2016%26volume%3D92%26issue%3D12%26spage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Edelweiss  Evrard</span>, <span class="hlFld-ContribAuthor ">Ivan  Efremov</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Kelly R.  Bales</span>, <span class="hlFld-ContribAuthor ">Eva  Hajos-Korcsok</span>, <span class="hlFld-ContribAuthor ">Heather E.  Murrey</span>, <span class="hlFld-ContribAuthor ">Leslie R.  Pustilnik</span>, <span class="hlFld-ContribAuthor ">Stefanus J.  Steyn</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Wood</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (4)
                                     , 908-913. <a href="https://doi.org/10.1016/j.bmcl.2014.12.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bindole-derived%252Bpyridopyrazine-1%25252C6-dione%252B%2525CE%2525B3-secretase%252Bmodulators%252Bthat%252Btarget%252Bpresenilin%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2015%26volume%3D25%26issue%3D4%26spage%3D908%26epage%3D913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kamlendra Singh  Bhadoriya</span>, <span class="hlFld-ContribAuthor ">Mukesh C.  Sharma</span>, <span class="hlFld-ContribAuthor ">Smita  Sharma</span>, <span class="hlFld-ContribAuthor ">Shailesh V.  Jain</span>, <span class="hlFld-ContribAuthor ">Mandar H.  Avchar</span>. </span><span class="cited-content_cbyCitation_article-title">An approach to design potent anti-Alzheimer’s agents by 3D-QSAR studies on fused 5,6-bicyclic heterocycles as γ-secretase modulators using kNN–MFA methodology. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2014,</strong> <em>7 </em>
                                    (6)
                                     , 924-935. <a href="https://doi.org/10.1016/j.arabjc.2013.02.002" title="DOI URL">https://doi.org/10.1016/j.arabjc.2013.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2013.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2013.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DAn%252Bapproach%252Bto%252Bdesign%252Bpotent%252Banti-Alzheimer%2525E2%252580%252599s%252Bagents%252Bby%252B3D-QSAR%252Bstudies%252Bon%252Bfused%252B5%25252C6-bicyclic%252Bheterocycles%252Bas%252B%2525CE%2525B3-secretase%252Bmodulators%252Busing%252BkNN%2525E2%252580%252593MFA%252Bmethodology%26aulast%3DBhadoriya%26aufirst%3DKamlendra%2BSingh%26date%3D2014%26volume%3D7%26issue%3D6%26spage%3D924%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomonori  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Seiji  Iwama</span>, <span class="hlFld-ContribAuthor ">Akira  Fusano</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Kato</span>, <span class="hlFld-ContribAuthor ">Atsushi  Ikeda</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Teranishi</span>, <span class="hlFld-ContribAuthor ">Akemi  Nishihara</span>, <span class="hlFld-ContribAuthor ">Masanori  Tobe</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of an aminopiperidine series of γ-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 378-381. <a href="https://doi.org/10.1016/j.bmcl.2013.10.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.10.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.10.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.10.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Ban%252Baminopiperidine%252Bseries%252Bof%252B%2525CE%2525B3-secretase%252Bmodulators%26aulast%3DKobayashi%26aufirst%3DTomonori%26date%3D2014%26volume%3D24%26issue%3D1%26spage%3D378%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeremy H.  Toyn</span>, <span class="hlFld-ContribAuthor ">Lorin A.  Thompson</span>, <span class="hlFld-ContribAuthor ">Kimberley A.  Lentz</span>, <span class="hlFld-ContribAuthor ">Jere E.  Meredith</span>, <span class="hlFld-ContribAuthor ">Catherine R.  Burton</span>, <span class="hlFld-ContribAuthor ">Sethu  Sankaranararyanan</span>, <span class="hlFld-ContribAuthor ">Valerie  Guss</span>, <span class="hlFld-ContribAuthor ">Tracey  Hall</span>, <span class="hlFld-ContribAuthor ">Lawrence G.  Iben</span>, <span class="hlFld-ContribAuthor ">Carol M.  Krause</span>, <span class="hlFld-ContribAuthor ">Rudy  Krause</span>, <span class="hlFld-ContribAuthor ">Xu-Alan  Lin</span>, <span class="hlFld-ContribAuthor ">Maria  Pierdomenico</span>, <span class="hlFld-ContribAuthor ">Craig  Polson</span>, <span class="hlFld-ContribAuthor ">Alan S.  Robertson</span>, <span class="hlFld-ContribAuthor ">R. Rex  Denton</span>, <span class="hlFld-ContribAuthor ">James E.  Grace</span>, <span class="hlFld-ContribAuthor ">John  Morrison</span>, <span class="hlFld-ContribAuthor ">Joseph  Raybon</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Zhuo</span>, <span class="hlFld-ContribAuthor ">Kimberly  Snow</span>, <span class="hlFld-ContribAuthor ">Ramesh  Padmanabha</span>, <span class="hlFld-ContribAuthor ">Michele  Agler</span>, <span class="hlFld-ContribAuthor ">Kim  Esposito</span>, <span class="hlFld-ContribAuthor ">David  Harden</span>, <span class="hlFld-ContribAuthor ">Margaret  Prack</span>, <span class="hlFld-ContribAuthor ">Sam  Varma</span>, <span class="hlFld-ContribAuthor ">Victoria  Wong</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhu</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Samuel  Gerritz</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  Marcin</span>, <span class="hlFld-ContribAuthor ">Mendi A.  Higgins</span>, <span class="hlFld-ContribAuthor ">Jianliang  Shi</span>, <span class="hlFld-ContribAuthor ">Cong  Wei</span>, <span class="hlFld-ContribAuthor ">Joseph L.  Cantone</span>, <span class="hlFld-ContribAuthor ">Dieter M.  Drexler</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, <span class="hlFld-ContribAuthor ">Richard E.  Olson</span>, <span class="hlFld-ContribAuthor ">Michael K.  Ahlijanian</span>, <span class="hlFld-ContribAuthor ">Charles F.  Albright</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Preclinical Pharmacology of the
              
                
                  γ
                
              
              -Secretase Modulator BMS-869780. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Alzheimer's Disease</span><span> <strong>2014,</strong> <em>2014 </em>, 1-22. <a href="https://doi.org/10.1155/2014/431858" title="DOI URL">https://doi.org/10.1155/2014/431858</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2014/431858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2014%2F431858%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DIdentification%252Band%252BPreclinical%252BPharmacology%252Bof%252Bthe%252B%2525CE%2525B3%252B-Secretase%252BModulator%252BBMS-869780%26aulast%3DToyn%26aufirst%3DJeremy%2BH.%26date%3D2014%26volume%3D2014%26spage%3D1%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Todd E.  Golde</span>, <span class="hlFld-ContribAuthor ">Edward H.  Koo</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Felsenstein</span>, <span class="hlFld-ContribAuthor ">Barbara A.  Osborne</span>, <span class="hlFld-ContribAuthor ">Lucio  Miele</span>. </span><span class="cited-content_cbyCitation_article-title">γ-Secretase inhibitors and modulators. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Biomembranes</span><span> <strong>2013,</strong> <em>1828 </em>
                                    (12)
                                     , 2898-2907. <a href="https://doi.org/10.1016/j.bbamem.2013.06.005" title="DOI URL">https://doi.org/10.1016/j.bbamem.2013.06.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamem.2013.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamem.2013.06.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Biomembranes%26atitle%3D%2525CE%2525B3-Secretase%252Binhibitors%252Band%252Bmodulators%26aulast%3DGolde%26aufirst%3DTodd%2BE.%26date%3D2013%26volume%3D1828%26issue%3D12%26spage%3D2898%26epage%3D2907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian Jeffrey  Chen</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Qian</span>, <span class="hlFld-ContribAuthor ">Kaustav  Biswas</span>, <span class="hlFld-ContribAuthor ">Chester  Yuan</span>, <span class="hlFld-ContribAuthor ">Albert  Amegadzie</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">Thomas  Nixey</span>, <span class="hlFld-ContribAuthor ">Joe  Zhu</span>, <span class="hlFld-ContribAuthor ">Mqhele  Ncube</span>, <span class="hlFld-ContribAuthor ">Robert M.  Rzasa</span>, <span class="hlFld-ContribAuthor ">Frank  Chavez</span>, <span class="hlFld-ContribAuthor ">Ning  Chen</span>, <span class="hlFld-ContribAuthor ">Frenel  DeMorin</span>, <span class="hlFld-ContribAuthor ">Shannon  Rumfelt</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Tegley</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Allen</span>, <span class="hlFld-ContribAuthor ">Stephen  Hitchcock</span>, <span class="hlFld-ContribAuthor ">Randy  Hungate</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Leeanne  Zalameda</span>, <span class="hlFld-ContribAuthor ">Yichin  Liu</span>, <span class="hlFld-ContribAuthor ">John D.  McCarter</span>, <span class="hlFld-ContribAuthor ">Jianhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>, <span class="hlFld-ContribAuthor ">Safura  Babu-Khan</span>, <span class="hlFld-ContribAuthor ">Yi  Luo</span>, <span class="hlFld-ContribAuthor ">Jodi  Bradley</span>, <span class="hlFld-ContribAuthor ">Paul H.  Wen</span>, <span class="hlFld-ContribAuthor ">Darren L.  Reid</span>, <span class="hlFld-ContribAuthor ">Frank  Koegler</span>, <span class="hlFld-ContribAuthor ">Charles  Dean</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Tiffany L.  Correll</span>, <span class="hlFld-ContribAuthor ">Toni  Williamson</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (23)
                                     , 6447-6454. <a href="https://doi.org/10.1016/j.bmcl.2013.09.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-methylpyridine-based%252Bbiaryl%252Bamides%252Bas%252B%2525CE%2525B3-secretase%252Bmodulators%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DChen%26aufirst%3DJian%2BJeffrey%26date%3D2013%26volume%3D23%26issue%3D23%26spage%3D6447%26epage%3D6454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Antonia F  Stepan</span>, <span class="hlFld-ContribAuthor ">Gregory W  Kauffman</span>, <span class="hlFld-ContribAuthor ">Douglas S  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 1349-1366. <a href="https://doi.org/10.1517/13543776.2013.821465" title="DOI URL">https://doi.org/10.1517/13543776.2013.821465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.821465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.821465%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNovel%252B%2525CE%2525B3-secretase%252Bmodulators%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252Ba%252Breview%252Bfocusing%252Bon%252Bpatents%252Bfrom%252B2010%252Bto%252B2012%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D1349%26epage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Mathre</span>, <span class="hlFld-ContribAuthor ">Ichiro  Shinkai</span>, <span class="hlFld-ContribAuthor ">Marek  Zaidlewicz</span>, <span class="hlFld-ContribAuthor ">Marek  Krzemiński</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Łączkowski</span>, <span class="hlFld-ContribAuthor ">Angela  Patti</span>, <span class="hlFld-ContribAuthor ">Sonia  Pedotti</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrahydro-1-methyl-3,3-diphenyl-1
              H
              , 3
              H
              -pyrrolo[1,2-
              c
              ][1,3,2]oxazaborole. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,<a href="https://doi.org/10.1002/047084289X.rt035s.pub3" title="DOI URL">https://doi.org/10.1002/047084289X.rt035s.pub3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/047084289X.rt035s.pub3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F047084289X.rt035s.pub3%26sid%3Dliteratum%253Aachs%26atitle%3DTetrahydro-1-methyl-3%25252C3-diphenyl-1%252BH%252B%25252C%252B3%252BH%252B-pyrrolo%25255B1%25252C2-%252Bc%252B%25255D%25255B1%25252C3%25252C2%25255Doxazaborole%26aulast%3DMathre%26aufirst%3DDavid%2BJ.%26date%3D2013%26date%3D2013%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DEncyclopedia%252Bof%252BReagents%252Bfor%252BOrganic%252BSynthesis%26date%3D2001%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Lian  Wu</span>, <span class="hlFld-ContribAuthor ">Theodros  Asberom</span>, <span class="hlFld-ContribAuthor ">Thomas  Bara</span>, <span class="hlFld-ContribAuthor ">Chad  Bennett</span>, <span class="hlFld-ContribAuthor ">Duane A.  Burnett</span>, <span class="hlFld-ContribAuthor ">John  Clader</span>, <span class="hlFld-ContribAuthor ">Martin  Domalski</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Hubert  Josien</span>, <span class="hlFld-ContribAuthor ">Mark  McBriar</span>, <span class="hlFld-ContribAuthor ">Murali  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Monica  Vicarel</span>, <span class="hlFld-ContribAuthor ">Ruo  Xu</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Robert A.  Del Vecchio</span>, <span class="hlFld-ContribAuthor ">Mary E.  Cohen-Williams</span>, <span class="hlFld-ContribAuthor ">Lixin  Song</span>, <span class="hlFld-ContribAuthor ">Julie  Lee</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Amin  Nomeir</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (3)
                                     , 844-849. <a href="https://doi.org/10.1016/j.bmcl.2012.11.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.11.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.11.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.11.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bactivity%252Brelationship%252Bstudies%252Bof%252Btricyclic%252Bbispyran%252Bsulfone%252B%2525CE%2525B3-secretase%252Binhibitors%26aulast%3DWu%26aufirst%3DWen-Lian%26date%3D2013%26volume%3D23%26issue%3D3%26spage%3D844%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Lian  Wu</span>, <span class="hlFld-ContribAuthor ">Thavalakulamgara K.  Sasikumar</span>, <span class="hlFld-ContribAuthor ">Martin S.  Domalski</span>, <span class="hlFld-ContribAuthor ">Li  Qiang</span>, <span class="hlFld-ContribAuthor ">Duane A.  Burnett</span>, <span class="hlFld-ContribAuthor ">John  Clader</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Tze-Ming  Chan</span>, <span class="hlFld-ContribAuthor ">Julie  Lee</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A-ring modification of SCH 900229 and related chromene sulfone γ-secretase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (3)
                                     , 850-853. <a href="https://doi.org/10.1016/j.bmcl.2012.11.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.11.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.11.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.11.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA-ring%252Bmodification%252Bof%252BSCH%252B900229%252Band%252Brelated%252Bchromene%252Bsulfone%252B%2525CE%2525B3-secretase%252Binhibitors%26aulast%3DWu%26aufirst%3DWen-Lian%26date%3D2013%26volume%3D23%26issue%3D3%26spage%3D850%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Influence of Bioisosteres in Drug Design: Tactical Applications to Address Developability Problems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 283-381. <a href="https://doi.org/10.1007/7355_2013_29" title="DOI URL">https://doi.org/10.1007/7355_2013_29</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2013_29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2013_29%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInfluence%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%25253A%252BTactical%252BApplications%252Bto%252BAddress%252BDevelopability%252BProblems%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2014%26spage%3D283%26epage%3D381%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DTactics%252Bin%252BContemporary%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongmei  Li</span>, <span class="hlFld-ContribAuthor ">Jun  Qin</span>, <span class="hlFld-ContribAuthor ">Pawan  Dhondi</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Monica  Vicarel</span>, <span class="hlFld-ContribAuthor ">Thomas  Bara</span>, <span class="hlFld-ContribAuthor ">David  Cole</span>, <span class="hlFld-ContribAuthor ">Hubert  Josien</span>, <span class="hlFld-ContribAuthor ">Dmitri  Pissarnitski</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>, <span class="hlFld-ContribAuthor ">Robert  Aslanian</span>, <span class="hlFld-ContribAuthor ">John  Clader</span>, <span class="hlFld-ContribAuthor ">Michael  Czarniecki</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Mary  Cohen-Williams</span>, <span class="hlFld-ContribAuthor ">Lynn  Hyde</span>, <span class="hlFld-ContribAuthor ">Lixin  Song</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Inhou  Chu</span>, <span class="hlFld-ContribAuthor ">Xianhai  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (2)
                                     , 466-471. <a href="https://doi.org/10.1016/j.bmcl.2012.11.055" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.11.055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.11.055%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252Bfused%252Boxadiazepines%252Bas%252Bgamma%252Bsecretase%252Bmodulators%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLi%26aufirst%3DHongmei%26date%3D2013%26volume%3D23%26issue%3D2%26spage%3D466%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianhai  Huang</span>, <span class="hlFld-ContribAuthor ">Dmitri  Pissarnitski</span>, <span class="hlFld-ContribAuthor ">Hongmei  Li</span>, <span class="hlFld-ContribAuthor ">Theodros  Asberom</span>, <span class="hlFld-ContribAuthor ">Hubert  Josien</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Zhu</span>, <span class="hlFld-ContribAuthor ">Monica  Vicarel</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Zhao</span>, <span class="hlFld-ContribAuthor ">Murali  Rajagopalan</span>, <span class="hlFld-ContribAuthor ">Anandan  Palani</span>, <span class="hlFld-ContribAuthor ">Robert  Aslanian</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis and reaction pathway studies of novel fused morpholine oxadiazolines for use as gamma secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (47)
                                     , 6451-6455. <a href="https://doi.org/10.1016/j.tetlet.2012.09.070" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.09.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.09.070%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DEfficient%252Bsynthesis%252Band%252Breaction%252Bpathway%252Bstudies%252Bof%252Bnovel%252Bfused%252Bmorpholine%252Boxadiazolines%252Bfor%252Buse%252Bas%252Bgamma%252Bsecretase%252Bmodulators%26aulast%3DHuang%26aufirst%3DXianhai%26date%3D2012%26volume%3D53%26issue%3D47%26spage%3D6451%26epage%3D6455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eda  Canales</span>, <span class="hlFld-ContribAuthor ">Joseph S.  Carlson</span>, <span class="hlFld-ContribAuthor ">Todd  Appleby</span>, <span class="hlFld-ContribAuthor ">Martijn  Fenaux</span>, <span class="hlFld-ContribAuthor ">Johnny  Lee</span>, <span class="hlFld-ContribAuthor ">Yang  Tian</span>, <span class="hlFld-ContribAuthor ">Neeraj  Tirunagari</span>, <span class="hlFld-ContribAuthor ">Melanie  Wong</span>, <span class="hlFld-ContribAuthor ">William J.  Watkins</span>. </span><span class="cited-content_cbyCitation_article-title">Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (13)
                                     , 4288-4292. <a href="https://doi.org/10.1016/j.bmcl.2012.05.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.05.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.05.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTri-substituted%252Bacylhydrazines%252Bas%252Btertiary%252Bamide%252Bbioisosteres%25253A%252BHCV%252BNS5B%252Bpolymerase%252Binhibitors%26aulast%3DCanales%26aufirst%3DEda%26date%3D2012%26volume%3D22%26issue%3D13%26spage%3D4288%26epage%3D4292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Pettersson</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Chakrapani  Subramanyam</span>, <span class="hlFld-ContribAuthor ">Kelly R.  Bales</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Benjamin A.  Fish</span>, <span class="hlFld-ContribAuthor ">Michael E.  Green</span>, <span class="hlFld-ContribAuthor ">Gregory W.  Kauffman</span>, <span class="hlFld-ContribAuthor ">Ricardo  Lira</span>, <span class="hlFld-ContribAuthor ">Patrick B.  Mullins</span>, <span class="hlFld-ContribAuthor ">Thayalan  Navaratnam</span>, <span class="hlFld-ContribAuthor ">Subas M.  Sakya</span>, <span class="hlFld-ContribAuthor ">Cory M.  Stiff</span>, <span class="hlFld-ContribAuthor ">Tuan P.  Tran</span>, <span class="hlFld-ContribAuthor ">Beth C.  Vetelino</span>, <span class="hlFld-ContribAuthor ">Longfei  Xie</span>, <span class="hlFld-ContribAuthor ">Liming  Zhang</span>, <span class="hlFld-ContribAuthor ">Leslie R.  Pustilnik</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Wood</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (8)
                                     , 2906-2911. <a href="https://doi.org/10.1016/j.bmcl.2012.02.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.02.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.02.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.02.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bdihydrobenzofuran%252Bamides%252Bas%252Borally%252Bbioavailable%25252C%252Bcentrally%252Bactive%252B%2525CE%2525B3-secretase%252Bmodulators%26aulast%3DPettersson%26aufirst%3DMartin%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D2906%26epage%3D2911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>, <span class="hlFld-ContribAuthor ">François P.  Bischoff</span>. </span><span class="cited-content_cbyCitation_article-title">Secretase Inhibitors and Modulators as a Disease-Modifying Approach Against Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 55-69. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00005-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00005-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00005-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00005-9%26sid%3Dliteratum%253Aachs%26atitle%3DSecretase%252BInhibitors%252Band%252BModulators%252Bas%252Ba%252BDisease-Modifying%252BApproach%252BAgainst%252BAlzheimer%252527s%252BDisease%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.M.%26date%3D2012%26spage%3D55%26epage%3D69%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>, <span class="hlFld-ContribAuthor ">Marc  Mercken</span>. </span><span class="cited-content_cbyCitation_article-title">-Secretase Modulators: Can We Combine Potency with Safety?. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Alzheimer's Disease</span><span> <strong>2012,</strong> <em>2012 </em>, 1-10. <a href="https://doi.org/10.1155/2012/295207" title="DOI URL">https://doi.org/10.1155/2012/295207</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2012/295207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2012%2F295207%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3D-Secretase%252BModulators%25253A%252BCan%252BWe%252BCombine%252BPotency%252Bwith%252BSafety%25253F%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.%2BM.%26date%3D2012%26volume%3D2012%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0015.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. NSAID and non-NSAID γ-secretase modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of 1,2,4-oxadiazoline as an amide isostere.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Monocyclic Oxadiazoline <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) microwave 150 °C, 30 min, THF; (b) NH<sub>2</sub>OH·HCl, KOAc, MeOH; (c) NCS/Py, DCM; (d) Et<sub>3</sub>N, DCM.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 5-Alkyl-5-aryl Bicyclic Oxadiazolines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, DMF; (b) Et<sub>3</sub>N, DMF; (c) <i>t</i>-BuOK, THF; (d) <i>t</i>-BuOK, THF; (e) NaBH<sub>4</sub>, THF/MeOH.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 3-(4-Fluorophenyl)-3-hydroxymethyl or 3-Aminomethyl Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MeMgBr, Et<sub>3</sub>N, THF; (b) (<i>S</i>)-2-methyl-CBS-oxazaborolidine in toluene, BH<sub>3</sub>·Me<sub>2</sub>S, THF; (c) NaBH<sub>4</sub>, THF/MeOH; (d) MeI, NaH, DMF; (e) Swern oxidation. (f) For <b>36</b> and <b>37</b>: NaBH(OAc)<sub>3</sub>, HOAc, the corresponding amine, DCE. For <b>38</b>: the reductive amination with 2-aminoethylbenzoate followed by hydrolysis with LiOH. (g) Acetic anhydride, Et<sub>3</sub>N, DCM; (h) MeSO<sub>2</sub>Cl, Et<sub>3</sub>N, DCM.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Ketimine <b>30b</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TMSCl, Et<sub>3</sub>N, DCM; (b) TMSOTf, DCM, reflux.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Ketoesters <b>45</b> and <b>46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>i</i>-PrMgCl·LiCl, THF.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Oxadiazine <b>53</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CbzNH<sub>2</sub>, NaOH/<i>tert</i>-butyl hypochlorite, (DHQ)<sub>2</sub>PHAL, K<sub>2</sub>OsO<sub>2</sub>(OH)<sub>4</sub>, PrOH/water; (b) H<sub>2</sub>/Pd(OH)<sub>2</sub>; (c) EDCI, HOBT, DIEA, DMF; (d), NaOMe, MeOH; (e) <i>N</i>-hydroxyphthalimide, PPh<sub>3</sub>, DIAD, THF; (f) NH<sub>2</sub>NH<sub>2</sub>, EtOH; (g) P<sub>2</sub>O<sub>5</sub>, EtOH, reflux.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Mass spectrometric analysis of Aβ peptides generated from HEK293<sup>Swe-Lon</sup> cells after treatment with vehicle (DMSO) or 10 μM <b>53</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Aβ<sub>total</sub>, Aβ<sub>40</sub>, and Aβ<sub>42</sub> in plasma (left), CSF (middle), and cortex (right) from rats treated acutely with various single oral doses of <b>53</b>(1–30 mg/kg). Data are the mean ± standard error of the mean averaged from several studies, expressed as % vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/medium/jm-2011-01407j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Aβ<sub>total</sub>, Aβ<sub>40</sub>, and Aβ<sub>42</sub> in plasma, CSF, and cortex from monkeys treated with <b>53</b> orally at 30 mg/kg at 4 h. Data are expressed as a percent of the predose value from the same animals (plasma) or as a percent of the control (vehicle)-treated monkeys (CSF and cortex).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201407j/production/images/large/jm-2011-01407j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201407j&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i65">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wimo, A.; Prince, M.</span><span> </span><span class="NLM_article-title">World Alzheimer Report 2010: The Global Economic Impact of Dementia</span>; <span class="NLM_publisher-name">Alzheimer’s Disease International (ADI)</span>: <span class="NLM_publisher-loc">London, U.K.</span>, September<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wimo%2C+A.%3B+Prince%2C+M.+World+Alzheimer+Report+2010%3A+The+Global+Economic+Impact+of+Dementia%3B+Alzheimer%E2%80%99s+Disease+International+%28ADI%29%3A+London%2C+U.K.%2C+September+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWimo%26aufirst%3DA.%26atitle%3DWorld%2520Alzheimer%2520Report%25202010%253A%2520The%2520Global%2520Economic%2520Impact%2520of%2520Dementia%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%2520%2528ADI%2529%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bienkowski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuck, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tory, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauley, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashler, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratman, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parodi, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurney, M. E.</span><span> </span><span class="NLM_article-title">Membrane-anchored aspartyl protease with Alzheimer’s disease β-secretase specificity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">533</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=533-537&author=R.+Yanauthor=M.+J.+Bienkowskiauthor=M.+E.+Shuckauthor=H.+Miaoauthor=M.+C.+Toryauthor=A.+M.+Pauleyauthor=J.+R.+Brashlerauthor=N.+C.+Stratmanauthor=W.+R.+Mathewsauthor=A.+E.+Buhlauthor=D.+B.+Carterauthor=A.+G.+Tomasselliauthor=L.+A.+Parodiauthor=R.+L.+Heinriksonauthor=M.+E.+Gurney&title=Membrane-anchored+aspartyl+protease+with+Alzheimer%E2%80%99s+disease+%CE%B2-secretase+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DR.%26aulast%3DBienkowski%26aufirst%3DM.%2BJ.%26aulast%3DShuck%26aufirst%3DM.%2BE.%26aulast%3DMiao%26aufirst%3DH.%26aulast%3DTory%26aufirst%3DM.%2BC.%26aulast%3DPauley%26aufirst%3DA.%2BM.%26aulast%3DBrashler%26aufirst%3DJ.%2BR.%26aulast%3DStratman%26aufirst%3DN.%2BC.%26aulast%3DMathews%26aufirst%3DW.%2BR.%26aulast%3DBuhl%26aufirst%3DA.%2BE.%26aulast%3DCarter%26aufirst%3DD.%2BB.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DParodi%26aufirst%3DL.%2BA.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26atitle%3DMembrane-anchored%2520aspartyl%2520protease%2520with%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25CE%25B2-secretase%2520specificity%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D533%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendiaz, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teplow, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amarante, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeloff, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edenson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lile, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosinski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biere, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treanor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">β-Secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1126%2Fscience.286.5440.735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=10531052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=735-741&author=R.+Vassarauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=S.+Kahnauthor=E.+A.+Mendiazauthor=P.+Denisauthor=D.+B.+Teplowauthor=S.+Rossauthor=P.+Amaranteauthor=R.+Loeloffauthor=Y.+Luoauthor=S+Fisherauthor=J.+Fullerauthor=S.+Edensonauthor=J.+Lileauthor=M.+A.+Jarosinskiauthor=A.+L.+Biereauthor=E.+Curranauthor=T.+Burgessauthor=J.-C.+Louisauthor=F.+Collinsauthor=J.+Treanorauthor=G.+Rogersauthor=M.+Citron&title=%CE%B2-Secretase+cleavage+of+Alzheimer%E2%80%99s+amyloid+precursor+protein+by+the+transmembrane+aspartic+protease+BACE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE</span></div><div class="casAuthors">Vassar, Robert; Bennett, Brian D.; Babu-Khan, Safura; Kahn, Steve; Mendiaz, Elizabeth A.; Denis, Paul; Teplow, David B.; Ross, Sandra; Amarante, Patricia; Loeloff, Richard; Luo, Yi; Fisher, Seth; Fuller, Janis; Edenson, Steven; Lile, Jackson; Jarosinski, Mark A.; Biere, Anja Leona; Curran, Eileen; Burgess, Teresa; Louis, Jean-Claude; Collins, Frank; Treanor, James; Rogers, Gary; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5440</span>),
    <span class="NLM_cas:pages">735-741</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cerebral deposition of amyloid β peptide (Aβ) is an early and crit. feature of Alzheimer's disease.  Aβ generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: β-secretase and γ-secretase.  These proteases are prime therapeutic targets.  A transmembrane aspartic protease with all the known characteristics of β-secretase was cloned and characterized.  Overexpression of this protease, termed BACE (for beta-site APP-cleaving enzyme) increased the amt. of β-secretase cleavage products, and these were cleaved exactly and only at known β-secretase positions.  Antisense inhibition of endogenous BACE mRNA decreased the amt. of β-secretase cleavage products, and purified BACE protein cleaved APP-derived substrates with the same sequence specificity as β-secretase.  Finally, the expression pattern and subcellular localization of BACE were consistent with that expected for β-secretase.  Future development of BACE inhibitors may prove beneficial for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSx3s1NFyByrVg90H21EOLACvtfcHk0ljPBXK9qPXpTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntFWit74%253D&md5=3f36e8e5b5e9441c7670ccaeb0d2dd4f</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5440.735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5440.735%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DMendiaz%26aufirst%3DE.%2BA.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DTeplow%26aufirst%3DD.%2BB.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DAmarante%26aufirst%3DP.%26aulast%3DLoeloff%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DFisher%26aufirst%3DS%26aulast%3DFuller%26aufirst%3DJ.%26aulast%3DEdenson%26aufirst%3DS.%26aulast%3DLile%26aufirst%3DJ.%26aulast%3DJarosinski%26aufirst%3DM.%2BA.%26aulast%3DBiere%26aufirst%3DA.%2BL.%26aulast%3DCurran%26aufirst%3DE.%26aulast%3DBurgess%26aufirst%3DT.%26aulast%3DLouis%26aufirst%3DJ.-C.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DRogers%26aufirst%3DG.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3D%25CE%25B2-Secretase%2520cleavage%2520of%2520Alzheimer%25E2%2580%2599s%2520amyloid%2520precursor%2520protein%2520by%2520the%2520transmembrane%2520aspartic%2520protease%2520BACE%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D735%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hussain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howlett, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloger, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southan, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dingwall, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christie, G.</span><span> </span><span class="NLM_article-title">Identification of a novel aspartic protease (Asp 2) as beta-secretase.</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">427</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1006%2Fmcne.1999.0811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=10656250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=419-427&author=I.+Hussainauthor=D.+Powellauthor=D.+R.+Howlettauthor=D.+G.+Tewauthor=T.+D.+Meekauthor=C.+Chapmanauthor=I.+S.+Glogerauthor=K.+E.+Murphyauthor=C.+D.+Southanauthor=D.+M.+Ryanauthor=T.+S.+Smithauthor=D.+L.+Simmonsauthor=F.+S.+Walshauthor=C.+Dingwallauthor=G.+Christie&title=Identification+of+a+novel+aspartic+protease+%28Asp+2%29+as+beta-secretase."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase</span></div><div class="casAuthors">Hussain, Ishrut; Powell, David; Howlett, David R.; Tew, David G.; Meek, Thomas D.; Chapman, Conrad; Gloger, Israel S.; Murphy, Kay E.; Southan, Christopher D.; Ryan, Dominic M.; Smith, Trudi S.; Simmons, David L.; Walsh, Frank S.; Dingwall, Colin; Christie, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-427</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The Alzheimer's disease β-amyloid peptide (Aβ) is produced by excision from the type 1 integral membrane glycoprotein amyloid precursor protein (APP) by the sequential actions of β- and then γ-secretases.  Here we report that Asp 2, a novel transmembrane aspartic protease, has the key activities expected of β-secretase.  Transient expression of Asp 2 in cells expressing APP causes an increase in the secretion of the N-terminal fragment of APP and an increase in the cell-assocd. C-terminal β-secretase APP fragment.  Mutation of either of the putative catalytic aspartyl residues in Asp 2 abrogates the prodn. of the fragments characteristic of cleavage at the β-secretase site.  The enzyme is present in normal and Alzheimer's disease (AD) brain and is also found in cell lines known to produce Aβ.  Asp 2 localizes to the Golgi/endoplasmic reticulum in transfected cells and shows clear colocalization with APP in cells stably expressing the 751-amino-acid isoform of APP.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDUBbUoO6SgLVg90H21EOLACvtfcHk0liiXetNJaTFXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnt1Chsrs%253D&md5=aba834d907c5dae03f060d94729576e9</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1999.0811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1999.0811%26sid%3Dliteratum%253Aachs%26aulast%3DHussain%26aufirst%3DI.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DHowlett%26aufirst%3DD.%2BR.%26aulast%3DTew%26aufirst%3DD.%2BG.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DGloger%26aufirst%3DI.%2BS.%26aulast%3DMurphy%26aufirst%3DK.%2BE.%26aulast%3DSouthan%26aufirst%3DC.%2BD.%26aulast%3DRyan%26aufirst%3DD.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BS.%26aulast%3DSimmons%26aufirst%3DD.%2BL.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DDingwall%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520novel%2520aspartic%2520protease%2520%2528Asp%25202%2529%2520as%2520beta-secretase.%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1999%26volume%3D14%26spage%3D419%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbour, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basi, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caccavello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dovey, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frigon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson-Croak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewett, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keim, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knops, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieberburg, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsuno, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suomensaari, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, J.</span><span> </span><span class="NLM_article-title">Purification and cloning of amyloid precursor protein β-secretase from human brain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=1999&pages=537-540&author=S.+Sinhaauthor=J.+P.+Andersonauthor=R.+Barbourauthor=G.+S.+Basiauthor=R.+Caccavelloauthor=D.+Davisauthor=M.+Doanauthor=H.+F.+Doveyauthor=N.+Frigonauthor=J.+Hongauthor=K.+Jacobson-Croakauthor=N.+Jewettauthor=P.+Keimauthor=J.+Knopsauthor=I.+Lieberburgauthor=M.+Powerauthor=H.+Tanauthor=G.+Tatsunoauthor=J.+Tungauthor=D.+Schenkauthor=P.+Seubertauthor=S.+M.+Suomensaariauthor=S.+Wangauthor=D.+Walkerauthor=J.+Zhaoauthor=L.+McConlogueauthor=J.+Varghese&title=Purification+and+cloning+of+amyloid+precursor+protein+%CE%B2-secretase+from+human+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBarbour%26aufirst%3DR.%26aulast%3DBasi%26aufirst%3DG.%2BS.%26aulast%3DCaccavello%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DDoan%26aufirst%3DM.%26aulast%3DDovey%26aufirst%3DH.%2BF.%26aulast%3DFrigon%26aufirst%3DN.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DJacobson-Croak%26aufirst%3DK.%26aulast%3DJewett%26aufirst%3DN.%26aulast%3DKeim%26aufirst%3DP.%26aulast%3DKnops%26aufirst%3DJ.%26aulast%3DLieberburg%26aufirst%3DI.%26aulast%3DPower%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DTatsuno%26aufirst%3DG.%26aulast%3DTung%26aufirst%3DJ.%26aulast%3DSchenk%26aufirst%3DD.%26aulast%3DSeubert%26aufirst%3DP.%26aulast%3DSuomensaari%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DVarghese%26aufirst%3DJ.%26atitle%3DPurification%2520and%2520cloning%2520of%2520amyloid%2520precursor%2520protein%2520%25CE%25B2-secretase%2520from%2520human%2520brain%26jtitle%3DNature%26date%3D1999%26volume%3D402%26spage%3D537%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Guardia-Laguarta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lleó, A.</span><span> </span><span class="NLM_article-title">γ-Secretase as a therapeutic target in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.2174%2F138945010790980349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=20015011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvV2jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=506-517&author=C.+Guardia-Laguartaauthor=M.+Peraauthor=A.+Lle%C3%B3&title=%CE%B3-Secretase+as+a+therapeutic+target+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">γ-secretase as a therapeutic target in Alzheimer's disease</span></div><div class="casAuthors">Guardia-Laguarta, C.; Pera, M.; Lleo, A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">506-517</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  γ-Secretase is an intramembranous multi-protein complex that cleaves many type-1 proteins with crit. roles in neuronal function.  In Alzheimer's disease (AD) interest in γ-secretase comes, in part, from the fact that this complex is responsible for the last cleavage step of the amyloid precursor protein (APP) that generates the amyloid-β peptide (Aβ).  Aβ represents the primary component of the amyloid plaque, one of the main pathol. hallmarks of AD.  Over the last years, considerable efforts have been made to develop drugs to reduce Aβ prodn. with the aim to slow AD progression.  Many inhibitors of this protease have been identified, although the clin. use has been limited by concerns about the possible toxicity of these compds.  γ-Secretase inhibitors have been shown to reduce Aβ in vitro and in vivo, but interference with Notch proteolysis causes immunol. and gastrointestinal toxicity in animal models.  The observation that some nonsteroidal anti-inflammatory drug (NSAID) derivs. are able to specifically lower Aβ42 and the development of inhibitors with Notch-sparing selectivity has revived the interest in γ-secretase as an attractive target for drug intervention in AD.  Despite the fact that all clin. trials with NSAIDs or γ-secretase modulators in AD have failed to show clin. benefit thus far, the main concern is that the Aβ-lowering potency of the tested compds. may be too low.  Active efforts are being made to develop compds. able to penetrate into the brain to lower Aβ at physiol. doses without interfering with the cleavage and function of other crit. γ-secretase substrates.  These novel inhibitors and modulators may soon offer hope in the Alzheimer's fight.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrzBNbV0vJrbVg90H21EOLACvtfcHk0liiXetNJaTFXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvV2jtrw%253D&md5=5deb524a552dc54e9b7ed72df9904838</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F138945010790980349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945010790980349%26sid%3Dliteratum%253Aachs%26aulast%3DGuardia-Laguarta%26aufirst%3DC.%26aulast%3DPera%26aufirst%3DM.%26aulast%3DLle%25C3%25B3%26aufirst%3DA.%26atitle%3D%25CE%25B3-Secretase%2520as%2520a%2520therapeutic%2520target%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2010%26volume%3D11%26spage%3D506%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hardy, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">256</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: progress and problem on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+progress+and+problem+on+the+road+to+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520progress%2520and%2520problem%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Walsh, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">Aβ oligomers: a decade of discovery</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1111%2Fj.1471-4159.2006.04426.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=17286590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=1172-1184&author=D.+M.+Walshauthor=D.+J.+Selkoe&title=A%CE%B2+oligomers%3A+a+decade+of+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ oligomers - a decade of discovery</span></div><div class="casAuthors">Walsh, Dominic M.; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1172-1184</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Converging lines of evidence suggest that progressive accumulation of the amyloid β-protein (Aβ) plays a central role in the genesis of Alzheimer's disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects.  Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β-amyloid precursor protein transgenic mice and human brain to suggest that pre-fibrillar, diffusible assemblies of Aβ are also deleterious.  Although the precise mol. identity of these sol. toxins remains unsettled, accumulating evidence suggests that sol. forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury.  Here the authors review recent progress in understanding the role of sol. oligomers in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrWrluV1aL7Vg90H21EOLACvtfcHk0lj0OpSXiF6VUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFensrc%253D&md5=263855754364d2ab520e6fd705b9f5f7</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.04426.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.04426.x%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BM.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DA%25CE%25B2%2520oligomers%253A%2520a%2520decade%2520of%2520discovery%26jtitle%3DJ.%2520Neurochem.%26date%3D2007%26volume%3D101%26spage%3D1172%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Artavanis-Tsakonas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rand, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, R. J.</span><span> </span><span class="NLM_article-title">Notch signaling: cell fate control and signal integration in development</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1999&pages=770-776&author=S.+Artavanis-Tsakonasauthor=M.+D.+Randauthor=R.+J.+Lake&title=Notch+signaling%3A+cell+fate+control+and+signal+integration+in+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArtavanis-Tsakonas%26aufirst%3DS.%26aulast%3DRand%26aufirst%3DM.%2BD.%26aulast%3DLake%26aufirst%3DR.%2BJ.%26atitle%3DNotch%2520signaling%253A%2520cell%2520fate%2520control%2520and%2520signal%2520integration%2520in%2520development%26jtitle%3DScience%26date%3D1999%26volume%3D284%26spage%3D770%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hüll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heneka, M.</span><span> </span><span class="NLM_article-title">Disease-modifying therapies in Alzheimer’s disease</span> <span class="citation_source-journal">Drug</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">2075</span><span class="NLM_x">–</span> <span class="NLM_lpage">2093</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.2165%2F00003495-200666160-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=17112302" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=2075-2093&author=M.+H%C3%BCllauthor=M.+Bergerauthor=M.+Heneka&title=Disease-modifying+therapies+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2165%2F00003495-200666160-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00003495-200666160-00004%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCll%26aufirst%3DM.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DHeneka%26aufirst%3DM.%26atitle%3DDisease-modifying%2520therapies%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrug%26date%3D2006%26volume%3D66%26spage%3D2075%26epage%3D2093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Siemers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsteinsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tariot, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoulnouni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span> </span><span class="NLM_article-title">Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=602-604&author=E.+R.+Siemersauthor=J.+F.+Quinnauthor=J.+Kayeauthor=M.+R.+Farlowauthor=A.+Porsteinssonauthor=P.+Tariotauthor=P.+Zoulnouniauthor=J.+E.+Galvinauthor=D.+M.+Holtzmanauthor=D.+S.+Knopmanauthor=J.+Satterwhiteauthor=C.+Gonzalesauthor=R.+A.+Deanauthor=P.+C.+May&title=Effects+of+a+%CE%B3-secretase+inhibitor+in+a+randomized+study+of+patients+with+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DPorsteinsson%26aufirst%3DA.%26aulast%3DTariot%26aufirst%3DP.%26aulast%3DZoulnouni%26aufirst%3DP.%26aulast%3DGalvin%26aufirst%3DJ.%2BE.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DSatterwhite%26aufirst%3DJ.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMay%26aufirst%3DP.%2BC.%26atitle%3DEffects%2520of%2520a%2520%25CE%25B3-secretase%2520inhibitor%2520in%2520a%2520randomized%2520study%2520of%2520patients%2520with%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26spage%3D602%26epage%3D604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fleisher, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becerra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peskind, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowell, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thal, L. J.</span><span> </span><span class="NLM_article-title">Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">1031</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1001%2Farchneur.65.8.1031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=18695053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A280%3ADC%252BD1crht1eitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=1031-1038&author=A.+S.+Fleisherauthor=R.+Ramanauthor=E.+R.+Siemersauthor=L.+Becerraauthor=C.+M.+Clarkauthor=R.+A.+Deanauthor=M.+R.+Farlowauthor=J.+E.+Galvinauthor=E.+R.+Peskindauthor=J.+F.+Quinnauthor=A.+Sherzaiauthor=B.+B.+Sowellauthor=P.+S.+Aisenauthor=L.+J.+Thal&title=Phase+2+safety+trial+targeting+amyloid+%CE%B2+production+with+a+%CE%B3-secretase+inhibitor+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease</span></div><div class="casAuthors">Fleisher Adam S; Raman Rema; Siemers Eric R; Becerra Lida; Clark Christopher M; Dean Robert A; Farlow Martin R; Galvin James E; Peskind Elaine R; Quinn Joseph F; Sherzai Abdullah; Sowell B Brooke; Aisen Paul S; Thal Leon J</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1031-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the safety, tolerability, and amyloid beta (Abeta) response to the gamma-secretase inhibitor LY450139 in Alzheimer disease.  DESIGN:  Multicenter, randomized, double-blind, dose-escalation, placebo-controlled trial.  SETTING:  Community-based clinical research centers.  Patients Fifty-one individuals with mild to moderate Alzheimer disease were randomized to receive placebo (n=15) or LY450139 (100 mg [n=22] or 140 mg [n=14]), with 43 completing the treatment phase.  Intervention The LY450139 groups received 60 mg/d for 2 weeks, then 100 mg/d for 6 weeks, and then either 100 or 140 mg/d for 6 additional weeks.  MAIN OUTCOME MEASURES:  Primary outcome measures were adverse events, plasma and cerebrospinal fluid Abeta levels, vital signs, electrocardiographic data, and laboratory safety test results.  Secondary outcome measures included the Alzheimer's Disease Assessment Scale cognitive subscale and the Alzheimer's Disease Cooperative Study Activities of Daily Living Scale.  RESULTS:  Group differences were seen in skin and subcutaneous tissue concerns (P=.05), including 3 possible drug rashes and 3 reports of hair color change in the treatment groups.  There were 3 adverse event-related discontinuations, including 1 transient bowel obstruction.  The plasma Abeta(40) concentration was reduced by 58.2% for the 100-mg group and 64.6% for the 140-mg group (P<.001).  No significant reduction was seen in cerebrospinal fluid Abeta levels.  No group differences were seen in cognitive or functional measures.  CONCLUSIONS:  LY450139 was generally well tolerated at doses of up to 140 mg/d for 14 weeks, with several findings indicating the need for close clinical monitoring in future studies.  Decreases in plasma Abeta concentrations were consistent with inhibition of gamma-secretase.  Trial Registration clinicaltrials.gov Identifier: NCT00244322.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqalGl_MMc4JotVjB3IRIyfW6udTcc2ebcGw77zRK0Bbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1crht1eitw%253D%253D&md5=629a70ec00cd620952cd78c83617e152</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1001%2Farchneur.65.8.1031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.65.8.1031%26sid%3Dliteratum%253Aachs%26aulast%3DFleisher%26aufirst%3DA.%2BS.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DBecerra%26aufirst%3DL.%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DFarlow%26aufirst%3DM.%2BR.%26aulast%3DGalvin%26aufirst%3DJ.%2BE.%26aulast%3DPeskind%26aufirst%3DE.%2BR.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DSowell%26aufirst%3DB.%2BB.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DThal%26aufirst%3DL.%2BJ.%26atitle%3DPhase%25202%2520safety%2520trial%2520targeting%2520amyloid%2520%25CE%25B2%2520production%2520with%2520a%2520%25CE%25B3-secretase%2520inhibitor%2520in%2520Alzheimer%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D2008%26volume%3D65%26spage%3D1031%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ness, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span> </span><span class="NLM_article-title">Safety, tolerability, and changes in amyloid β concentrations after administration of a γ-secretase inhibitor in volunteers</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=126-132&author=E.+Siemersauthor=M.+Skinnerauthor=R.+A.+Deanauthor=C.+Gonzalesauthor=J.+Satterwhiteauthor=M.+Farlowauthor=D.+Nessauthor=P.+C.+May&title=Safety%2C+tolerability%2C+and+changes+in+amyloid+%CE%B2+concentrations+after+administration+of+a+%CE%B3-secretase+inhibitor+in+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DSkinner%26aufirst%3DM.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DSatterwhite%26aufirst%3DJ.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DNess%26aufirst%3DD.%26aulast%3DMay%26aufirst%3DP.%2BC.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520changes%2520in%2520amyloid%2520%25CE%25B2%2520concentrations%2520after%2520administration%2520of%2520a%2520%25CE%25B3-secretase%2520inhibitor%2520in%2520volunteers%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2007%26volume%3D28%26spage%3D126%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bateman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawuenyega, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browning, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigurdson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarasheski, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMattos, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span> </span><span class="NLM_article-title">A γ-secretase inhibitor decreases amyloid-β production in the central nervous system</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1002%2Fana.21623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=19360898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWju7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=48-64&author=R.+J.+Batemanauthor=E.+R.+Siemersauthor=K.+G.+Mawuenyegaauthor=G.+Wenauthor=K.+R.+Browningauthor=W.+C.+Sigurdsonauthor=K.+E.+Yarasheskiauthor=S.+W.+Friedrichauthor=R.+B.+DeMattosauthor=P.+C.+Mayauthor=S.+M.+Paulauthor=D.+M.+Holtzman&title=A+%CE%B3-secretase+inhibitor+decreases+amyloid-%CE%B2+production+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">A γ-secretase inhibitor decreases amyloid-β production in the central nervous system</span></div><div class="casAuthors">Bateman, Randall J.; Siemers, Eric R.; Mawuenyega, Kwasi G.; Wen, Guolin; Browning, Karen R.; Sigurdson, Wendy C.; Yarasheski, Kevin E.; Friedrich, Stuart W.; De Mattos, Ronald B.; May, Patrick C.; Paul, Steven M.; Holtzman, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-54</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Objective: Accumulation of amyloid-β (Aβ) by overprodn. or underclearance in the central nervous system (CNS) is hypothesized to be a necessary event in the pathogenesis of Alzheimer's disease.  However, previously, there has not been a method to det. drug effects on Aβ prodn. or clearance in the human CNS.  The objective of this study was to det. the effects of a γ-secretase inhibitor on the prodn. of Aβ in the human CNS.  Methods: We utilized a recently developed method of stable-isotope labeling combined with cerebrospinal fluid sampling to directly measure Aβ prodn. during treatment of a γ-secretase inhibitor, LY450139.  We assessed whether this drug could decrease CNS Aβ prodn. in healthy men (age range, 21-50 years) at single oral doses of 100, 140, or 280mg (n = 5 per group).  Results: LY450139 significantly decreased the prodn. of CNS Aβ in a dose-dependent fashion, with inhibition of Aβ generation of 47, 52, and 84% over a 12-h period with doses of 100, 140, and 280mg, resp.  There was no difference in Aβ clearance.  Interpretation: Stable isotope labeling of CNS proteins can be utilized to assess the effects of drugs on the prodn. and clearance rates of proteins targeted as potential disease-modifying treatments for Alzheimer's disease and other CNS disorders.  Results from this approach can assist in making decisions about drug dosing and frequency in the design of larger and longer clin. trials for diseases such as Alzheimer's disease, and may accelerate effective drug validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGcrw_WczwGLVg90H21EOLACvtfcHk0lg7OiAm_-QmIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWju7fM&md5=8f950c978d6fc83d0436ab1138227dd6</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1002%2Fana.21623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21623%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DSiemers%26aufirst%3DE.%2BR.%26aulast%3DMawuenyega%26aufirst%3DK.%2BG.%26aulast%3DWen%26aufirst%3DG.%26aulast%3DBrowning%26aufirst%3DK.%2BR.%26aulast%3DSigurdson%26aufirst%3DW.%2BC.%26aulast%3DYarasheski%26aufirst%3DK.%2BE.%26aulast%3DFriedrich%26aufirst%3DS.%2BW.%26aulast%3DDeMattos%26aufirst%3DR.%2BB.%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26atitle%3DA%2520%25CE%25B3-secretase%2520inhibitor%2520decreases%2520amyloid-%25CE%25B2%2520production%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DAnn.%2520Neurol.%26date%3D2009%26volume%3D66%26spage%3D48%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Carlson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estergard, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barakos, J.</span><span> </span><span class="NLM_article-title">Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1016%2Fj.jalz.2011.05.2353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=21784350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1Oqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=396-401&author=C.+Carlsonauthor=W.+Estergardauthor=J.+Ohauthor=J.+Suhyauthor=C.+R.+Jackauthor=E.+Siemersauthor=J.+Barakos&title=Prevalence+of+asymptomatic+vasogenic+edema+in+pretreatment+Alzheimer%E2%80%99s+disease+study+cohorts+from+phase+3+trials+of+semagacestat+and+solanezumab"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab</span></div><div class="casAuthors">Carlson, Christopher; Estergard, Wahiba; Oh, Joonmi; Suhy, Joyce; Jack, Clifford R., Jr.; Siemers, Eric; Barakos, Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">396-401</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Cerebral vasogenic edema (VE) has been reported to occur during antiamyloid immunotherapy.  VE may be assocd. with central nervous system pathol. with blood-brain barrier disruptions; however, less is known about the prevalence of naturally occurring VE in patients with Alzheimer's disease (AD).  Methods: Fluid-attenuated inversion recovery imaging sequences were obtained from four ongoing multicenter, randomized, double-blind, placebo-controlled, phase 3 trials in patients with mild-to-moderate AD.  The first set of baseline scans was from patients in volumetric magnetic resonance imaging addenda in the Interrupting Alzheimer's Dementia by EvaluatiNg Treatment of Amyloid PaThol. (IDENTITY) studies examg. semagacestat, a γ-secretase inhibitor (cohort 1, n = 621).  The second set of baseline scans was from the EXPanding alzhEimer's Disease InvestigaTIONs (EXPEDITION) studies examg. solanezumab, an anti-Aβ monoclonal antibody (cohort 2, n = 2141).  Readers were blinded to patient-identifying information and future treatment.  A third set of baseline scans was from the first 700 patients who underwent protocol-specified magnetic resonance imaging before randomization in the EXPEDITION studies (cohort 3).  The anal. used three neuroradiologists: two performed independent primary interpretations and the third was the adjudicator.  Readers were blinded to patient information, treatment, protocol, and time point.  Results: Four cases of asymptomatic VE were detected at baseline/screening.  Two VE cases were due to underlying extra-axial mass lesions.  The third VE case was assocd. with numerous microhemorrhages in keeping with cerebral amyloid angiopathy-related inflammation or Aβ-related angiitis.  The final VE case demonstrated localized sulcal fluid-attenuated inversion recovery imaging hyperintensity.  No VE was detected in cohort 3 by readers blinded to patient baseline status.  Conclusions: VE seems to be rare at baseline in patients with AD in clin. trials, 2 of 2762 assocd. with AD.  Addnl. cohorts should be evaluated to support these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8b79pO8a-grVg90H21EOLACvtfcHk0lg7OiAm_-QmIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1Oqtb8%253D&md5=7ab127032d186ee51237e1260c127344</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.05.2353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.05.2353%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DC.%26aulast%3DEstergard%26aufirst%3DW.%26aulast%3DOh%26aufirst%3DJ.%26aulast%3DSuhy%26aufirst%3DJ.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DBarakos%26aufirst%3DJ.%26atitle%3DPrevalence%2520of%2520asymptomatic%2520vasogenic%2520edema%2520in%2520pretreatment%2520Alzheimer%25E2%2580%2599s%2520disease%2520study%2520cohorts%2520from%2520phase%25203%2520trials%2520of%2520semagacestat%2520and%2520solanezumab%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D396%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saqi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrzik, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Findlay, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bulter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquez-Sterlingk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span> </span><span class="NLM_article-title">A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">414</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1038%2F35102591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=11700559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFahsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2001&pages=212-216&author=S.+Weggenauthor=J.+Eriksenauthor=P.+Dasauthor=S.+A.+Saqiauthor=R.+Wangauthor=C.+U.+Pietrzikauthor=K.+A.+Findlayauthor=T.+E.+Smithauthor=M.+P.+Murphyauthor=T.+Bulterauthor=D.+E.+Kangauthor=N.+Marquez-Sterlingkauthor=T.+E.+Goldeauthor=E.+H.+Koo&title=A+subset+of+NSAIDs+lower+amyloidogenic+A%CE%B242+independently+of+cyclooxygenase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity</span></div><div class="casAuthors">Weggen, Sascha; Eriksen, Jason L.; Das, Pritam; Sagl, Sarah A.; Wang, Rong; Pletrzik, Claus U.; Findlay, Kirk A.; Smith, Tawnya E.; Murphy, Michael P.; Bulter, Thomas; Kang, David E.; Marquez-Steriling, Numa; Golde, Todd E.; Koo, Edward H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue">6860</span>),
    <span class="NLM_cas:pages">212-216</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Epidemiol. studies have documented a reduced prevalence of Alzheimer's disease among users of nonsteroidal anti-inflammatory drugs (NSAIDs).  It has been proposed that NSAIDs exert their beneficial effects in part by reducing neurotoxic inflammatory responses in the brain, although this mechanism has not been proved.  Here we report that the NSAIDs ibuprofen, indomethacin and sulindac sulfide preferentially decrease the highly amyloidogenic Aβ42 peptide (the 42-residue isoform of the amyloid-β peptide) produced from a variety of cultured cells by as much as 80%.  This effect was not seen in all NSAIDs and seems not to be mediated by inhibition of cyclooxygenase (COX) activity, the principal pharmacol. target of NSAIDs.  Furthermore, short-term administration of ibuprofen to mice that produce mutant β-amyloid precursor protein (APP) lowered their brain levels of Aβ42.  In cultured cells, the decrease in Aβ42 secretion was accompanied by an increase in the Aβ(1-38) isoform, indicating that NSAIDs subtly alter γ-secretase activity without significantly perturbing other APP processing pathways or Notch cleavage.  Our findings suggest that NSAIDs directly affect amyloid pathol. in the brain by reducing Aβ42 peptide levels independently of COX activity and that this Aβ42-lowering activity could be optimized to selectively target the pathogenic Aβ42 species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVOE6e2axj77Vg90H21EOLACvtfcHk0liUAIX9Nkg0-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFahsLc%253D&md5=134200e7533409c6f6ad5092f680be70</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2F35102591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35102591%26sid%3Dliteratum%253Aachs%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DEriksen%26aufirst%3DJ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DSaqi%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DPietrzik%26aufirst%3DC.%2BU.%26aulast%3DFindlay%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DBulter%26aufirst%3DT.%26aulast%3DKang%26aufirst%3DD.%2BE.%26aulast%3DMarquez-Sterlingk%26aufirst%3DN.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26atitle%3DA%2520subset%2520of%2520NSAIDs%2520lower%2520amyloidogenic%2520A%25CE%25B242%2520independently%2520of%2520cyclooxygenase%2520activity%26jtitle%3DNature%26date%3D2001%26volume%3D414%26spage%3D212%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kukar, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kache, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastasiadis, P. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fauq, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1038%2Fnm1235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=15834426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVOls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=545-550&author=T.+Kukarauthor=M.+P.+Murphyauthor=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=S.+Weggenauthor=T.+E.+Smithauthor=T.+Laddauthor=M.+A.+Khanauthor=R.+Kacheauthor=J.+Beardauthor=M.+Dodsonauthor=S.+Meritauthor=V.+V.+Ozolsauthor=P.+Z.+Anastasiadisauthor=P.+Dasauthor=A.+Fauqauthor=E.+H.+Kooauthor=T.+E.+Golde&title=Diverse+compounds+mimic+Alzheimer+disease-causing+mutations+by+augmenting+A%CE%B242+production"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production</span></div><div class="casAuthors">Kukar, Thomas; Murphy, Michael Paul; Eriksen, Jason L.; Sagi, Sarah A.; Weggen, Sascha; Smith, Tawnya E.; Ladd, Thomas; Khan, Murad A.; Kache, Rajashaker; Beard, Jenny; Dodson, Mark; Merit, Sami; Ozols, Victor V.; Anastasiadis, Panos Z.; Das, Pritam; Fauq, Abdul; Koo, Edward H.; Golde, Todd E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">545-550</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Increased Aβ42 prodn. has been linked to the development of Alzheimer disease.  We now identify a no. of compds. that raise Aβ42.  Among the more potent Aβ42-raising agents identified are fenofibrate, an antilipidemic agent, and celecoxib, a COX-2-selective NSAID.  Many COX-2-selective NSAIDs tested raised Aβ42, including multiple COX-2-selective derivs. of two Aβ42-lowering NSAIDs.  Compds. devoid of COX activity and the endogenous isoprenoids FPP and GGPP also raised Aβ42.  These compds. seem to target the γ-secretase complex, increasing γ-secretase-catalyzed prodn. of Aβ42 in vitro.  Short-term in vivo studies show that two Aβ42-raising compds. increase Aβ42 levels in the brains of mice.  The elevations in Aβ42 by these compds. are comparable to the increases in Aβ42 induced by Alzheimer disease-causing mutations in the genes encoding amyloid β protein precursor and presenilins, raising the possibility that exogenous compds. or naturally occurring isoprenoids might increase Aβ42 prodn. in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtRxKDIW3Gh7Vg90H21EOLACvtfcHk0ljFtGo6KXqmyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVOls78%253D&md5=78e435c12ca6f7c6af227cd38bffe131</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fnm1235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1235%26sid%3Dliteratum%253Aachs%26aulast%3DKukar%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DM.%2BP.%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DLadd%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DM.%2BA.%26aulast%3DKache%26aufirst%3DR.%26aulast%3DBeard%26aufirst%3DJ.%26aulast%3DDodson%26aufirst%3DM.%26aulast%3DMerit%26aufirst%3DS.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DAnastasiadis%26aufirst%3DP.%2BZ.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DFauq%26aufirst%3DA.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DDiverse%2520compounds%2520mimic%2520Alzheimer%2520disease-causing%2520mutations%2520by%2520augmenting%2520A%25CE%25B242%2520production%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D545%26epage%3D550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pettersson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">am Ende, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span> </span><span class="NLM_article-title">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1517%2F13543776.2011.547479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=21231889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=205-226&author=M.+Petterssonauthor=G.+W.+Kauffmanauthor=C.+W.+am+Endeauthor=N.+C.+Patelauthor=C.+Stiffauthor=T.+P.+Tranauthor=D.+S.+Johnson&title=Novel+%CE%B3-secretase+modulators%3A+a+review+of+patents+from+2008+to+2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel γ-secretase modulators: a review of patents from 2008 to 2010</span></div><div class="casAuthors">Pettersson, Martin; Kauffman, Gregory W.; am Ende, Christopher W.; Patel, Nandini C.; Stiff, Cory; Tran, Tuan P.; Johnson, Douglas S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amyloid precursor protein is first cleaved by β-secretase to generate a 99-residue membrane-bound CTF (C99 or β-CTF), which is subsequently cleaved by γ-secretase to generate amyloid β (Aβ) peptides and the APP intracellular domain.  The amyloidogenic Aβ42 has attracted considerable attention because it is thought to be the most pathogenic species assocd. with Alzheimer's disease progression.  New classes of compds., called γ-secretase modulators (GSMs), have been shown to selectively lower Aβ42 prodn. without shutting down key γ-secretase-dependent signaling pathways.  This has become an important therapeutic strategy aimed at modulating Aβ prodn.  The progress on the clin. development of γ-secretase inhibitors is briefly covered in this review, followed by a discussion of the potential differentiating attributes of GSMs.  Then, the patent literature covering novel GSMs is reviewed, focusing on patents from 2008 to 2010.  Much progress has been made in the past 2 years on developing GSMs with improved potency for lowering the prodn. of Aβ42.  However, many of these chemotypes are in a challenging chem. space and generally possess higher lipophilicity than most CNS drugs.  It will be important to gain a better understanding of the specific target(s) that these GSMs interact with in order to facilitate future drug design efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocCQHiTfGSILVg90H21EOLACvtfcHk0ljFtGo6KXqmyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvVentL0%253D&md5=9e52482a492eea96f9f88b59742e38ce</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.547479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.547479%26sid%3Dliteratum%253Aachs%26aulast%3DPettersson%26aufirst%3DM.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3Dam%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DTran%26aufirst%3DT.%2BP.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26atitle%3DNovel%2520%25CE%25B3-secretase%2520modulators%253A%2520a%2520review%2520of%2520patents%2520from%25202008%2520to%25202010%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D205%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Czirr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span> </span><span class="NLM_article-title">γ-Secretase modulation with Aβ42-lowering nonsteroidal anti-inflammatory drugs and derived compounds</span> <span class="citation_source-journal">Neurodegener. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1159%2F000095270" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=17047371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2hu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=298-304&author=E.+Czirrauthor=S.+Weggen&title=%CE%B3-Secretase+modulation+with+A%CE%B242-lowering+nonsteroidal+anti-inflammatory+drugs+and+derived+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase modulation with Aβ42-lowering nonsteroidal anti-inflammatory drugs and derived compounds</span></div><div class="casAuthors">Czirr, Eva; Weggen, Sascha</div><div class="citationInfo"><span class="NLM_cas:title">Neurodegenerative Diseases</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">298-304</span>CODEN:
                <span class="NLM_cas:coden">NDEIA6</span>;
        ISSN:<span class="NLM_cas:issn">1660-2854</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">A review.  The amyloid-β (Aβ) peptides and specifically the highly amyloidogenic isoform Aβ42 appear to be key agents in the pathogenesis of familial and sporadic forms of Alzheimer's disease (AD).  The final step in the generation of Aβ from the amyloid precursor protein is catalyzed by the multiprotein complex γ-secretase, which constitutes a prime drug target for prevention and therapy of the disease.  However, highly potent γ-secretase inhibitors that block formation of all Aβ peptides have provoked troubling side effects in preclin. animal models of AD.  This toxicity can be readily explained by the promiscuous substrate specificity of γ-secretase and its essential role in the NOTCH signaling pathway.  For that reason and because of the crucial role of Aβ42 in the pathogenesis of the disease, selective inhibition of Aβ42 prodn. would seem to be a more promising alternative to complete inhibition of γ-secretase activity.  This theor. concept has edged much closer to clin. reality with the surprising finding that certain nonsteroidal anti-inflammatory drugs (NSAIDs), including ibuprofen, and derived compds. display preferential Aβ42-lowering activity.  In contrast to γ-secretase inhibitors, these γ-secretase modulators effectively suppress Aβ42 prodn. while sparing processing of NOTCH and other γ-secretase substrates.  Although not fully resolved on the mol. level, the mechanism of action of Aβ42-lowering NSAIDs is independent of cyclooxygenase inhibition and most likely involves direct interaction with components of the γ-secretase complex or its substrates.  Current efforts to improve the pharmacol. shortcomings of available γ-secretase modulators will hopefully lead to the development of clin. useful Aβ42-lowering compds. in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq74m9n6Jxoi7Vg90H21EOLACvtfcHk0lhlulGlO2wHmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2hu7nK&md5=e6d31bb9f7a939b823b7df568b761905</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1159%2F000095270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000095270%26sid%3Dliteratum%253Aachs%26aulast%3DCzirr%26aufirst%3DE.%26aulast%3DWeggen%26aufirst%3DS.%26atitle%3D%25CE%25B3-Secretase%2520modulation%2520with%2520A%25CE%25B242-lowering%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520and%2520derived%2520compounds%26jtitle%3DNeurodegener.%2520Dis.%26date%3D2006%26volume%3D3%26spage%3D298%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J.-C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J. M.</span><span> </span><span class="NLM_article-title">γ-Secretase modulators as potential disease modifying anti-Alzheimer’s drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101168r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=669-698&author=D.+Oehlrichauthor=D.+J.-C+Berthelotauthor=H.+J.+M.+Gijsen&title=%CE%B3-Secretase+modulators+as+potential+disease+modifying+anti-Alzheimer%E2%80%99s+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1021%2Fjm101168r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101168r%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.-C%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520modulators%2520as%2520potential%2520disease%2520modifying%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D669%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Olson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcin, L. R.</span><span> </span><span class="NLM_article-title">Secretase inhibitors and modulators for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=27-47&author=R.+E.+Olsonauthor=L.+R.+Marcin&title=Secretase+inhibitors+and+modulators+for+the+treatment+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DR.%2BE.%26aulast%3DMarcin%26aufirst%3DL.%2BR.%26atitle%3DSecretase%2520inhibitors%2520and%2520modulators%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D27%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giardina, G. A. M.</span><span> </span><span class="NLM_article-title">γ-Secretase inhibitors and modulators for the treatment of Alzheimer’s disease: disappointments and hopes</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1570</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.2174%2F156802611795860942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=21510832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotFOrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=1555-1570&author=B.+P.+Imbimboauthor=G.+A.+M.+Giardina&title=%CE%B3-Secretase+inhibitors+and+modulators+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+disappointments+and+hopes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8gR"><div class="casContent"><span class="casTitleNuber">8g</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes</span></div><div class="casAuthors">Imbimbo, Bruno P.; Giardina, Giuseppe A. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1555-1570</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  According to the β-amyloid (Aβ) hypothesis, compds. that inhibit or modulate γ-secretase, the pivotal enzyme that generates Aβ, are potential therapeutics for Alzheimer's disease (AD).  Studies in both transgenic and non-transgenic animal models of AD have indicated that γ-secretase inhibitors, administered by the oral route, are able to lower brain Aβ concns.  However, scanty data are available on the effects of these compds. on brain Aβ deposition after chronic administration.  Behavioral studies are also scarce with only one study indicating pos. cognitive effects of a peptidomimetic compd. acutely administered (DAPT).  γ-Secretase inhibitors may cause abnormalities in the gastrointestinal tract, thymus, spleen, and skin in exptl. animals and in man.  These toxic effects are likely due to inhibition of Notch cleavage, a transmembrane receptor involved in regulating cell-fate decisions.  Some non-steroidal anti-inflammatory drugs (NSAIDs) and other small org. mols. were found to modulate γ-secretase shifting its cleavage activity from longer to shorter β-amyloid species without affecting Notch cleavage.  Long-term histopathol. and behavioral animal studies are available with these NSAIDs (mainly ibuprofen) but it is unclear if the obsd. in vivo effects on Aβ brain pathol. and learning depend on their activity on γ-secretase or on other biol. targets.  The most studied γ-secretase inhibitor, semagacestat (LY-450139), was shown to dose-dependently decrease the generation of Aβ in the cerebrospinal fluid of healthy humans.  Unfortunately, 2 large Phase 3 clin. trials of semagacestat in mild-to-moderate AD patients were prematurely interrupted because of the observation of detrimental effects on cognition and functionality in patients receiving the drug compared to those receiving placebo.  These detrimental effects were mainly ascribed to the inhibition of Notch processing and to the accumulation of the neurotoxic precursor of Aβ (the carboxy-terminal fragment of APP, or CTFβ) resulting from the block of the γ-secretase cleavage activity on APP.  Two large Phase 3 studies in mild AD patients with tarenflurbil (R-flurbiprofen), a putative γ-secretase modulator, were also completely neg.  The failure of tarenflurbil was ascribed to low potency and brain penetration.  New Notch-sparing γ-secretase inhibitors and more potent, more brain penetrant γ-secretase modulators are being developed with the hope of overcoming the previous setbacks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4MVK1ienYPrVg90H21EOLACvtfcHk0lhlulGlO2wHmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotFOrurw%253D&md5=316bdea0acc108a062a1015894b77c88</span></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.2174%2F156802611795860942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802611795860942%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26aulast%3DGiardina%26aufirst%3DG.%2BA.%2BM.%26atitle%3D%25CE%25B3-Secretase%2520inhibitors%2520and%2520modulators%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520disappointments%2520and%2520hopes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2011%26volume%3D11%26spage%3D1555%26epage%3D1570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larbig, G.</span><span> </span><span class="NLM_article-title">Inhibitors and modulators of β- and γ-secretase</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.2174%2F156802606776287027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=16611149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVahsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=377-392&author=B.+Schmidtauthor=S.+Baummanauthor=H.+A.+Braunauthor=G.+Larbig&title=Inhibitors+and+modulators+of+%CE%B2-+and+%CE%B3-secretase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8h</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors and modulators of β- and γ-secretase</span></div><div class="casAuthors">Schmidt, Boris; Baumann, Stefanie; Braun, Hannes A.; Larbig, Gregor</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">377-392</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Most gene mutations assocd. with Alzheimer's disease point to the metab. of amyloid precursor protein as potential cause.  The β- and γ-secretases are 2 executioners of amyloid precursor protein processing resulting in amyloid β.  Significant progress was made in the selective inhibition of both proteases, regardless of structural information for γ-secretase.  Several peptidic and non-peptidic leads were identified and first drug candidates are in clin. trials.  This review focuses on the development since 2003.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdqvWbXNyBs7Vg90H21EOLACvtfcHk0lhlulGlO2wHmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVahsbs%253D&md5=f7dee5bf60dcb32f1e3d0c22defb6489</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.2174%2F156802606776287027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776287027%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DBaumman%26aufirst%3DS.%26aulast%3DBraun%26aufirst%3DH.%2BA.%26aulast%3DLarbig%26aufirst%3DG.%26atitle%3DInhibitors%2520and%2520modulators%2520of%2520%25CE%25B2-%2520and%2520%25CE%25B3-secretase%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D377%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kounnas, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyree, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackerman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleynet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digregorio, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauderman, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sisodia, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, S. L.</span><span> </span><span class="NLM_article-title">Modulation of γ-secretase reduces β-amyloid deposition in a transgenic mouse model of Alzheimer’s disease</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=769-780&author=M.+Z.+Kounnasauthor=A.+M.+Danksauthor=S.+Chengauthor=C.+Tyreeauthor=E.+Ackermanauthor=X.+Zhangauthor=K.+Ahnauthor=P.+Nguyenauthor=D.+Comerauthor=L.+Maoauthor=C.+Yuauthor=D.+Pleynetauthor=P.+J.+Digregorioauthor=G.+Velicelebiauthor=K.+A.+Staudermanauthor=W.+T.+Comerauthor=W.+C.+Mobleyauthor=Y.-M+Liauthor=S.+S.+Sisodiaauthor=R.+E.+Tanziauthor=S.+L.+Wagner&title=Modulation+of+%CE%B3-secretase+reduces+%CE%B2-amyloid+deposition+in+a+transgenic+mouse+model+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKounnas%26aufirst%3DM.%2BZ.%26aulast%3DDanks%26aufirst%3DA.%2BM.%26aulast%3DCheng%26aufirst%3DS.%26aulast%3DTyree%26aufirst%3DC.%26aulast%3DAckerman%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAhn%26aufirst%3DK.%26aulast%3DNguyen%26aufirst%3DP.%26aulast%3DComer%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DPleynet%26aufirst%3DD.%26aulast%3DDigregorio%26aufirst%3DP.%2BJ.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DStauderman%26aufirst%3DK.%2BA.%26aulast%3DComer%26aufirst%3DW.%2BT.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DLi%26aufirst%3DY.-M%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DWagner%26aufirst%3DS.%2BL.%26atitle%3DModulation%2520of%2520%25CE%25B3-secretase%2520reduces%2520%25CE%25B2-amyloid%2520deposition%2520in%2520a%2520transgenic%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuron%26date%3D2010%26volume%3D67%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onstead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Randle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smithson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwizinski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, E.</span><span> </span><span class="NLM_article-title">Aβ40 inhibits amyloid deposition in vivo</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1523%2FJNEUROSCI.4849-06.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=17234594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=627-633&author=J.+Kimauthor=L.+Onsteadauthor=S.+Randleauthor=R.+Priceauthor=L.+Smithsonauthor=C.+Zwizinskiauthor=D.+W.+Dicksonauthor=T.+Goldeauthor=E.+McGowan&title=A%CE%B240+inhibits+amyloid+deposition+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ40 inhibits amyloid deposition in vivo</span></div><div class="casAuthors">Kim, Jungsu; Onstead, Luisa; Randle, Suzanne; Price, Robert; Smithson, Lisa; Zwizinski, Craig; Dickson, Dennis W.; Golde, Todd; McGowan, Eileen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">627-633</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Numerous studies have established a pivotal role for Aβ42 in Alzheimer's disease (AD) pathogenesis.  In contrast, although Aβ40 is the predominant form of amyloid β (Aβ) produced and accumulates to a variable degree in the human AD brain, its role in AD pathogenesis has not been established.  It has generally been assumed that an increase in Aβ40 would accelerate amyloid plaque formation in vivo.  We have crossed BRI-Aβ40 mice that selectively express high levels of Aβ40 with both Tg2576 (APPswe, K670N + M671L) mice and BRI-Aβ42A mice expressing Aβ42 selectively and analyzed parenchymal and cerebrovascular Aβ deposition in the bitransgenic mice compared with their singly transgenic littermates.  In the bitransgenic mice, the increased steady-state levels of Aβ40 decreased Aβ deposition by 60-90%.  These results demonstrate that Aβ42 and Aβ40 have opposing effects on amyloid deposition: Aβ42 promotes amyloid deposition but Aβ40 inhibits it.  In addn., increasing Aβ40 levels protected BRI-Aβ40/Tg2576 mice from the premature-death phenotype obsd. in Tg2576 mice.  The protective properties of Aβ40 with respect to amyloid deposition suggest that strategies that preferentially target Aβ40 may actually worsen the disease course and that selective increases in Aβ40 levels may actually reduce the risk for development of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBkk_HKSaW0bVg90H21EOLACvtfcHk0lhOHd-3AsSzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSkurg%253D&md5=503d71263bf85911413a264fe360490a</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4849-06.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4849-06.2007%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DOnstead%26aufirst%3DL.%26aulast%3DRandle%26aufirst%3DS.%26aulast%3DPrice%26aufirst%3DR.%26aulast%3DSmithson%26aufirst%3DL.%26aulast%3DZwizinski%26aufirst%3DC.%26aulast%3DDickson%26aufirst%3DD.%2BW.%26aulast%3DGolde%26aufirst%3DT.%26aulast%3DMcGowan%26aufirst%3DE.%26atitle%3DA%25CE%25B240%2520inhibits%2520amyloid%2520deposition%2520in%2520vivo%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D627%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, C.</span><span> </span><span class="NLM_article-title">Aβ40 promotes neuronal cell fate in neural progenitor cells</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1038%2Fcdd.2008.94" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=18566600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=386-394&author=Y.+Chenauthor=C.+Dong&title=A%CE%B240+promotes+neuronal+cell+fate+in+neural+progenitor+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Aβ40 promotes neuronal cell fate in neural progenitor cells</span></div><div class="casAuthors">Chen, Y.; Dong, C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">386-394</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sequential cleavage of the amyloid precursor protein (APP) by β- and then γ- secretase gives rise to Aβ1-40 (Aβ40), a major species of Aβ (β-amyloid) produced by neurons under physiol. conditions.  Aβ1-42 (Aβ42), a minor species of Aβ, is also produced by a similar but less understood mechanism of the γ-secretase.  The physiol. functions of these Aβ species remain to be defined.  In this report, we demonstrate that freshly prepd. sol. Aβ40 significantly promotes neurogenesis in primary neural progenitor cells (NPCs).  First, Aβ40 increases neuronal markers as detd. by NeuN expression and Tuj1 promoter activity, differing from Aβ42, which induces astrocyte markers in NPCs.  Second, Aβ40 induces neuronal differentiation at the end of S-phase in the cell cycle.  Third, Aβ40 promotes NPC entry into S-phase, playing a role in NPC self-renewal.  Interestingly, Aβ40 does not significantly increase apoptotic indexes such as DNA condensation and DNA fragmentation.  In addn., Aβ40 does not augment caspase-3 activation in NeuN+ or nestin+ cells.  Collectively, this report provides strong evidence that Aβ40 is a neurogenic factor and suggests that the debilitated function of Aβ40 in neurogenesis may account for the shortage of neurons in Alzheimer's disease.  Cell Death and Differentiation (2009) 16, 386-394; doi:10.1038/cdd.2008.94; published online 20 June 2008.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6f495t2azg7Vg90H21EOLACvtfcHk0lhOHd-3AsSzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wktbg%253D&md5=c25316bc3e0442b1ebecf7a4dc1f41c8</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2008.94&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2008.94%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DC.%26atitle%3DA%25CE%25B240%2520promotes%2520neuronal%2520cell%2520fate%2520in%2520neural%2520progenitor%2520cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2009%26volume%3D16%26spage%3D386%26epage%3D394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Abramov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolev, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccotosto, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slutsky, I.</span><span> </span><span class="NLM_article-title">Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1567</span><span class="NLM_x">–</span> <span class="NLM_lpage">1576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1038%2Fnn.2433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=19935655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=1567-1576&author=E.+Abramovauthor=I.+Dolevauthor=H.+Fogelauthor=G.+D.+Ciccotostoauthor=E.+Ruffauthor=I.+Slutsky&title=Amyloid-%CE%B2+as+a+positive+endogenous+regulator+of+release+probability+at+hippocampal+synapses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β as a positive endogenous regulator of release probability at hippocampal synapses</span></div><div class="casAuthors">Abramov, Efrat; Dolev, Iftach; Fogel, Hilla; Ciccotosto, Giuseppe D.; Ruff, Eyal; Slutsky, Inna</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1567-1576</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulation of cerebral amyloid-β peptide (Aβ) is essential for developing synaptic and cognitive deficits in Alzheimer's disease.  However, the physiol. functions of Aβ, as well as the primary mechanisms that initiate early Aβ-mediated synaptic dysfunctions, remain largely unknown.  Here we examine the acute effects of endogenously released Aβ peptides on synaptic transfer at single presynaptic terminals and synaptic connections in rodent hippocampal cultures and slices.  Increasing extracellular Aβ by inhibiting its degrdn. enhanced release probability, boosting ongoing activity in the hippocampal network.  Presynaptic enhancement mediated by Aβ was found to depend on the history of synaptic activation, with lower impact at higher firing rates.  Notably, both elevation and redn. in Aβ levels attenuated short-term synaptic facilitation during bursts in excitatory synaptic connections.  These observations suggest that endogenous Aβ peptides have a crucial role in activity-dependent regulation of synaptic vesicle release and might point to the primary pathol. events that lead to compensatory synapse loss in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvuRVsAXup4LVg90H21EOLACvtfcHk0lhOHd-3AsSzVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlur%252FP&md5=ae3f09cc8ddec7dcb30876535a76051d</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1038%2Fnn.2433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2433%26sid%3Dliteratum%253Aachs%26aulast%3DAbramov%26aufirst%3DE.%26aulast%3DDolev%26aufirst%3DI.%26aulast%3DFogel%26aufirst%3DH.%26aulast%3DCiccotosto%26aufirst%3DG.%2BD.%26aulast%3DRuff%26aufirst%3DE.%26aulast%3DSlutsky%26aufirst%3DI.%26atitle%3DAmyloid-%25CE%25B2%2520as%2520a%2520positive%2520endogenous%2520regulator%2520of%2520release%2520probability%2520at%2520hippocampal%2520synapses%26jtitle%3DNat.%2520Neurosci.%26date%3D2009%26volume%3D12%26spage%3D1567%26epage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, H.</span><span> </span><span class="NLM_article-title">Wild-type presenilin 1 protects against Alzheimer disease mutation-induced amyloid pathology</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">15330</span><span class="NLM_x">–</span> <span class="NLM_lpage">15336</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=15330-15336&author=R.+Wangauthor=B.+Wangauthor=W.+Heauthor=H.+Zheng&title=Wild-type+presenilin+1+protects+against+Alzheimer+disease+mutation-induced+amyloid+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DH.%26atitle%3DWild-type%2520presenilin%25201%2520protects%2520against%2520Alzheimer%2520disease%2520mutation-induced%2520amyloid%2520pathology%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D15330%26epage%3D15336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Imbimbo, B. P.</span><span> </span><span class="NLM_article-title">Why did tarenflurbil fail in Alzheimer’s disease?</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=19542625" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVChsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=757-760&author=B.+P.+Imbimbo&title=Why+did+tarenflurbil+fail+in+Alzheimer%E2%80%99s+disease%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Why Did Tarenflurbil Fail in Alzheimer's Disease?</span></div><div class="casAuthors">Imbimbo, Bruno P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">757-760</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  There has been a lot of disappointment surrounding the recent failure of the largest ever study in patients with Alzheimer's disease (AD) with tarenflurbil, a compd. believed to modulate the activity of γ-secretase, the pivotal enzyme that generates the amyloid-β (Aβ) peptide from the amyloid-β protein precursor.  What are the reasons for this setback after the previous apparently encouraging results in a Phase II study A straightforward explanation of this failure is that the γ-secretase is not the right target for therapy or that, in general, blocking Aβ does not produce clin. benefits in AD.  If one still accepts a physiopathol. role of Aβ in AD, tarenflurbil could not be the right compd. because of its weak pharmacol. activity as an Aβ1-42 lowering agent and its poor brain penetration.  In addn., based on previous neg. results with several anti-inflammatory drugs in AD, it is hypothesized that the residual anti-inflammatory activity of tarenflurbil may have a detrimental effect on disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoZkD60p6dMbVg90H21EOLACvtfcHk0liZoIXV2aPnTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVChsbc%253D&md5=a825d380c2734cb1645f70bc09605891</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DImbimbo%26aufirst%3DB.%2BP.%26atitle%3DWhy%2520did%2520tarenflurbil%2520fail%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253F%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2009%26volume%3D17%26spage%3D757%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eriksen, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagi, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weggen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozols, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavitz, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koo, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golde, T. E.</span><span> </span><span class="NLM_article-title">NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2003&pages=440-449&author=J.+L.+Eriksenauthor=S.+A.+Sagiauthor=T.+E.+Smithauthor=S.+Weggenauthor=P.+Dasauthor=D.+C.+McLendonauthor=V.+V.+Ozolsauthor=K.+W.+Jessingauthor=K.+H.+Zavitzauthor=E.+H.+Kooauthor=T.+E.+Golde&title=NSAIDs+and+enantiomers+of+flurbiprofen+target+%CE%B3-secretase+and+lower+A%CE%B242+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEriksen%26aufirst%3DJ.%2BL.%26aulast%3DSagi%26aufirst%3DS.%2BA.%26aulast%3DSmith%26aufirst%3DT.%2BE.%26aulast%3DWeggen%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DP.%26aulast%3DMcLendon%26aufirst%3DD.%2BC.%26aulast%3DOzols%26aufirst%3DV.%2BV.%26aulast%3DJessing%26aufirst%3DK.%2BW.%26aulast%3DZavitz%26aufirst%3DK.%2BH.%26aulast%3DKoo%26aufirst%3DE.%2BH.%26aulast%3DGolde%26aufirst%3DT.%2BE.%26atitle%3DNSAIDs%2520and%2520enantiomers%2520of%2520flurbiprofen%2520target%2520%25CE%25B3-secretase%2520and%2520lower%2520A%25CE%25B242%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2003%26volume%3D112%26spage%3D440%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cheng, S.; Comer, D. D.; Mao, L.; Balow, G. P.; Pleynet, D.</span><span> </span><span class="NLM_article-title">Aryl Compounds and Uses Thereof in Modulating Amyloid β</span>. WO 2004110350,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=S.+Cheng&author=D.+D.+Comer&author=L.+Mao&author=G.+P.+Balow&author=D.+Pleynet&title=Aryl+Compounds+and+Uses+Thereof+in+Modulating+Amyloid+%CE%B2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DS.%26atitle%3DAryl%2520Compounds%2520and%2520Uses%2520Thereof%2520in%2520Modulating%2520Amyloid%2520%25CE%25B2%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Shin, K.; Miyagawa, T.; Kaneko, T.; Ito, K.; Takaishi, M.; Sasaki, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Cinnamide Compound</span>. US 20060004013,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=K.+Shin&author=T.+Miyagawa&author=T.+Kaneko&author=K.+Ito&author=M.+Takaishi&author=T.+Sasaki&author=H.+Hagiwara&title=Cinnamide+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DCinnamide%2520Compound%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kimura, T.; Kawano, K.; Doi, E.; Kitazawa, N.; Takaishi, M.; Ito, K.; Kaneko, T.; Sasaki, T.; Sato, N.; Miyagawa, T.; Hagiwara, H.</span><span> </span><span class="NLM_article-title">Morpholine Type Cinnamide Compound</span>. US20070117798,<span class="NLM_x"> </span><span class="NLM_year">2007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+Kimura&author=K.+Kawano&author=E.+Doi&author=N.+Kitazawa&author=M.+Takaishi&author=K.+Ito&author=T.+Kaneko&author=T.+Sasaki&author=N.+Sato&author=T.+Miyagawa&author=H.+Hagiwara&title=Morpholine+Type+Cinnamide+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26atitle%3DMorpholine%2520Type%2520Cinnamide%2520Compound%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gustafsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyström, J.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bredberg, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gyzander, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, K.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ungell, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sörensen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Någård, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bylund, R.</span><span> </span><span class="NLM_article-title">The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects</span> <span class="citation_source-journal">Thromb. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1016%2FS0049-3848%2800%2900399-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm201407j&amp;key=11228340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsVKmurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=171-181&author=D.+Gustafssonauthor=J.-E.+Nystr%C3%B6mauthor=S.+Carlssonauthor=U.+Bredbergauthor=U.+Erikssonauthor=E.+Gyzanderauthor=M.+Elgauthor=T.+Antonssonauthor=K.-J.+Hoffmannauthor=A.-L.+Ungellauthor=H.+S%C3%B6rensenauthor=S.+N%C3%A5g%C3%A5rdauthor=A.+Abrahamssonauthor=R.+Bylund&title=The+direct+thrombin+inhibitor+melagatran+and+its+oral+prodrug+H+376%2F95%3A+intestinal+absorption+properties%2C+biochemical+and+pharmacodynamic+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects</span></div><div class="casAuthors">Gustafsson, D.; Nystrom, J.-E.; Carlsson, S.; Bredberg, U.; Eriksson, U.; Gyzander, E.; Elg, M.; Antonsson, T.; Hoffmann, K.-J.; Ungell, A.-L.; Sorensen, H.; Nagard, S.; Abrahamsson, A.; Bylund, R.</div><div class="citationInfo"><span class="NLM_cas:title">Thrombosis Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">171-181</span>CODEN:
                <span class="NLM_cas:coden">THBRAA</span>;
        ISSN:<span class="NLM_cas:issn">0049-3848</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Suboptimal gastrointestinal absorption is a problem for many direct thrombin inhibitors.  The studies presented herein describe the new oral direct thrombin inhibitor H 376/95, a prodrug with 2 protecting residues added to the direct thrombin inhibitor melagatran.  Absorption properties in vitro: H 376/95 is uncharged at intestinal pH while melagatran is charged.  H 376/95 is 170 times more lipophilic (octanol water partition coeff.) than melagatran.  As a result, the permeability coeff. across cultured epithelial Caco-2 cells is 80 times higher for H 376/95 than for melagtran.  Pharmacokinetic studies in healthy volunteers: H 376/95 is converted to melagatran in man.  Oral bioavailability, measured as melagatran in plasma, is about 20% after oral administration of H 376/95, which is 2.7-5.5 times higher than after oral administration of melagatran.  The variability in the area under the drug plasma concn. vs. time curve (AUC) is much smaller with oral H 376/95 (coeff. of variation 20%) than with oral melagatran (coeff. of variation 38%).  Pharmacodynamic properties: H 376/95 is inactive towards human α-thrombin compared with melagatran [inhibition const. (Ki) ratio, 185 times], a potential advantage for patients with silent gastrointestinal bleeding.  In an exptl. thrombosis model in the rat, oral H 376/95 was more effective than the s.c. low mol. wt. heparin dalteparin in preventing thrombosis.  Conclusion: By the use of the prodrug principle, H 376/95 endows the direct thrombin inhibitor melagatran with pharmacokinetic properties required for oral administration without compromising the promising pharmacodynamic properties of melagatran.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_S2pHMWUQ9rVg90H21EOLACvtfcHk0liZoIXV2aPnTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsVKmurw%253D&md5=63260995e92c84cd2a2f753b1513bb9f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0049-3848%2800%2900399-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0049-3848%252800%252900399-6%26sid%3Dliteratum%253Aachs%26aulast%3DGustafsson%26aufirst%3DD.%26aulast%3DNystr%25C3%25B6m%26aufirst%3DJ.-E.%26aulast%3DCarlsson%26aufirst%3DS.%26aulast%3DBredberg%26aufirst%3DU.%26aulast%3DEriksson%26aufirst%3DU.%26aulast%3DGyzander%26aufirst%3DE.%26aulast%3DElg%26aufirst%3DM.%26aulast%3DAntonsson%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DK.-J.%26aulast%3DUngell%26aufirst%3DA.-L.%26aulast%3DS%25C3%25B6rensen%26aufirst%3DH.%26aulast%3DN%25C3%25A5g%25C3%25A5rd%26aufirst%3DS.%26aulast%3DAbrahamsson%26aufirst%3DA.%26aulast%3DBylund%26aufirst%3DR.%26atitle%3DThe%2520direct%2520thrombin%2520inhibitor%2520melagatran%2520and%2520its%2520oral%2520prodrug%2520H%2520376%252F95%253A%2520intestinal%2520absorption%2520properties%252C%2520biochemical%2520and%2520pharmacodynamic%2520effects%26jtitle%3DThromb.%2520Res.%26date%3D2001%26volume%3D101%26spage%3D171%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tomczuk, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedde, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crysler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisennagel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spurlino, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bone, R.</span><span> </span><span class="NLM_article-title">Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1495-1498&author=B.+Tomczukauthor=T.+Luauthor=R.+M.+Sollauthor=C.+Feddeauthor=A.+Wangauthor=L.+Murphyauthor=C.+Cryslerauthor=M.+Dasguptaauthor=S.+Eisennagelauthor=J.+Spurlinoauthor=R.+Bone&title=Oxyguanidines%3A+application+to+non-peptidic+phenyl-based+thrombin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTomczuk%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DT.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DFedde%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DCrysler%26aufirst%3DC.%26aulast%3DDasgupta%26aufirst%3DM.%26aulast%3DEisennagel%26aufirst%3DS.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DBone%26aufirst%3DR.%26atitle%3DOxyguanidines%253A%2520application%2520to%2520non-peptidic%2520phenyl-based%2520thrombin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1495%26epage%3D1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gandolfi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grünanger, P.</span><span> </span><span class="NLM_article-title">1,3-Dipolar cycloaddition of nitrile oxides to 8-azaheptafulvenes</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">638</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1995&pages=619-638&author=R.+Gandolfiauthor=A.+Gambaauthor=P.+Gr%C3%BCnanger&title=1%2C3-Dipolar+cycloaddition+of+nitrile+oxides+to+8-azaheptafulvenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGandolfi%26aufirst%3DR.%26aulast%3DGamba%26aufirst%3DA.%26aulast%3DGr%25C3%25BCnanger%26aufirst%3DP.%26atitle%3D1%252C3-Dipolar%2520cycloaddition%2520of%2520nitrile%2520oxides%2520to%25208-azaheptafulvenes%26jtitle%3DHeterocycles%26date%3D1995%26volume%3D40%26spage%3D619%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Malamdou-Xenikaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutouli-Argyropoulou, E.</span><span> </span><span class="NLM_article-title">Preparation and catalytic hydrogenation of 1,2,4-oxadiazolo[4,5-<i>a</i>]indolines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">7865</span><span class="NLM_x">–</span> <span class="NLM_lpage">7872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1990&pages=7865-7872&author=E.+Malamdou-Xenikakiauthor=E.+Coutouli-Argyropoulou&title=Preparation+and+catalytic+hydrogenation+of+1%2C2%2C4-oxadiazolo%5B4%2C5-a%5Dindolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalamdou-Xenikaki%26aufirst%3DE.%26aulast%3DCoutouli-Argyropoulou%26aufirst%3DE.%26atitle%3DPreparation%2520and%2520catalytic%2520hydrogenation%2520of%25201%252C2%252C4-oxadiazolo%255B4%252C5-a%255Dindolines%26jtitle%3DTetrahedron%26date%3D1990%26volume%3D46%26spage%3D7865%26epage%3D7872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_contrib-group">Kabakov, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budagova, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malyutina, Y. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latchman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csermely, P.</span><span> </span><span class="NLM_article-title">Pharmacological attenuation of apoptosis in re-oxygenated endothelial cells</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3076</span><span class="NLM_x">–</span> <span class="NLM_lpage">3086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1007%2Fs00018-004-4204-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=3076-3086&author=A.+E.+Kabakovauthor=K.+R.+Budagovaauthor=Y.+V.+Malyutinaauthor=D.+S.+Latchmanauthor=P.+Csermely&title=Pharmacological+attenuation+of+apoptosis+in+re-oxygenated+endothelial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1007%2Fs00018-004-4204-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-004-4204-y%26sid%3Dliteratum%253Aachs%26aulast%3DKabakov%26aufirst%3DA.%2BE.%26aulast%3DBudagova%26aufirst%3DK.%2BR.%26aulast%3DMalyutina%26aufirst%3DY.%2BV.%26aulast%3DLatchman%26aufirst%3DD.%2BS.%26aulast%3DCsermely%26aufirst%3DP.%26atitle%3DPharmacological%2520attenuation%2520of%2520apoptosis%2520in%2520re-oxygenated%2520endothelial%2520cells%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2005%26volume%3D61%26spage%3D3076%26epage%3D3086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Azizian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Souzangarzadeh, S.</span><span> </span><span class="NLM_article-title">One-pot synthesis of novel derivatives of spiro-[6<i>H</i>-indolo[2,1-<i>b</i>]quinazoline-6,3′-[1,2,4]oxadiazoline]</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1081%2FSCC-200050932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtFaju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=765-768&author=J.+Azizianauthor=M.+Madaniauthor=S.+Souzangarzadeh&title=One-pot+synthesis+of+novel+derivatives+of+spiro-%5B6H-indolo%5B2%2C1-b%5Dquinazoline-6%2C3%E2%80%B2-%5B1%2C2%2C4%5Doxadiazoline%5D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">One-pot synthesis of novel derivatives of spiro-[6H-indolo [2,1-b]quinazoline-6,3'-[1,2,4]oxadiazoline]</span></div><div class="casAuthors">Azizian, Javad; Madani, Masoud; Souzangarzadeh, Saeid</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">765-768</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Novel spiro-indoles I (R = H, Br; R1 = H, Cl; R2 = H, Cl, Br) are prepd. via a one-pot 1,3-dipolar cycloaddn. reaction of nitrile oxide with tryptanthrine imines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodDZgbOeAw0bVg90H21EOLACvtfcHk0lgv4DofYV_7ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtFaju74%253D&md5=47378403b79324eb7ec320fd22546052</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1081%2FSCC-200050932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FSCC-200050932%26sid%3Dliteratum%253Aachs%26aulast%3DAzizian%26aufirst%3DJ.%26aulast%3DMadani%26aufirst%3DM.%26aulast%3DSouzangarzadeh%26aufirst%3DS.%26atitle%3DOne-pot%2520synthesis%2520of%2520novel%2520derivatives%2520of%2520spiro-%255B6H-indolo%255B2%252C1-b%255Dquinazoline-6%252C3%25E2%2580%25B2-%255B1%252C2%252C4%255Doxadiazoline%255D%26jtitle%3DSynth.%2520Commun.%26date%3D2005%26volume%3D35%26spage%3D765%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tsuge, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanemasa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suga, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, N.</span><span> </span><span class="NLM_article-title">Synthesis of 2-(1-phosphorylalkyl)acetonitrile oxide and its cycloaddition to olefins. Synthetic applications to 3,5-disubstituted 2-isoxazolines</span> <span class="citation_source-journal">Bull. Chem. Soc. Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2463</span><span class="NLM_x">–</span> <span class="NLM_lpage">2473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1987&pages=2463-2473&author=O.+Tsugeauthor=S.+Kanemasaauthor=H.+Sugaauthor=N.+Nakagawa&title=Synthesis+of+2-%281-phosphorylalkyl%29acetonitrile+oxide+and+its+cycloaddition+to+olefins.+Synthetic+applications+to+3%2C5-disubstituted+2-isoxazolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsuge%26aufirst%3DO.%26aulast%3DKanemasa%26aufirst%3DS.%26aulast%3DSuga%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DN.%26atitle%3DSynthesis%2520of%25202-%25281-phosphorylalkyl%2529acetonitrile%2520oxide%2520and%2520its%2520cycloaddition%2520to%2520olefins.%2520Synthetic%2520applications%2520to%25203%252C5-disubstituted%25202-isoxazolines%26jtitle%3DBull.%2520Chem.%2520Soc.%2520Jpn.%26date%3D1987%26volume%3D60%26spage%3D2463%26epage%3D2473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Selva, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tundo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marques, C. A.</span><span> </span><span class="NLM_article-title">A simple one-port synthesis of functionalized ketimines from ketones and amine hydrochloride salts</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm201407j&amp;key=10.1080%2F00397919508011368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm201407j&amp;key=1%3ACAS%3A528%3ADyaK2MXjsVyrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1995&pages=369-378&author=M.+Selvaauthor=P.+Tundoauthor=C.+A.+Marques&title=A+simple+one-port+synthesis+of+functionalized+ketimines+from+ketones+and+amine+hydrochloride+salts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A simple one-pot synthesis of functionalized ketimines from ketones and amine hydrochloride salts</span></div><div class="casAuthors">Selva, Maurizio; Tundo, Pietro; Marques, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">369-78</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">Functionalized ketimines R1R2C:NCH2R [R = CN, CH2Cl, CO2Me; R1 = Ph, R2 = Me, Et, Ph, R1 = R2 = Pr or R1R2 = (CH2)5] have been prepd. by condensation of ketones with primary amine hydrochloride salts H2NCH2R.HCl.  The reaction proceeds in DMF with TiCl4 as drying agent in a single step without isolation of the free amine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBfmLcoCoa9bVg90H21EOLACvtfcHk0lhlvSygUh2sSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjsVyrtL8%253D&md5=c1925e613cc636f610a2b905f0e3e47d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1080%2F00397919508011368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919508011368%26sid%3Dliteratum%253Aachs%26aulast%3DSelva%26aufirst%3DM.%26aulast%3DTundo%26aufirst%3DP.%26aulast%3DMarques%26aufirst%3DC.%2BA.%26atitle%3DA%2520simple%2520one-port%2520synthesis%2520of%2520functionalized%2520ketimines%2520from%2520ketones%2520and%2520amine%2520hydrochloride%2520salts%26jtitle%3DSynth.%2520Commun.%26date%3D1995%26volume%3D25%26spage%3D369%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lee, J.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. O.</span><span> </span><span class="NLM_article-title">Practical synthesis of aminoethyl-<i>o</i>-carboranes</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/om020803q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=445-449&author=J.-D.+Leeauthor=Y.-J.+Leeauthor=H.-J.+Jeongauthor=J.+S.+Leeauthor=C.-H.+Leeauthor=J.+Koauthor=S.+O.+Kang&title=Practical+synthesis+of+aminoethyl-o-carboranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fom020803q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom020803q%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.-D.%26aulast%3DLee%26aufirst%3DY.-J.%26aulast%3DJeong%26aufirst%3DH.-J.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DC.-H.%26aulast%3DKo%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%2BO.%26atitle%3DPractical%2520synthesis%2520of%2520aminoethyl-o-carboranes%26jtitle%3DOrganometallics%26date%3D2003%26volume%3D22%26spage%3D445%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Morimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sekiya, M.</span><span> </span><span class="NLM_article-title">A convenient synthetic method for Schiff bases. The trimethyl trifluoromethanesulfonate-catalyzed reaction of <i>N</i>,<i>N</i>-bis(trimethylsilyl)amines with aldehydes and ketones</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">1371</span><span class="NLM_x">–</span> <span class="NLM_lpage">1372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=1371-1372&author=T.+Morimotoauthor=M.+Sekiya&title=A+convenient+synthetic+method+for+Schiff+bases.+The+trimethyl+trifluoromethanesulfonate-catalyzed+reaction+of+N%2CN-bis%28trimethylsilyl%29amines+with+aldehydes+and+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorimoto%26aufirst%3DT.%26aulast%3DSekiya%26aufirst%3DM.%26atitle%3DA%2520convenient%2520synthetic%2520method%2520for%2520Schiff%2520bases.%2520The%2520trimethyl%2520trifluoromethanesulfonate-catalyzed%2520reaction%2520of%2520N%252CN-bis%2528trimethylsilyl%2529amines%2520with%2520aldehydes%2520and%2520ketones%26jtitle%3DChem.%2520Lett.%26date%3D1985%26spage%3D1371%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ohtani, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakisawa, H.</span><span> </span><span class="NLM_article-title">High-field FT NMR application of Mosher’s method. The absolute configurations of marine terpenoids</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">4092</span><span class="NLM_x">–</span> <span class="NLM_lpage">4096</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00011a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1991&pages=4092-4096&author=I.+Ohtaniauthor=T.+Kusumiauthor=Y.+Kashmanauthor=H.+Kakisawa&title=High-field+FT+NMR+application+of+Mosher%E2%80%99s+method.+The+absolute+configurations+of+marine+terpenoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja00011a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00011a006%26sid%3Dliteratum%253Aachs%26aulast%3DOhtani%26aufirst%3DI.%26aulast%3DKusumi%26aufirst%3DT.%26aulast%3DKashman%26aufirst%3DY.%26aulast%3DKakisawa%26aufirst%3DH.%26atitle%3DHigh-field%2520FT%2520NMR%2520application%2520of%2520Mosher%25E2%2580%2599s%2520method.%2520The%2520absolute%2520configurations%2520of%2520marine%2520terpenoids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1991%26volume%3D113%26spage%3D4092%26epage%3D4096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Reddy, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpless, K. B.</span><span> </span><span class="NLM_article-title">From styrenes to enantiopure <i>R</i>-arylglycines in two steps</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">1207</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9728177" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=1998&pages=1207-1217&author=K.+L.+Reddyauthor=K.+B.+Sharpless&title=From+styrenes+to+enantiopure+R-arylglycines+in+two+steps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja9728177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9728177%26sid%3Dliteratum%253Aachs%26aulast%3DReddy%26aufirst%3DK.%2BL.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26atitle%3DFrom%2520styrenes%2520to%2520enantiopure%2520R-arylglycines%2520in%2520two%2520steps%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1998%26volume%3D120%26spage%3D1207%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">We propose to use the term “druggable motif” to describe some of the well understood pharmacophores that have proven records for achieving good pharmacokinetic, pharmacodynamic, and toxicological profiles. Deliberate attention to suitable “druggable motifs” would help medicinal chemists achieve a balanced approach in evaluating SAR directions. Detailed discussions will be the subject of another publication.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pozharskii, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitkina, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chegolya, T. N.</span><span> </span><span class="NLM_article-title">Nature of the interaction of phenyl and imidazole rings in <i>N</i>-arylimidazoles. IV. Derivatives of <i>N</i>-phenylimidazole with substituents on the benzene ring</span> <span class="citation_source-journal">Khim. Geterotsikl. Soedin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1970&pages=209-213&author=A.+F.+Pozharskiiauthor=L.+M.+Sitkinaauthor=A.+M.+Simonovauthor=T.+N.+Chegolya&title=Nature+of+the+interaction+of+phenyl+and+imidazole+rings+in+N-arylimidazoles.+IV.+Derivatives+of+N-phenylimidazole+with+substituents+on+the+benzene+ring"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPozharskii%26aufirst%3DA.%2BF.%26aulast%3DSitkina%26aufirst%3DL.%2BM.%26aulast%3DSimonov%26aufirst%3DA.%2BM.%26aulast%3DChegolya%26aufirst%3DT.%2BN.%26atitle%3DNature%2520of%2520the%2520interaction%2520of%2520phenyl%2520and%2520imidazole%2520rings%2520in%2520N-arylimidazoles.%2520IV.%2520Derivatives%2520of%2520N-phenylimidazole%2520with%2520substituents%2520on%2520the%2520benzene%2520ring%26jtitle%3DKhim.%2520Geterotsikl.%2520Soedin.%26date%3D1970%26volume%3D6%26spage%3D209%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rubas, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jezyk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, G. M.</span><span> </span><span class="NLM_article-title">Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=113-118&author=W.+Rubasauthor=N.+Jezykauthor=G.+M.+Grass&title=Comparison+of+the+permeability+characteristics+of+a+human+colonic+epithelial+%28Caco-2%29+cell+line+to+colon+of+rabbit%2C+monkey%2C+and+dog+intestine+and+human+drug+absorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRubas%26aufirst%3DW.%26aulast%3DJezyk%26aufirst%3DN.%26aulast%3DGrass%26aufirst%3DG.%2BM.%26atitle%3DComparison%2520of%2520the%2520permeability%2520characteristics%2520of%2520a%2520human%2520colonic%2520epithelial%2520%2528Caco-2%2529%2520cell%2520line%2520to%2520colon%2520of%2520rabbit%252C%2520monkey%252C%2520and%2520dog%2520intestine%2520and%2520human%2520drug%2520absorption%26jtitle%3DPharm.%2520Res.%26date%3D1993%26volume%3D10%26spage%3D113%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Makhey, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinko, P. J.</span><span> </span><span class="NLM_article-title">Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1160</span><span class="NLM_x">–</span> <span class="NLM_lpage">1167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=1160-1167&author=V.+D.+Makheyauthor=A.+Guoauthor=D.+A.+Norrisauthor=P.+Huauthor=J.+Yanauthor=P.+J.+Sinko&title=Characterization+of+the+regional+intestinal+kinetics+of+drug+efflux+in+rat+and+human+intestine+and+in+Caco-2+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMakhey%26aufirst%3DV.%2BD.%26aulast%3DGuo%26aufirst%3DA.%26aulast%3DNorris%26aufirst%3DD.%2BA.%26aulast%3DHu%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DSinko%26aufirst%3DP.%2BJ.%26atitle%3DCharacterization%2520of%2520the%2520regional%2520intestinal%2520kinetics%2520of%2520drug%2520efflux%2520in%2520rat%2520and%2520human%2520intestine%2520and%2520in%2520Caco-2%2520cells%26jtitle%3DPharm.%2520Res.%26date%3D1998%26volume%3D15%26spage%3D1160%26epage%3D1167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ida, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pantel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerfass, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forstl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandbrink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyreuther, K.</span><span> </span><span class="NLM_article-title">Analysis of heterogeneous Aβ42 peptide in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">22908</span><span class="NLM_x">–</span> <span class="NLM_lpage">22914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22908-22914&author=N.+Idaauthor=T.+Hartmannauthor=J.+Pantelauthor=J.+Schroderauthor=R.+Zerfassauthor=H.+Forstlauthor=R.+Sandbrinkauthor=C.+L.+Mastersauthor=K.+Beyreuther&title=Analysis+of+heterogeneous+A%CE%B242+peptide+in+human+cerebrospinal+fluid+and+blood+by+a+newly+developed+sensitive+Western+blot+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIda%26aufirst%3DN.%26aulast%3DHartmann%26aufirst%3DT.%26aulast%3DPantel%26aufirst%3DJ.%26aulast%3DSchroder%26aufirst%3DJ.%26aulast%3DZerfass%26aufirst%3DR.%26aulast%3DForstl%26aufirst%3DH.%26aulast%3DSandbrink%26aufirst%3DR.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DBeyreuther%26aufirst%3DK.%26atitle%3DAnalysis%2520of%2520heterogeneous%2520A%25CE%25B242%2520peptide%2520in%2520human%2520cerebrospinal%2520fluid%2520and%2520blood%2520by%2520a%2520newly%2520developed%2520sensitive%2520Western%2520blot%2520assay%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D22908%26epage%3D22914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asberom, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasikumar, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span> </span><span class="NLM_article-title">Identification of presenilin 1-selective γ-secretase inhibitors with reconstituted γ-secretase complexes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4973</span><span class="NLM_x">–</span> <span class="NLM_lpage">4980</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi200026m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=4973-4980&author=J.+Leeauthor=L.+Songauthor=G.+Terracinaauthor=T.+Baraauthor=H.+Josienauthor=T.+Asberomauthor=T.+K.+Sasikumarauthor=D.+A.+Burnettauthor=J.+Claderauthor=E.+M.+Parkerauthor=L.+Zhang&title=Identification+of+presenilin+1-selective+%CE%B3-secretase+inhibitors+with+reconstituted+%CE%B3-secretase+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fbi200026m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi200026m%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DL.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DAsberom%26aufirst%3DT.%26aulast%3DSasikumar%26aufirst%3DT.%2BK.%26aulast%3DBurnett%26aufirst%3DD.%2BA.%26aulast%3DClader%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520presenilin%25201-selective%2520%25CE%25B3-secretase%2520inhibitors%2520with%2520reconstituted%2520%25CE%25B3-secretase%2520complexes%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D4973%26epage%3D4980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wong, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulet, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josien, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinzon-Ortiz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span> </span><span class="NLM_article-title">Chronic treatment with the γ-secretase inhibitor LY-411,575 inhibits β-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">12876</span><span class="NLM_x">–</span> <span class="NLM_lpage">12882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=12876-12882&author=G.+T.+Wongauthor=D.+Manfraauthor=F.+M.+Pouletauthor=Q.+Zhangauthor=H.+Josienauthor=T.+Baraauthor=L.+Engstromauthor=M.+Pinzon-Ortizauthor=J.+S.+Fineauthor=H.-J.+J.+Leeauthor=L.+Zhangauthor=G.+A.+Higginsauthor=E.+M.+Parker&title=Chronic+treatment+with+the+%CE%B3-secretase+inhibitor+LY-411%2C575+inhibits+%CE%B2-amyloid+peptide+production+and+alters+lymphopoiesis+and+intestinal+cell+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DG.%2BT.%26aulast%3DManfra%26aufirst%3DD.%26aulast%3DPoulet%26aufirst%3DF.%2BM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJosien%26aufirst%3DH.%26aulast%3DBara%26aufirst%3DT.%26aulast%3DEngstrom%26aufirst%3DL.%26aulast%3DPinzon-Ortiz%26aufirst%3DM.%26aulast%3DFine%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DH.-J.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26atitle%3DChronic%2520treatment%2520with%2520the%2520%25CE%25B3-secretase%2520inhibitor%2520LY-411%252C575%2520inhibits%2520%25CE%25B2-amyloid%2520peptide%2520production%2520and%2520alters%2520lymphopoiesis%2520and%2520intestinal%2520cell%2520differentiation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D12876%26epage%3D12882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201407j&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-1%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm201407j%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201407j" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799534fc81cd1df","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
